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Abstract
Proteins regulate almost every biological process in living organisms through diverse func-
tional properties. This is achieved by precisely controlled molecular interactions, that act
together in a complicated regulatory network. To understand all these complex mechanisms
is one of the goals of biology. For this purpose, proteins and their interactions with other
molecules have been studied intensively by a variety of techniques in vitro as well as in vivo.
However, information about protein function is still largely missing. While high-throughput
screens have been established to identify a large number of protein interaction partners,
sensitive techniques are necessary to characterize their molecular and biophysical properties
in more detail. Consequently, the quantity and quality of data vary immensely and results
are often non-conforming amongst different methodological approaches. Comprehensive
characterization of protein interactions thus requires the development of new technologies
capable of both, mapping and quantitatively measuring interactions.
This thesis describes the development of alternative approaches to study protein inter-
actions. For this purpose, first two methods to synthesize proteins on a microarray were
investigated: Arrays of yeast cells expressing recombinant fusion proteins and expression-
ready DNA templates, respectively, were coupled to a microfluidic device with several hundred
individually programmable reaction chambers and transformed into protein arrays in situ.
These protein-on-demand microarrays were assessed thoroughly for protein expression
levels, reproducibility and integrity.
Undoubtedly, using genetically engineered cell libraries represented the fastest approach
to produce on-chip protein arrays at minimal cost. On the other hand, cell-free protein
expression from linear DNA templates showed higher robustness and reproducibility, a
preferable criterion for detecting protein interactions under controlled conditions. For this
reason, a simple and inexpensive method was developed to generate expression-ready
DNA templates directly from cell libraries based on a single-step PCR (polymerase chain
reaction). The process was optimized to minimize hands-on time and omit labor as well as
resource consuming liquid transfer and purification procedures, a major drawback in many
other large-scale protein interaction studies.
Taking cell-free protein expression to a high-throughput level, a DNA template library was con-
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structed to generate a protein array, containing many of the known Drosophila melanogaster
transcription factors (TFs). This on-chip TF-array was successfully screened for protein-DNA
interactions, technically enabled through an integrated microfluidic platform with a sensitive
detection mechanism, which assured highly quantitative data. Detected interactions were
characterized in detail using the same platform, which allowed binding affinity and specificity
measurements as well as the discovery of new binding motifs. In conclusion, this thesis
presents different approaches to generate large-scale protein microarrays, which can be
used to identify and characterize protein interactions in high-throughput.
Keywords: protein (micro-)array; protein interactions; TF-DNA interaction; microfluidics;
MITOMI; high-throughput; cell-free protein synthesis; cell array; binding affinity; Kd
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Zusammenfassung
Proteine regulieren nahezu jeden Ablauf in lebenden Organismen durch verschiedene
Funktionen. Dies wird was über unzählige präzise abgestimmte und vernetzte molekulare
Interaktionen erreicht. Ein Ziel der Biologie ist daher, diese komplizierten Mechanismen zu
verstehen. Daher wurden Proteine und ihr Zusammenspiel mit anderen Molekülen mittels
unterschiedlichster Methoden intensiv erforscht, sowohl in vitro als auch in vivo. Trotzdem
sind bis heute nur wenige Funktionen von Proteinen ausreichend aufgeklärt. Zum einen
wurden zwar Verfahren entwickelt, um eine große Anzahl von Molekülen zu identifizieren,
die an Proteine binden, aber für die Charakterisierung der molekularen und biophysikali-
schen Eigenschaften dieser Bindung im Detail bedarf es andere, hochsensible Techniken.
Folglich variieren auch Datenquantität und -qualität enorm und Ergebnisse von methodisch
unterschiedlichen Studien stimmen oft nicht überein. Eine umfassende und schlüssige Cha-
rakterisierung von Proteininteraktionen erfordert daher die Entwicklung neuer Technologien,
die sowohl eine Vielzahl von Wechselwirkung identifizieren als auch quantitativ messen
können.
Diese Doktorarbeit befasst sich mit der Entwicklung von alternativen Methoden zur Er-
forschung von diesen Proteininteraktionen. Dafür wurden zuerst zwei Methoden erforscht,
mit denen man Proteine auf einem Microarray synthetisieren kann: Hefezellen, die ein re-
kombinantes Protein exprimieren, bzw. DNA-Moleküle mit der Information für ein Protein,
wurden in einen Mikrofluidik-chip mit mehreren hundert individuell ansteuerbaren Reaktions-
kammern integriert und anschließend auf dem Chip (in situ) zu Proteinen synthetisiert. Diese
sogenannten Protein-nach-Bedarf Microarrays wurden eingehend auf ihre Expressionsraten,
Reproduzierbarkeit sowie den Proteinzustand getestet.
Zweifellos ist die Herstellung eines Proteinarrays direkt von genetisch manipulierten Zellen
die schnellste und günstigere Variante. Auf der anderen Seite zeigten erste Versuche mit den
aus DNA synthetisierten Proteinarrays eine höhere Reproduzierbarkeit und Stabilität, was für
die Detektion von Protein Interaktionen unter kontrollierten Bedingungen unerlässlich ist. Aus
diesem Grund, wurde weiterhin eine einfache und preiswerte Methode entwickelt, um diese
DNA-Moleküle direkt aus Zellen mittels einer einstufigen PCR (Polymerase-Kettenreaktion) zu
gewinnen. Die Optimierung der Methode war auf minimale manuelle Arbeit und Kosten ausge-
richtet, die oft durch Produkttransfer und Aufreinigungsprozesse in anderen großangelegten
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Studien dieser Art anfallen.
Um diese Methode auch für einen hohen Durchsatz zu etablieren, wurde ein Proteinar-
ray hergestellt mit einer Vielzahl der identifizierten Transkriptionsfaktoren (TF) von Drosophila
melanogaster. Mittels eines Mikrofluidik-Chips mit einem empfindlichen Detektionsmechanis-
mus wurden auf dem TF-Array Interaktionen mit DNA-Molekülen detektiert. Die erfassten
Interaktionen wurden anschließend mit dem selben Chip detailliert charakterisiert, Stärke
sowie Spezifizität der Bindung gemessen und spezifische Bindungssequenzen identifiziert.
Im Laufe dieser Doktorarbeit wurden verschiedene Methoden zur Herstellung von Pro-
teinarrays erforscht, die nun dazu dienen können, Proteininteraktionen im großen Maßstab
zu identifizieren und quantitativ zu charakterisieren.
Schlüsselwörter: Proteinarray; Proteininteraktionen; TF-DNA Interaktionen; Mikrofluidik;
MITOMI; high-throughput screening (HTS); zellfreie Genexpression; Zell-Microarray; Disso-
ziationskonstante; Kd
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Résumé
Les protéines régulent pratiquement tous les processus biologiques des organismes vivants
à travers diverses propriétés fonctionnelles. Ceci est rendu possible par le contrôle précis
des interactions moléculaires qui forment des réseaux de régulation complexes. Comprendre
ces mécanismes est un objectif important en biologie. Pour l’atteindre, les protéines et leurs
interactions moléculaires ont été étudiées intensément par différentes techniques in vitro
et in vivo. Cependant, la fonction de ces protéines n’est principalement pas connue à ce
jour. Des criblages à haut débit ont permis d’identifier un grand nombre d’interactions. Mais
des techniques plus précises sont nécessaires pour caractériser avec plus de détails leurs
propriétés moléculaires et biophysiques. En conséquence, la quantité et la qualité des don-
nées varient immensément et les résultats ne coïncident pas entre différentes méthodologies.
Pour obtenir une meilleure caractérisation des interactions protéinaires, il est donc important
de développer de nouvelles technologies, capable de les quantifier et de les cartographier.
Cette thèse décrit le développement d’approches alternatives pour l’étude de ces interactions,
basées sur la synthèse de protéines sur micro-puce. Deux méthodes ont été investiguées :
des matrices de cellules de levures exprimant des protéines de fusion recombinantes et
l’expression de séquence d’ADN in vitro. Ces méthodes sont couplées à des dispositifs
microfluidiques, comprenant des centaines de chambres de réaction programmables et
permettant la génération de matrices de protéines in situ. L’expression des protéines, la
répétabilité et l’intégrité des micro-puces ont été déterminées de manière approfondie.
L’utilisation de librairie de cellules génétiquement modifiées fut l’application la plus rapide
et la moins chère pour produire des micro-puces de protéines. Par contre, la synthèse de
protéines à partir de séquences d’ADN démontra une plus grande fiabilité et reproductibilité.
Ces critères sont préférables pour obtenir une bonne détection des interactions protéinaires,
dans des conditions contrôlées. Pour ces raisons, une méthode simple et bon marchée a été
développée pour générer des séquences d’ADN prêtes à l’expression, à partir de librairies de
cellules et basée sur une PCR (réaction de polymérase en chaîne) à une étape. Ce procédé
a été optimisé afin de minimiser l’intervention manuelle de l’expérimentaliste et de limiter la
consommation de réactifs et les procédures de purification, qui représentent un désavantage
majeur dans les études d’interactions de protéines à large échelle.
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Résumé
Une librairie de séquence d’ADN, comprenant les facteurs de transcription (TFs) connus
de Drosophila melanogaster, a permis de générer des matrices de protéines, en utilisant la
synthèse de protéines in vitro. Combinée à une plate-forme microfluidique et un système
de détection précis, cette micro-puce de TFs a été criblée avec succès, pour identifier les
interactions protéine-ADN. Les interactions détectées ont été caractérisées en détail avec la
même plate-forme, précisant leur affinité et leur spécificité, et permettant la découverte de
nouveau motif de liaison. En conclusion, cette thèse démontre différentes approches pour
générer des micro-puces de protéines à large échelle, pour l’identification et la caractérisation
systématique des interactions de protéines.
mots clés : micro-puces de protéines ; protein interactions ; interactions protéine-ADN ;
microfluidique ; MITOMI ; criblage à haut débit (high-throughput screening, HTS) ; synthèse
des protéines in vitro ; matrice cellulaire ; constante de dissociation ; Kd
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1 Motivation and Objectives
1.1 Motivation
Molecular interactions occur in biological processes of all living organisms involving numer-
ous molecules at the same time. Many of these interactions take place in the cell nucleus,
where they regulate gene expression and have been subject to a variety of investigations to
reveal the mechanisms that govern them. As a result we are now able to illustrate complex
processes like protein biosynthesis or embryo development.
Key components in these cellular interactions are transcription factors (TFs), a family of
proteins that activates or represses genes by binding to specific DNA sequences in response
to diverse stimuli. Dysfunction, overrepresentation or alterations in the activity and regula-
tory specificity of human TFs are responsible for numerous diseases, such as cancer [1]
and developmental disorders [2], but are also likely to give rise to phenotypic diversity and
evolutionary adaptation [3, 4]. Investigating the mechanisms that govern TF binding and
regulation is therefore crucial to understand their role in gene expression. However, despite
great interest in research on transcriptional regulation, surprisingly little is known about TFs
and their target binding sites, which may be attributed to the complexity associated with
studying them: TFs are extremely promiscuous and regulate a variety of genes, including the
genes for their own expression. They achieve this alone or together with other proteins in a
complex, contributing to an immensely dense network of interactions.
We only begin to uncover the complexity of these interaction networks and systems bi-
ology has emerged as an inter-disciplinary field that aims to study the interactions within
biological systems from a more holistic perspective. One of its goals is to systematically
map all protein interactions in an organism. A considerably more challenging task than cata-
loguing the identity and abundance of proteins, which was comprehensively done for a vast
majority of proteins in model systems such as Saccharomyces cerevisiae, Escherichia coli or
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Drosophila melanogaster. Characterization of protein interactions requires the development
of new technologies and the integration of existing techniques, capable of answering complex
questions.
Protein and DNA microarrays provide such a multiplexed approach to study molecular
interactions in a miniaturized format. Depositing proteins as microarrays and interrogating
them with functional assays has been the gold standard to test for binding activity and speci-
ficity of proteins in large-scale. This way, the entire yeast proteome was successfully arrayed
[5], its protein activity analyzed [6] and binding behavior quantitated [7]. More recently, a
similar laborious large-scale effort allowed profiling the human protein-DNA interactome [8].
However, classical protein arrays are extremely labor intensive to produce, have not been
integrated with advanced detection mechanisms and the stability of the arrayed proteins
is questionable. These difficulties could be largely avoided when using DNA microarrays.
Cell-free E. coli in vitro transcription/translation (ITT) systems enable the in situ synthesis
of a protein array from DNA [9]. Generating high-density arrays has been challenging due
to diffusional limitations and thus not been applied to map protein interactions. Moreover,
traditional arraying techniques missed the detection of interactions with low affinities or very
fast off-rates due to loss of specifically bound material during washing.
These limitations have been overcome with the development of a high-throughput microfluidic
device based on the principle of mechanically induced trapping of molecular interactions
(MITOMI). MITOMI devices allow sensitive measurements of binding energies of transient
and low affinity interactions by physical separation and trapping of samples on a glass slide
through micromechanical valves. The versatility of this microfluidic approach has been
demonstrated in studying a broad range of protein interactions, including those with DNA
and RNA, other proteins and small molecules [10, 11, 12, 13].
1.2 Objectives and Overview
Given the potential of MITOMI and the shortcomings of current protein arrays, coupling
MITOMI to a new generation of protein arrays would offer a sensitive method to map and
characterize protein interaction. Therefore the overall goal of this PhD thesis was the imple-
mentation of new experimental approaches to generate a platform to comprehensively study
protein interactions in large-scale using a highly integrated microfluidic device. The approach
should be fast, inexpensive and reliable for the characterization of protein interactions on a
proteomic scale. Particularly, this platform will need to overcome the limitations of current
methods applied for interaction studies, which are reviewed in chapter 2. It should be able to
sensitively map abundant and transient interactions in relatively high throughput, while also
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determining binding specificity and affinity.
Chapter 3 of this thesis elaborates on the applications and capacity of existing MITOMI
platforms and proposes new scale-up designs to increase the throughput of investigations in
a single experiment.
The feasibility of generating a protein array from yeast cells as a first approach to pro-
duce an alternative to classical protein arrays is investigated in chapter 4. A major focus in
this chapter was to develop a protocol for robust array generation and pull-down of on-chip
extracted protein using two different types of recombinant yeast fusion libraries.
Chapter 5 describes the generation of a protein array from expression-ready DNA tem-
plates obtained from yeast libraries. It includes a new PCR-based method for the fast and
low-tech production of expression-ready DNA templates directly from yeast cells.
In chapter 6, a high-throughput microfluidic method for integrated systems-level interaction
mapping (iSLIM) of TF-DNA interactions is presented, which is based on in situ synthesis
of full length proteins from linear expression templates coding for Drosophila melanogaster
TFs. A comprehensive approach was developed to demonstrate mapping and characterizing
gene regulatory networks with highly accurate, quantitative data. Using a highly integrated
microfluidic platform for this approach yielded comparable if not higher detection rates for
protein interactions at reduced labor time and cost than other current methods.
Chapter 7 summarizes this work, outlines current limitations and future applications of
this microfluidic platform in the field of molecular and cell biology in particular, and gives an
outlook for microfluidics in biology related research in general.
3

2 Introduction
Most biological processes are mediated through the functional properties of protein entities.
Key to those properties is often the ability to recognize and bind interaction partners with high
selectivity and specificity. Once bound they can accomplish their function, such as catalyzing
reactions as enzymes, identifying foreign objects such as bacteria and viruses, mediating
signal transduction, activating or repressing DNA transcription or regulating the translation
of mRNA into protein. In the nucleus a variety of proteins regulate the crucial process of
transcription, including RNA polymerases, histones, chromatin remodeling proteins, general
transcription factors, several co-factors, and sequence-specific transcription factors (TFs).
Protein interactions are essential for every cellular process and as such have been the focus
of many in vitro and in vivo studies using purified proteins from various sources. Genetic
engineering is the state-of-the-art technology to obtain proteins with a tag that facilitates pu-
rification. This requires the knowledge of the proteins genetic sequence, which will translate
into the protein of interest.
While full-genome sequencing identified a large number of open reading frames (ORFs),
information about gene function is still largely missing. Screens for protein function using
random complementary DNA (cDNA) libraries and analysis of the biochemical activities of
the encoded protein have been traditionally used to shed light on the underlying networks.
However, these approaches require tedious protein purifications, a procedure that is difficult
to implement on a proteome-wide level. The next section describes common methods for the
discovery of protein interactions in high-throughput, including two-hybrid screens (section
2.1.1), classical protein microarrays (section 2.1.2.1) as well as more recent technologies of
microarray studies (sections 2.1.2.2 and 2.1.2.3).
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2.1 Methods to study protein interactions
2.1.1 Two hybrid screens
Large-scale yeast two-hybrid (Y2H) screens are frequently used to study protein function
in high-throughput by testing for physical interactions between proteins or protein and DNA,
respectively. Uetz et al. [14] constructed a library of over 6000 Saccharomyces cerevisiae
transformants, each expressing a different full-length ORF as a fusion to an activation domain
(AD), which they mated with 192 yeast DBD hybrids to screen for protein-protein interactions.
They complemented this protein array of activation-domain hybrids with a second approach,
in which they generated a similar library of all yeast ORFs, this time fused to the Gal4 binding
domain. Each DBD hybrid transformant was then mated to the entire ORF-AD library (5,341
clones) and screened for protein interactions. Despite their unprecedented high-throughput
they managed to detect only a fraction of the yeast ORFs in protein-protein interactions, which
overlapped only marginally with those detected in another large-scale high-throughput Y2H
study by Ito et al. [15]. Considering the high false positive/negative rate, dramatic variability
and low reproducibility of Y2H systems, the interpretation of the gained results is difficult
without further confirmation by other lower throughput assays of higher confidence [16]. A
comparative study demonstrated that using a complementary set of multiple Y2H variants
generates interaction data of similar quality as five different methods to study protein-protein
interactions [17]. Nevertheless, reliably detecting interactions to determine protein function
remains challenging and tedious.
The obvious demand for robust platforms to study gene expression and proteins in high-
throughput fashion advanced technological developments in other fields and vice versa.
Microarrays, generated by spotting biomolecules on a solid surface at high spatial density,
offer these features and allow the investigation of thousands of targets in parallel.
2.1.2 Microarrays
There are two main types of microarrays: DNA and protein microarrays. DNA microarrays
were first applied to screen for gene expression profiles [18] before they were used to observe
protein interactions, transcriptional regulation or to understand various disease states [19, 20].
However, we cannot easily predict protein expression levels from gene expression, let alone
draw conclusion about protein function. To this end, protein microarrays found their way
into quantitative proteomics through the development of quantitative antibody microarrays
[21] and functional protein microarrays [5, 22], respectively. Protein detection is based on
immunoassay strategies, but while immunoassays immobilize capture antibodies to the solid
support to detect proteins, protein microarrays directly array the proteins.
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2.1.2.1 Classical protein microarray
Quantitative protein microarrays, similar to DNA microarrays, measure protein expression
levels exploiting the sandwich principle of ELISA: molecules from the sample are captured
on the surface with an antibody (or other capture agent) and detected with a second fluo-
rescently labeled antibody which recognizes a different part of the antigen [23]. Quantitative
and analytical protein microarrays find applications in biomarker identification (reviewed in
[24]), clinical diagnostics [25, 26], or environmental and food safety analysis. Alternatively,
in reverse-phase protein microarrays cellular lysate is spotted directly onto the glass slide
without the need of a capture antibody and then assayed with a fluorescently labeled antibody
[27].
Functional protein microarrays on the other hand probe the activity of a protein against
many targets simultaneously. With the development of methods to clone ORFs as fusion pro-
teins into an inducible expression vector it was feasible to express and purify large numbers of
proteins, which can then be spotted onto chemically derivatized glass slides using a commer-
cially available contact printing robot. The challenges for that type of array include spotting
purified proteins without forfeiting their activity. Functional protein microarrays have been
applied to many aspects of discovery-based biology, including protein-protein, protein-lipid,
protein-DNA, protein-drug, and protein-peptide interactions as well as examining enzyme
activity or substrate specificity.
Among the first who demonstrated the broad applicability of protein microarrays in high-
throughput functional assays were the groups of MacBeath and Snyder in 2000. MacBeath
et al. [5] screened for protein-protein interactions and identified the substrates of protein
kinases and protein targets of small molecules by printing proteins with a contact-printing
robot on chemically modified glass slides and immersing the sample spots with the respective
solutions. Zhu et al. took a different approach: a silicon elastomer microwell chip placed
onto a microscope slide was used to analyze the biochemical activity of nearly all protein
kinases from Saccharomyces cerevisiae [22]. Following the printing approach of MacBeath,
Snyder and coworkers then printed 5,800 unique yeast proteins and probed these “proteome
chips" with labeled liposomes to detect phospholipid-binding proteins [6]. In an advanced
study, a phosphorylation map was generated from the results of a proteome chip, which
was used to detect the activity and specificity of yeast protein kinases in more than 4000
phosphorylation events [28]. Measuring the binding affinity of protein domains for peptides
using protein microarrays uncovered a first quantitative protein interaction network [7, 29].
This mapping approach was extended to the human protein-DNA interactome through the
systematic characterization of 4,191 purified human proteins with 460 DNA motifs on a
protein array, which identified 17,781 protein-DNA interactions [8].
Although the previous examples demonstrate the potential of protein microarrays for high-
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throughput studies, their overall success and feasibility is limited due to challenges in array
production and the nature of the detected interactions. Generating protein microarrays is
more difficult than DNA microarrays for three reasons:
1. Unlike DNA, which can be amplified by PCR, proteins have to be individually expressed
in a suitable cellular host, followed by bench-top purification.
2. The arraying process may alter protein function, conformation, folding, and access to
binding sites.
3. Many proteins are unstable or have a very short lifetime when not in their native
environments [30].
2.1.2.2 Proteins binding microarray (PBM)
One large-scale, high-throughput approach to acquire information is protein-binding microar-
rays (PBMs), on which double-stranded (ds)DNA oligonucleotides with different sequences
are immobilized to glass slides, incubated with TFs or DNA binding domains (DBDs) to
saturate the DNA with protein. Subsequently, unbound material is removed in stringent
washing steps, bound proteins are detected with fluorescence-labeled antibodies and the
binding specificity of the TF is quantified computationally. Developed by Bulyk and coworkers
over a decade ago [31], PBMs have greatly increased the throughput for studying protein
function by characterizing their binding to DNA, which is addressed below in section 2.2.1.5
relating to TF-DNA interactions.
2.1.2.3 Cell-free protein microarrays
Technical issues associated with conventional protein array production have been partly
overcome by in situ protein microarrays [32, 33, 34]. Cell free expression systems syn-
thesize proteins from expression-ready DNA templates (plasmid or linear DNA) using cell
extracts (lysate), which contain all essential components for transcription and translation.
Common lysate sources include Escherichia coli, wheat germ and rabbit reticulocyte, which
are all commercially available as in vitro transcription / translation (ITT) systems. Due to
their different attributes the system should be chosen considering the protein yield required,
protein origin and complexity, downstream processing needs, and cost. Proteins expressed
in situ typically contain an N- or C-terminal affinity tag for immobilization to a treated glass
slide. Constructs of expression-ready DNA can also serve a dual purpose as template for
protein synthesis and capture reagent: Chatterjee et al. designed an ’on-demand’ protein
array, where Tus-fusion proteins (Tus...terminus utilization substance) were expressed from
plasmid and then bind with high affinity to a 20 bp DNA sequence encoded on the same
plasmid [35].
Although, cell-free expression systems facilitate high-throughput studies with proteins, espe-
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cially those that are hard to express and purify, high-density arrays still face considerable
challenges concerning the integrity of the expressed proteins as well as limitations due to
sample diffusion. A drawback of all the previously discussed protein arrays is that many
protein interactions tend to show low affinities and/or very fast off-rates and cannot be de-
tected by traditional protein microarray techniques, which involve several washing steps. This
problem was recently solved by implementing a novel detection method called mechanically
induced trapping of molecular interaction (MITOMI) on a microfluidic device [36], which is
explained in more detail in chapter 3.
2.2 TF-DNA Interactions
TFs are proteins that bind to specific DNA sequences via one or more DNA-binding domains
(DBDs). They regulate the transcription of genes from DNA to mRNA by either promoting
(as an activator) or blocking (as a repressor) the recruitment of RNA polymerase to specific
genes. A mechanistic understanding of these transcription processes requires detailed
knowledge of binding affinities of all its entities, including their co-operative interactions.
Surprisingly, very little is known of the regulators themselves, let alone their co-operative
interactions in a moderate spatial-temporal resolution. Even the presumably trivial question
of how many TFs the genome of any given larger organism contains cannot be answered
with confidence. Today, the initial estimate of 2,000 to 3,000 sequence-specific DNA-binding
human TFs has been corrected to 1,300 - 1, 900 TFs, and yet only a third have been anno-
tated in the largest public databases for TFs, Jasper and UniProbe [37]. This discrepancy
arises mainly from the limitations that accompany most of the numerous methods, both
experimental and computational, which exist to study protein interactions in general including
TF-DNA interactions. Existing experimental methods to analyze TF-DNA interactions vary
widely in throughput, sensitivity and relative information content per measurement and are
summarized for in vitro (Table 2.1) and in vivo studies (Table 2.2). After a brief description of
early methods in the field, more recently developed assays are discussed.
2.2.1 Experimental methods for the analysis of TF-DNA interactions
2.2.1.1 Traditional methods
DNA footprinting was amongst the first methods, which helped to elucidate the binding
specificities of proteins to a DNA region of interest. DNA is labeled either with radioactive
reagents or fluorophores, incubated with the protein of interest and then subjected to cleav-
age agents that can degrade DNA, such as DNase I [38] or hydroxyl radicals [39]. Bound
DNA regions are protected from cleavage and the resulting DNA fragments generate a typical
ladder pattern (“footprint") when separated by gel electrophoresis. The scope of footprinting
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applications has been expanded to identify DNA-binding proteins in crude extracts [40]
and to determine binding affinities containing multiple binding sites, which are involved in
cooperative interactions [41].
Another early method to characterize TF binding sites (TFBS) was electrophoretic mo-
bility shift assay (EMSA) [42, 43], which is based on the fact that the mobility of DNA in
a gel is slowed when proteins are bound to it and therefore results in a band shift of the
product on the gel. Smith and Humphries [44] advanced the conventional protocol with the
multiplexed competitor electrophoretic mobility shift assay (MC-EMSA), which uses a series
of unlabeled DNA consensus competitors, in combination with a standard electrophoretic
mobility shift assay procedure, to identify uncertain DNA-binding proteins. Stenger et al.
[45] developed a method to identify RNA binding proteins from a dried EMSA gel by mass
spectrometry following autoradiography, which increased the sensitivity and accuracy of
identified RNA-protein complexes.
Despite its popularity, EMSA is considered a qualitative method and other more quantitative
methods have been developed to characterize the binding specificity of TFs to DNA in a less
laborious manner.
Most traditional methods for DNA-TF binding specificity analysis aim to find target se-
quences for one TF at a time, often require purified proteins and are generally low-throughput,
which made comparison between different experiments difficult.
To overcome these limitations, several methods have been developed with increased through-
put and resolution through the incorporation of microarrays and multiplexing; notably in vitro
selection techniques (section 2.1.3.2), methods based on chromatin immunoprecipitation
(ChIP) (section 2.1.3.3), one-hybrid techniques (section 2.1.3.4) and protein microarrays
(section 2.1.3.5).
2.2.1.2 In vitro selection
One of the first methods to discover and accurately determine TFBS was in vitro selection
or in vitro evolution, a technique developed independently several times in the early 1990s.
It is most commonly referred to as SELEX (systematic evolution of ligands by exponential
enrichment) [46], but also known as CASTing (cyclic amplification and selection of targets)
[47] or SAAB (selected and amplified binding sites) [48]. In SELEX purified TFs are allowed
to bind to a pool of random DNA oligos, then bound DNA fragments are amplified by PCR,
re-incubated with the TF for several cycles until left with the consensus sequence, to which
the TF binds with the highest affinity. This selective amplification leads to an overrepresen-
tation of high-affinity binding sites and may exclude other relevant TFBS. One approach to
overcome this limitation and to increase throughput, was to couple SELEX to massive parallel
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sequencing (SELEX-seq). HT-SELEX requires only one selection round to sufficiently deter-
mine consensus sites of enriched DNA fragments and allows a multiplexed analysis approach
by indexing samples with different tag-sequences or DNA barcodes [49, 50]. Moreover, using
cell extracts Jolma et al. circumvented the laborious step of protein purification and limitations
related to it. They validated their technology on 19 TFs expressed in mammalian cells from
14 structural classes, showing that it can be used to characterize DNA-binding preferences
of proteins that are often excluded from analysis, like proteins that need post-translational
modifications or that express poorly [49]. In a similar approach Slattery et al. demonstrated
the effect of a cofactor on the DNA-binding specificities of all 8 homeobox TFs in Drosophila,
which all bind to highly related sequences in vitro, despite their different functions [51].
Arguably, HT-SELEX represents the method with the highest throughput and the ability
to identify much longer high-quality binding profiles (up to 25 bp) than current microarray-
based methods at a better cost-efficiency.
2.2.1.3 Methods based on chromatin immunoprecipitation (ChIP)
The biochemical binding specificity of a TF can also be estimated with in vivo methods,
such as chromatin immunoprecipitation (ChIP) coupled to microarray analysis (ChIP-chip)
[52, 53, 54, 55] or high-throughput sequencing (ChIP-seq) [56, 57]. For ChIP experiments
the TF is cross-linked to the DNA in situ by formaldehyde fixation and sheared into 100-500 bp
fragments. TF-DNA complexes are then precipitated from solution with an antibody specific
to the bound TF, before reversing the cross-linking to purify the DNA for either hybridization
to DNA microarrays or deep sequencing.
Although ChIP is an extremely important validation tool for in vitro methods as it detects
full-length TFs in their native environment and locates TFBSs within the genome, it is not
a reliable method to measure TF affinities and its accuracy is limited to around 100 bp due
to the relatively low resolution of the technique. Another drawback is the requirement of an
antibody against the protein of interest, a limitation that was overcome by expressing the
protein as a fusion protein with bacterial DNA adenine methyltransferase (DamID), which
catalyzes methylation of a specific DNA sequence (GATC) upon TF binding [58]. Detection
of methylated DNA can be attributed to TF binding nearby since the process of adenosine
methylation does not naturally occur in eukaryotes.
DNA immunoprecipitation (DIP) [59] is another ChIP-based approach, which borrows ele-
ments from in vitro selection (SELEX). However, instead of synthetic random DNA oligos it
uses purified chromosomal DNA fragments. While genomic DNA is useful for the detection
of very long and highly specific TFBSs, which are generally underrepresented in synthetic
libraries, DIP is very sensible to analyze shorter TFBSs, which are more evenly covered by
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random DNA libraries. Similar to ChIP-Seq the potential to discover new TFBS is limited due
to its low resolution.
To increase TFBS resolution of ChIP-seq, a method called ChIP-exo was developed to
improve ChIP-seq: an exonuclease removes flanking and contaminating DNA from the
crosslinked site and bound locations are detected as peak pairs by deep sequencing [60].
Rhee and Pugh applied the method to precisely locate 6,045 transcription pre-initiation
complexes (PICs) in Saccharomyces [61] as well as to show genome-wide binding of 4 yeast
TFs and human transcriptional repressor CTCF (zinc-finger TF) [60]. ChiP-exo can potentially
identify novel, low-occupancy binding sites at single nucleotide resolution.
Recently, Re-ChIP was described as a sequential immunoprecipitation assay for the identi-
fication of multiple proteins on a single DNA sequence, which can determine higher order
protein-protein interactions involving chromatin. Re-ChIP is used to analyze multiple, simulta-
neous, posttranslational modifications to histones to determine the combinatorial pattern of
modifications associated with transcriptional status of a gene [62].
2.2.1.4 One-hybrid technologies
One-hybrid systems arose as a variation of the two-hybrid systems. While two-hybrid sys-
tems can assess both protein-protein interactions and protein-DNA interactions, one-hybrid
systems were developed to specially focus on the latter.
In yeast one-hybrid (Y1H) systems a prey protein is fused to the transcriptional activation
domain (AD) and direct interaction with the DNA binding domain (DBD) is detected as reporter
gene expression [63]. Often a cDNA expression library of DBD sequences is generated and
inserted in the promoter region of the reporter gene. Usually, the library is constructed in
an E. coli-yeast shuttle vector, which produces hybrid proteins consisting of a library protein
(prey) and the AD from the yeast GAL4 transcription factor. An increased throughput was
achieved in Y2H and Y1H, by combining both systems with the Gateway Technology, where
multiple DNA bait sequences were cloned into compatible vectors based on recombination
instead of restriction enzymes [64, 65].
The introduction of E. coli based methods allowed use of larger libraries (more than 108)
due to higher transformation efficiency and faster growth rates. Similar to the yeast based
system, bacteria two-hybrid (B2H) requires two fusion proteins within the bacterial cell
whose interaction stimulates transcription of a reporter gene [66]. The bacteria one-hybrid
version (B1H) uses a randomized DNA prey library, which are cloned upstream of a positive
(HIS3) and negative (URA3) selection marker. The TF (bait) is expressed on a second
plasmid as a fusion to subunit of bacterial RNA polymerase. Upon TF binding to the target
region (prey), the RNA polymerase is recruited to the promoter and activates the transcription
of the downstream reporter genes. Negative selection allows the elimination/removal of
12
2.2. TF-DNA Interactions
sequences that drive marker expression in the absence of the TF fusion protein. Positively
selected clones can be analyzed and sequenced [67]. B1H systems show lower false positive
rates than their yeast-based counterparts, allow studies on proteins that would be toxic to
yeast and they offer a low-tech alternative to microarray-based technologies.
Several large-scale, gene-centered approaches have used B1H and Y1H systems to charac-
terize TF-DNA interactions in Drosophila melanogaster [68], C. elegans [69, 70], humans
[71], and even plants [72].
One- and two hybrid-systems have significant advantages over other methods that investigate
protein-DNA interactions, notably that they do not require specific antibodies and purification
of proteins and proteins can bind DNA as monomers and in complexes. However, multiple
drawbacks outweigh these advantages and generally, the results are of lower quality and
resolution than those acquired with other methods [73].
Coupling Y1H [70, 74] and B1H [75] systems, to high throughput sequencing platforms
clearly reduced turn around times and their results indicate that they are useful to uncover
previously unknown interactions with putative biological importance. Nonetheless, they also
show that other complementary techniques are required for validation and qualitative results.
2.2.1.5 Microarray-related methods
Protein binding microarrays (PBMs) have greatly increased the throughput for assessing the
in vitro binding specificities of TFs to double-stranded DNA microarrays. Taking advantage of
existing DNA array technology (here Affymetrix) used for gene expression profiling, Bulyk et
al. converted a single-stranded into a double-stranded oligonucleotide array [31]. The dsDNA
array is incubated with purified epitope-tagged TF DBDs. After stringent washing processes
specific binding events are quantified using fluorophore-labeled antibodies. The protein-DNA
specificity is determined by assessing the fluorescence intensity of significantly bound DNA
spots resulting in binding profiles. In the first-genome-scale PBM study, three yeast TFs were
examined for binding to a whole-genome yeast intergenic PCR amplicon microarray, which
resulted in the identification of many new binding site motifs [76]. Microarrays constructed
with longer DNAs from PCR amplification of genomic regions allows covering a much larger
sequence space in fewer spots and representing TF-binding sites with their native genomic
flanking sequences.
Based on the mathematical concept of the De Bruijn sequence, Bulyk and coworkers [77]
designed a maximally compact PBM, which represented all possible DNA sequence variants
of a given length k (all k-mers, here k=10), covering all permutations of a 10-mer sequence.
Given that there are 410 possible 10 bp binding sites, this would give rise to 1,048,576 probes.
However, computational segmenting this De Bruijn sequence into 26 distinct, overlapping
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10-mer subsequences allowed them to print a ∼44,000 single-stranded feature array, which
contains more than a million probes of 10 bp. The design also represents sequence variants
longer than k as well as gapped k-mers. Therefore, TFs with TFBS longer and shorter than
10 bp can be detected, while TFBS shorter than 10 bp provide an internal control as they are
represented several times on the array. In several high-throughput studies, the potential of
PBMs was demonstrated by determining the binding specificities for TFs of different structural
classes from yeast, worm, mouse and human [77, 78, 79, 80, 81].
Another DNA array approach designed duplex DNA sequences as self-complementary
palindromes that form dsDNA hairpins to profile DNA-binding molecules for their relative
binding preferences [82]. Coupling this Cognate Site Identifier (CSI) microarray platform to
DNase I footprinting gave rise to their binding affinities [83].
Recently, a conceptually simple high-throughput sequencing procedure was implemented
on a converted Illumina Genome sequencing instrument to directly measure affinity land-
scape between ∼100 million DNA clusters on a PBM and TFs in a microfluidic flow cell
[84]. HiTS-FLIP (high-throughput sequencing - fluorescent ligand interaction profiling) allows
the simultaneous measurement of hetero- and homodimer forms in the same experiment.
Given the throughput and depth of this technology (up to ∼440 million binding measurement
per experiment), HiTS-FLIP is expected to add substantially to the understanding of gene
regulation through the contribution of comprehensive DNA affinities.
PBMs and their variations are undoubtedly an important technological development as
they offer a rapid, inexpensive, unbiased high-throughput in vitro approach to determine
binding specificities of TFs without prior knowledge of the conditions in which a TF binds
its genomics sites. However, PBMs as well as traditional protein arrays all have an intrinsic
problem: They fail to detect interactions with low affinities and/or very fast dissociation rates
due to their stringent washing procedure at the end.
2.2.1.6 Surface-plasmon resonance (SPR)
Surface plasmon resonance is an optical technique to study the interaction between an
immobilized molecule and an analyte in solution, which can be measured as a change in the
reflection angle of light hitting a surface submerged in the solution upon an increase of the
surface thickness, such as after analyte binding. For DNA-protein interaction studies, either
the DNA-molecule is attached, for instance by means of biotinylation, or the protein is immo-
bilized using tags, such as poly-histidine (His) or glutathione-S-transferase (GST). Since the
first SPR immunoassay in 1983 [85] the technique has gained much popularity in biomolecu-
lar studies in basic research as well as drug screening because of its advantages over other
affinity-based assays: Unlike many other immunoassays SPR is a label-free, real-time assay,
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which can measure binding affinities and kinetics simultaneously. With regard to quantita-
tive measurements, this procedure has been the gold standard for protein interaction analysis.
SPR has been adapted as an affinity detection technique in proteomics and genomics
studies, such as for biomarker profiling, aptamer and antibody selections and has been used
as the gold standard to quantitatively measure biomolecular interactions. However, the ex-
perimental throughput is relatively low and the setup not yet compatible with high-throughput
microarray technology. Bulyk and coworkers developed a hybrid SPR-PBM to determine
the influence of cofactors and complex formation on DNA binding specificity by measuring
the absolute binding affinities of a TF versus a TF complex to thousands of individual DNA
binding sequences [81].
2.2.1.7 MITOMI
To date, the only quantitative high-throughput method, which can identify TFBS and measure
their specificity as well as their absolute affinity, is a microfluidic platform, which detects novel
interactions based on the principle of mechanically induced trapping of molecular interactions
(MITOMI) [36]. Detailed information on fabrication and recent applications can be found in
chapter 3.
2.2.2 Gene-centered and TF-centered approach
The physical TF-DNA interaction can be studied by two conceptually different approaches
(Figure 2.1): TF-centered (protein-to-DNA) and gene-centered (DNA-to-protein). While
TF-centered methods aim to identify genomic DNA fragments to which a certain TF or set of
TFs binds to, gene-centered methods look at one or more regulatory DNA sequences to find
TFs that interact with these fragments.
Numerous TF-centered approaches exist for measuring TF binding in vivo and in vitro.
ChIP-based methods have become popular for mapping all genomic binding locations of
a transcription factor in vivo and gather epigenetic information [87]. Amongst the in vitro
approaches, protein binding microarrays (PBMs) [80, 78], HT-SELEX [88, 49], HiTS-FLIP
[84], and MITOMI [36] have been used in different studies to determine a TF’s consensus
motif, binding specificities, and affinities.
Gene-centered approaches attempt to derive a comprehensive list of TFs, which can bind
to a given DNA element. The dominant method for large-scale gene-centered mapping of
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TF-centered gene-centered
ChIP-based, PBM, HT-SELEX,
MITOMI
Y1H, (protein microarrays)
MITOMI
Figure 2.1: TF-DNA interactions can be studied with two approaches: In TF-centered approaches the TF of
interest is presented to a wide range of DNA fragments to identify the genetic sequence(s) it binds to. TF-centered
in vitro approaches such as protein binding microarrays (PBMs), in vitro selection techniques (HT-SELEX) and
MITOMI are capable of determining the consensus motif, binding specificity and affinity of a TF by quantitative
measurements, while in vivo techniques are usually limited to map binding locations. Gene-centered mapping of
gene regulatory networks (GRN) is predominantly qualitative by identifying the binding preference of various TFs
to a given (set of) DNA fragment(s). Currently, only yeast one-hybrid (Y1H) assays are used for this gene-centered
approach, but could be equally well feasible on a MITOMI device. Adapted from [86]. ©2009 Oxford University
Press
GRNs is based on one-hybrid techniques [89]. Although capable of testing a large number
of TFs against a specific DNA element, Y1H approaches have several technical limitations
including: (i) a high false positive/negative rate, (ii) intracellular interactions allow no control
over the reaction conditions, and (iii) mapping of DNA elements requires ∼2 weeks, leading
to low turn-around times [74]. Due to some of these reasons Y1H assays have recently been
combined with MITOMI for downstream hit validation.
Another approach to gene-centered mapping of GRNs [90] is the use of classical pro-
tein arrays, as recently shown by Hu et al. who expressed, purified, arrayed, and interrogated
4,191 human proteins [8]. But classical protein arrays remain extremely labor intensive to
produce and have not been integrated with advanced detection mechanisms. The develop-
ment of nucleic acid programmable protein arrays (NAPPA) solved some of the problems
associated with generating protein arrays but have not been applied to GRN mapping [9].
Gene-centered and TF-centered approaches are regarded as being highly complemen-
tary. However, MITOMI is the only method that could be applied to both approaches on the
same platform: TF-DNA interactions are qualitatively mapped by interrogating a protein-array
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with specific DNA elements in a gene-centered approach. Protein binding affinity and speci-
ficity are then measured using an oligonucleotide array to quantitatively characterize the
identified interactions in a TF-centered fashion.
MITOMI is currently the only method which can study gene regulatory networks (GRNs) in
two conceptually different ways, from a gene-centered and a TF-centered approach, which
will be elaborated in chapter 6.
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Table 2.1: Commonly used in vitro techniques for analysis of DNA-protein interactions
 1 
 
Assay 
(synonym) 
Method of 
interaction 
detection 
Advantages Limitations 
Through
-put 
(max. 
sites) 
Resolution Ref. 
EMSA 
(Electro-
phoretic 
mobility shift 
assay) 
Band shift in 
gel upon 
binding of 
protein 
- technically simple assay  
- semi-quantitative analysis  
- multiplexed competition of large 
  sets of consensus sequences  
  allows for identification of TFs 
- low throughput 
- no immediate information on  
  involved proteins or TFBS 
- weak or unstable reaction are 
  often not detected  
~10  Few 
binding 
sites 
[43] 
[91]!
[44] 
 
DNA 
footprinting 
Localization 
of binding 
site on gel 
after cleaving 
of DNA 
around 
binding site 
- simple technical setup 
- binding affinity measurements  
  by quantitative footprinting 
- detection of methylation sites  
  with in vivo footprinting  
- low throughput 
- incomplete binding often  
  results in unclear footprint 
- labor-intensive, time-  
  consuming 
~10  Single-
base  
[92] 
[93] 
[40] 
[41] 
 
HT-SELEX 
(High 
throughput 
systematic 
evolution of 
ligands by 
exponential 
enrichment)  
Selection of 
target 
sequences 
(often 
coupled to 
next 
generation 
sequencing) 
- very high throughput 
- simultaneous analysis of  
  multiple TFs  
- TFBS up to 35 bp (longer sites) 
 
- sensitivity: selects for strongest 
  binding (high affinity TFBS)  
- only relative Kd 
- PCR and sequencing can  
  introduce bias to some  
  sequences and artefacts 
- usually requires in vitro  
  synthesis or purification of  
  recombinant proteins 
> 2 x 105 Nucleotide 
resolution 
[46] 
[50] 
[49] 
[51] 
 
SPR  
(Surface 
plasmon 
resonance) 
Optical mea-
surement of 
reflection 
angle 
change upon 
binding 
- absolute affinity measurements 
  (absolute Kd, kon, koff) 
- real-time recording of  
  association and dissociation  
  constants 
- label-free  
- low throughput 
- special immobilization required 
- requires special equipment  
 
~100 Few 
binding 
sites only 
[94] 
[81] 
Microarrays 
 
      
PBM 
(Protein-
binding 
microarray) 
 
Intensity 
readout of 
proteins 
bound to ds 
DNA micro-
array 
- very high throughput 
- determination of relative  
  binding affinities (relative Kd) 
- microarray equipment available 
  at relatively low cost 
- no determination of absolute 
  affinities  
- stringent washing procedure  
  (removes weakly bound  
   proteins usually purification of 
   proteins)  
~1 
million 
Nucleotide
resolution 
[76] 
[80] 
[81] 
[77] 
CSI  
(Cognate Site 
Identifier) 
Intensity 
readout of 
proteins 
bound to ds 
DNA hairpin 
microarray 
- simultaneous measurements of 
  affinity and specificity land- 
  scapes 
- microarray equipment available 
  at relatively low cost 
- stringent washing procedure  
- usually requires in vitro  
  synthesis or purification of  
  recombinant proteins 
~1 
million 
Nucleotide 
resolution 
[82] 
[83] 
[95] 
HiTS-FLIP 
(High-
throughput 
sequencing – 
fluorescent 
ligand 
interaction 
profiling) 
Intensity 
readout of 
proteins 
bound to 
double-
stranded 
DNA micro-
array 
- very high throughput 
- microarray equipment available 
  at relatively low cost 
- direct measurement of affinity 
  landscapes 
- simultaneous measurement of  
  hetero- and homodimer forms 
- possibility to multiplex 
- stringent washing procedure  
- usually requires in vitro  
  synthesis or purification of  
  recombinant proteins  
~100 
million  
Nucleotide
resolution 
[84] 
MITOMI   
(Mechanically 
induced 
trapping of 
molecular 
interactions) 
Mechanical 
trapping on 
microfluidic 
device 
- detection of low and high- 
  affinity binding sites 
- determination of relative and  
  absolute binding affinities (abs. 
  Kd, kon, koff) 
- PWM/motif discovery 
- gene-centered and TF-centered 
  approach 
- requires integration with  
  microfluidic setup (special  
  equipment) 
- currently only medium  
  throughput 
 
~4000 Nucleotide
-resolution  
[36] 
[10] 
[13] 
[96] 
[11] 
[97] 
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Table 2.2: Commonly used in vivo techniques for analysis of DNA-protein interactions
 2 
 
Assay 
(synonym) 
Method of 
interaction 
detection 
Advantages Limitations 
Through
-put 
(max. 
sites) 
Resolution Ref. 
Y1H & B1H 
(Yeast one-
hybrid & 
bacterial one-
hybrid system) 
Cloning into 
& expression 
of TF in host  
- high throughput 
- detection of binding sites 
- semi-quantitative analysis 
  process  
- can be automated 
- no protein purification required 
- high false positive/negative rate 
- intracellular interactions allow 
  no control over reaction  
  conditions  
- long turn-around times (mating 
  and incubation times) 
All 
genomic 
sites 
- [67] 
[68] 
[65] 
[70]!
ChiP-based 
(Chromatin 
immuno-
precipitation) 
 
      
ChIP-chip 
(ChIP coupled 
to microarray) 
Pulldown of 
cross-linked 
DNA-protein 
complexes 
on a micro-
array  
- allows detection of post-trans- 
  lational modifications 
- high throughput 
- no protein purification required 
- dependent on antibody  
  availability and specificity  
- low resolution of binding sites 
- could detect non-specifically  
  bound DNA due to abundance 
  of available DNA sequences 
All 
genomic 
sites 
100–500 
bp 
[52] 
[53] 
[54] 
[55] 
ChIP-seq 
(ChIP coupled 
to high-
throughput 
sequencing) 
Pulldown of 
cross-linked 
DNA-protein 
complexes 
followed by 
sequencing 
- allows detection of post-trans- 
  lational modifications  
- high throughput  
- no protein purification required 
 
- dependent on antibody  
  availability and specificity  
- low resolution of binding sites 
- could detect non-specifically  
  bound DNA due to abundance 
  of available DNA sequences 
All 
genomic 
sites 
100–500 
bp 
[56] 
[57] 
 
DIP-chip 
(DNA immune-
precipitation)  
Microarray 
analysis of 
enriched 
DNA frag-
ments 
- uses purified chromosomal  
  DNA instead of synthetic oligos 
- resolution limited by sheared  
  fragment size  
- DNA purification steps 
- bias towards high-affinity sites 
All 
genomic 
sites 
100–500 
bp 
[59] 
 
DamID 
(DNA adenine 
methyltransfera
se 
identification) 
TF mediated 
DNA 
methylation  
- no antibody required 
 
- resolution limited to distance  
  between 2 methylated binding 
  sites 
All 
genomic 
sites 
100–500 
bp 
[58] 
 
Reverse ChIP/ 
PICh 
(proteomics 
of isolated 
chromatin) 
mass spec 
identification 
of TF-DNA 
composition 
at genomic 
loci  
- identification of proteins bound  
  to regulatory sequence based  
  solely upon the identity of that 
  DNA sequence  
- low throughput 1 
genomic 
site  
- [98] 
 
Digital genomic 
footprinting / 
DNase-chip 
 
Identification 
of DNase I 
hypersen-
sitive sites 
using DNA 
tiling arrays 
- unbiased, genome-wide map- 
  ping of protein binding  
- resolution limited by sheared  
  fragment size & DNase I hyper- 
  sensitive sites (~250 bp) 
- exclusion of repetitive DNA 
- requires large cell numbers 
All 
genomic 
sites 
Nucleotide 
resolution 
possible 
[99] 
[100] 
[101] 
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2.2.3 Determining the binding specificity and affinity of TF-DNA interactions
Many of the new high-throughput methods discussed above rapidly deliver comprehensive
information on DNA-protein binding with detailed views of regulatory networks in cells. Identi-
fying the specific DNA sequences and proteins that bind to them elucidates only a fraction of
the underlying genomic regulation. Far more insightful are the dynamics, which govern this
spatial-temporal regulation of GRNs.
The basis for this understanding lies in the process of specific DNA recognition by a certain
amino acid motif in DNA binding proteins, predominantly TFs. The majority of TFs make
contacts to the bases exposed in the major groove of the negatively charged DNA via a
positively charged alpha-helical segment [102]. Some TFs are dimeric with two alpha-helices:
the short helix binds to DNA, while the longer helix mediates dimerization by folding and
packing against another helix, which in turn regulates the activity of the TF. However, the
specificity of a TF to a DNA sequence arises from its base-specific contact. The strength with
which a TF binds to the preferred binding sequence can be quantitated as relative affinity
and specificity.
2.2.3.1 Binding affinity
Binding of a TF to a particular DNA sequence (Si ) can be described as a two-state process,
which is regulated by an on-rate (kon) for the complex formation and an off-rate (koff) for its
dissociation.
TF +Si
kon,i−−−*)−−
koff,i
TF ·Si (2.1)
The binding affinity of the TF is then defined as the dissociation constant Kd , the concentration
of free TF [TF] for which half of the free DNA in solution [Si ] is bound in a TF-DNA complex
[TF ][Si ].
Kd ,i =
koff,i
kon,i
= [TF ][Si ]
[TF ·Si ]
; ∆G◦ =RT ln(Kd ,i ) (2.2)
Equation (2.2) represents the concentration of all entities at equilibrium, where ∆G◦ is the
Gibbs standard free energy, R the gas constant and T the temperature in Kelvin.
The binding affinity of individual sequences is usually experimentally determined by gen-
erating saturation binding curves from either TF or DNA concentration-dependent binding
measurements. The dissociation equilibrium constant is calculated by performing a nonlinear
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regression fit using a one-site binding model to the data plotted as the ratio of surface bound
target DNA (in RFU) to surface bound protein concentration (in RFU) as a function of total
target DNA concentration (RFU). The relative Kd (in RFU−1) is then transformed into absolute
Kd (in M−1) using a calibration curve, generated by measuring known concentrations of the
fluorescence-labeled DNA. Kd values for several hundred TF-DNA interactions can be easily
obtained from binding curves measured with a MITOMI device, as is shown in section 6.4.2.1.
In an environment of excess TF, the probability of the sequence Si being bound to a TF is:
P (bound)= [TF ·Si ]
[TF ·Si ]+ [Si ]
= 1
1+ 1Kd ,i [TF ]
(2.3)
However, determining the binding affinity of one TF to a single finely dosed DNA sequence
does not give a realistic picture of the circumstances in vivo, where each TF is submerged
in a pool of highly concentrated DNA sequences at any given time. For a TF to properly
regulate gene expression, it is therefore crucial to distinguish its specific regulatory site from
the pool of competing non-regulatory sites [73]. Determining the relative binding affinities
for all potential binding sites is referred to as specificity of a TF, which can be defined by the
sum of all Kd values:
Spec≡∑
Si
Kd (Si )∑
Kd (Si )
ln
(
Kd (Si )
〈Kd (Si )〉
)
(2.4)
2.2.3.2 Representation of binding motifs
With the advances in high-throughput technology described in previous sections (2.2.1.2,
2.2.1.4, 2.2.1.5 and 2.2.1.7) it became much easier to obtain the probability of binding and
binding affinities of all possible TFBSs. Nonetheless, having a model to describe and visualize
how a TF binds to DNA, facilitates their communication among researchers. Arguably, the
simplest approach to display the sequence to which a TF binds with highest affinity is called
consensus sequence. More quantitative information contains a position weight matrix
(PWM), where a score is assigned to each of the four possible nucleotide bases at every
position in the binding site. The sum of all position-specific scores for each base results in
the final PWM score, which is graphically represented as a sequence logo [103]. The early
basic model of additive PWMs assumes that each base contributes independently to binding.
While more complex models with higher-order contributions can undoubtedly determine more
accurately the binding site specificity, additive models provide very good approximations
in the discovery and prediction of TFBSs in genomic DNA [104]. A PWM is constructed
from each TF interacting with the PBM by applying a Seed-and-Wobble algorithm, which
21
Chapter 2. Introduction
first identifies the top-scoring 8-mer (with the greatest PBM enrichment or E-score) as a
seed and then systematically tests the relative preference of each nucleotide variant at each
position, both within and outside the seed [105]. Using PBMs and a modified algorithm
searching for additional secondary binding motifs to assess the binding specificity, Badis
et al. [80] revealed a complex binding landscape, which suggested that some TFs have a
more complicated DNA recognition mode and that most binding profiles can be much better
represented by multiple motifs than by a single motif. These assumptions were challenged
by a recent method, which derives PWMs from PBMs, termed BEEML-PBM (binding energy
estimation by maximum likelihood for PBMs) [106]. The conclusions still remain open but
the lively scientific discussion [107] on the topic of DNA binding specificity demonstrates that
is crucial to employ optimized analysis methods to maximize the information obtained from
PBMs.
2.2.3.3 Complementarity of in vitro and in vivo studies
The enormous amount of data produced with current high-throughput technologies in vitro as
well as in vivo, has considerably improved our understanding of TF-DNA binding specificity
on a systems level and allows us to predict gene regulation. Though in vitro methods have
fostered the discovery of protein interactions, identification of consensus sequences of TFBSs,
measurement of binding energy landscapes and quantification of biophysical properties, they
are difficult to translate directly into in vivo function. Many in vitro approaches cannot account
for secondary effects in vivo like masking of TFBSs by competing TFs or nucleosomes, the
widespread nonfunctional binding, or the presence of other proteins and post-translational
modifications, which mediate interactions [108]. Here, in vivo-based methods can help to
evaluate newly identified TFBSs in the relevant biological context, albeit, at the expense of
resolution and identifying the binding causalities. ChIP-based methods are able to indicate
the location to which a specific TF binds in different conditions in vivo, but the resolution
is generally not precise enough to determine the exact TFBS and the specificity of a TF.
Moreover, motif discovery algorithms often fail to reveal the accurate TF binding motif from
ChIP-data because of the confounding factors that occur in vivo. The binding preference
and mode of a TF depends very much on the context, like cell type, developmental stage,
environmental conditions, and other cooperating or competing binding partners. Inversely,
the occupancy of a binding site sheds light on the accessibility of the site and the binding
behavior of TFs. While some TFs predominantly bind DNA indirectly through protein partners,
others interact directly as well as indirectly. The complexity of parameters that determine
each individual binding event in the cell limits the throughput of in vivo measurements.
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Currently neither in vivo nor in vitro methods can characterize TF-DNA interactions sufficiently.
Despite the abundance of experimental methods, there is still a lack of reliable and coherent
data sets on TF-DNA interaction. This bottleneck is compounded by the expensive and
laborious analysis of TF-DNA experiments as well as a high rate of false predictions. Thus, in
order to gain a quantitative understanding of GRNs, a serial combination or hybrid approach
of in vitro and in vivo measurements combined with computational modeling appears to be
the best strategy.
In conclusion, there has been progress in elucidating the different aspects of protein activities
on a global scale with various studies by massive parallel screening of the proteome of
different organisms, which in concert with biocomputational and modeling efforts contribute
towards our current understanding of cellular networks. Nevertheless, the sheer complexity
and precision of regulation require ever more sophisticated techniques and ways to analyze
them. And certainly, advances in proteomics and other fields are intimately linked with the
development of new and improvement of existing technologies, which will help to answer
some questions but probably raise even more.
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3 Microfluidic devices in biology
Progress in molecular biology in the last two decades, particular the high-throughput measure-
ments in genomics and proteomics, moved our understanding of biology to a systems-level
and gave rise to the new field of Systems Biology around the year 2000. These advances in
scale would not have been possible without the development of innovative technologies from
interdisciplinary research at the cutting edge of science and engineering.
One of these emerging technologies is microfluidics, which started to grow from the fields of
analytical chemistry and microtechnology in the early 1990s with the development of microflu-
idic devices for capillary electrophoresis [109, 110, 111]. The term microfluidics refers to the
science and technology of systems that process or manipulate very small amounts of fluids,
exploiting special characteristics of fluids in flow channels at the micro- or even nanoscale.
Scaling down existing bench-top assays to a postage-sized footprint allows researchers in
biology, chemistry and other fields to perform multiple complex reactions simultaneously with
smaller volumes and therefore at lower costs.
3.1 Milestones in the development of microfluidics
Two developments in microfabrication techniques can be seen as milestones in the evolution
of integrated microfluidic systems: The first one was the introduction of soft lithography to
fabricate replicate structures from a master template using moldable elastomeric polymers,
such as polydimethylsiloxane (PDMS). The master templates are typically manufactured
using photolithography and etching steps, common techniques in the semi-conductor industry.
The second milestone was a simple method for the fabrication of pneumatically activated
components by multilayer soft lithography (MSL), developed in the Quake lab [112], which
generates devices with two or more stacked, micro-patterned layers. Key component for
fluid-handling functionality in these devices is a monolithic micromechanical valve, generated
by two actuated crossing channels, which are separated by a thin PDMS membrane between
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the two distinct layers and may be deflected up or down, depending on which channel is
pressurized.
Incorporating valves allowed for more complexity and the design modularity of PDMS devices
fabricated by MSL gave rise to microfluidic functional elements such as fluid input trees,
pumps [112], sieve valves [113], multiplexers [114], and freestanding membranes [36]. The
intention to integrate and automate all lab processes in chip-format, led to the development
of more complex next-generation microfluidic devices, which coined the term microfluidic
large-scale integration (MLSI). MLSI devices can integrate thousands of micromechanical
valves on a very small footprint, which allows for hundreds of assays to be run in parallel.
The application of microfluidic devices shows obvious advantages that can be attributed to a
smaller scale: (i) smaller volumes reduce sample/reagent consumption; (ii) shorter distances
decrease mass and heat transport time and thereby reduce reaction times; (iii) denser
packaging of microfluidic devices allow higher degrees of parallelization. As a consequence,
microfluidics provides novel processes and detection mechanisms that cannot be achieved
on larger length-scales.
Owing to its obvious benefits, the field of microfluidics has an ever-increasing impact on
all fields of biology. Today, microfluidic devices have been applied to almost all classical
biological methods, which can be seen on the growing list of applications:
• Protein crystallography [115]
• PCR [116, 117, 118] and RT-PCR [119]
• Single cell analysis [113, 120]
• ChIP [121, 122], ELISA [123]
• Two-dimensional electrophoresis [124]
• gene transfection [125] and cloning [126]
• separation and purification of DNA [127, 126], proteins [128], and other small particles
[129]
• SPR [130, 131]
• in vitro transcription/translation (ITT) for protein synthesis from DNA [10, 13]
• high-throughput screening of protein interactions [36, 13], drugs [11], enzymes [132],
antibodies [133] and cells [134, 135]
• cell trapping [136, 137], sorting [138, 139], and 3D-growth characterization [140]
• point-of-care diagnostic and clinical assays [141, 142, 140, 143]
Microfluidics has already been incorporated as an important tool in life science research,
especially systems biology, and is likely to become a standard practice in the near future as
highly integrated microfluidic screening platforms promise to overcome limitations in scaling
and high-throughput problems in the research world of “-omics".
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3.2 MITOMI
During the past decade ever more complex microfluidic devices have evolved and their
application advanced progress in almost all areas of life science. The development of a high-
throughput microfluidic platform with a novel mechanism to detection molecular interactions
in 2007 by Maerkl et al. introduced a completely new way studying molecular binding events
[36]. Microfluidic devices based on mechanically induced trapping of molecular interactions
(MITOMI) allow for direct measurement of binding affinities and specificities in relative high-
throughput. MITOMI can therefore also capture low affinity and transient interactions at
equilibrium, which are usually missed by most other methods that detect binding due to
stringent washing processes. Principally, in a MITOMI experiment, a protein is bound to
an antibody immobilized to a restricted region on the surface of a glass slide. Interactions
with the molecule(s) of interest, such as proteins, DNA or drugs, are trapped by collapsing
a deflectable membrane to trap interactions in equilibrium before washing off non-bound
material (see Figure 3.1).
Transcription 
Factor 
Penta-His
Antibody
Cy5-labeled
Target DNA
PDMS 
membrane
Epoxy 
glass slide Surface chemistry layers of
BSA-biotin / Neutravidin / BSA -biotin
Microfluidic 
channel
(10-14 µm)
1 Binding in equilibrium state 2 Mechanical Trapping 3 Washing unbound molecules
Figure 3.1: Schematic of the MITOMI principle. The gray structure at the top of each panel represents the
deflectable button membrane that can be brought into contact with the glass surface. (1) His-tagged TFs are
localized to immobilized penta-His antibody at the epoxy-coated glass slide. Specific binding between Cy5-labeled
target DNA and TFs are at steady state when (2) the button membrane is actuated and brought into contact with
the surface. Any molecules in solution are expelled while surface-bound material is mechanically trapped. (3)
Unbound material that was not physically protected is washed away, and the remaining molecules are quantified.
The MITOMI device harbors several hundred to thousands of dumbbell-shaped unit cells
(Figure 3.2 A), each individually programmed with samples and controlled by three valves
(Figure 3.2 B): the neck or chamber valve separates the sample chamber from the detection
area, the sandwich valves compartmentalize adjacent unit cells, and the button membrane is
a circular, freestanding membrane hovering over the detection area, which can be collapsed
to protect the area underneath (Figure 3.2 E).
In order to program each unit cell with a different sample, microarrays are spotted with small
pins within a microarrayer from a multiwell plate. Solutions and samples are introduced via
inputs, which are arranged in a tree-like fashion (Figure 3.2 C), each branch controlled by
a separate valve. Additional control of fluid control and flexibility in sample choice can be
achieved by adding a multiplexer to the inlet tree (Figure 3.2 D).
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Figure 3.2: Schematic of a MITOMI chip (A) Drawing of a MITOMI device with 768 unit cells in the flow layer
(purple) which are controlled (grey) by 2,388 valves. Resistance equalizers toward solution inlets and outlet
ensure equal flow velocities and derivatization in each row of the channels. (B) The magnified view shows two
individual unit cells, each controlled by three separate micromechanical valves: Each dumbbell-shaped unit cell
can host a different sample, contained by the neck valve. Sandwich valves compartmentalize individual unit
cells to prevent diffusional cross-contamination of samples during incubation periods. The freestanding button
membrane can be collapsed to protect the circular area underneath. (C) A cross-section of a unit cell is shown to
illustrate the detection mechanism based on mechanically induced trapping of molecular interactions (MITOMI).
The deflectable membrane is pushed down by actuating the water-filled control channel to trap bound molecules.
(D) Different sample solutions are loaded via the sample inlet. Loading of the device with samples via the inlets
(S2-S7) is controlled by opening and closing the corresponding control valves (1-8). (E) A multiplexer allows
individual addressing of each flow channel with additional valves acting on consecutive stages of the flow inlet
tree, which separate in two at each conjunction. The clockwise-rotated zoom of the multiplexer illustrates flow
through the first channel (dark purple), but not through all the other 15 channels (light purple) on the array after
closing a combination of control valves (indicated with a cross).
3.2.1 Applications of MITOMI
The potential of MITOMI has been exploited in a number of studies. In their seminal publica-
tion, Maerkl and Quake [36] used 17 MITOMI chips to map the binding energy landscapes
of four eukaryotic TFs from the basic helix-loop-helix (bHLH) family by measuring their
binding affinities to 464 different DNA variants, which allowed them to test binding specificity
hypothesis and predict in vivo function of these TFs. In a second publication, the Quake
group programmed the device with target RNA sequences instead of DNA and validated
the platform for measuring binding constants of interactions between membrane-bound
protein and RNA. They expressed the trans-membrane protein in vitro using a cell lysate
supplemented with microsomal membrane to resemble natural folding conditions. Having
determined the binding specificity and affinity of the trans-membrane protein, they screened
a compound library of potential target drugs for their effect on the protein and identified
inhibitors of protein interactions [11]. Gerber et al. [10] expanded the range of possible
interaction studies by characterizing all pair-wise interactions between 43 bacterial proteins,
applying an on-chip in vitro transcription-translation procedure to synthesize proteins in situ
from a spotted library of expression-ready DNA templates. The scope and sensitivity of
MITOMI studies were highlighted in a study on the evolvability of a TF family, where Maerkl
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and Quake [12] measured the detailed DNA-binding behavior of all 95 single-point mutations
in five DNA-binding sites of a human TF within this TF family. They were able to predict
92% of the naturally occurring diversity at these positions, but also pointed out that not all
functional mutations could be found in vivo, which led to their conclusion that mutations are
not solely selected based on their functionality. In an unpublished study, Maerkl demonstrated
the potential of the MITOMI device to generate live yeast cell arrays and yeast protein arrays,
respectively.
All the above studies demonstrate the variability and flexibility of MITOMI-based studies.
The principal can be applied to screen virtually any molecular interactions as long as the
molecules of interest can be solubilized. MITOMI has been recognized in the literature
as a reliable and robust method to determine the binding affinity and specificity of protein
to DNA [73] and is currently used to validate and complement other detection methods
[74, 144, 96, 145].
3.2.2 MITOMI versions
Since the inception of multilayer soft lithography by the Quake lab in 2000 [112] ever more
complex fluidic devices were fabricated by MLSI with more and more micromechanical valves
on a postage stamp footprint. The fast increase of valve density on microfluidic devices
has even outpaced Moore’s law, which in electronics describes the exponential growth of
transistor counts on integrated circuits with transistor counts doubling approximately every
two years. While conventional methods to produce integrated circuits in the semi-conductor
industry reaches its physical limits, soft lithography allows a sustainable, more rapid growth
with valve density doubling every 4 months (source: http://www.fluidigm.com).
The increasing demand for screens of large sample libraries in biology and chemistry
asks for more functionally complex microfluidic devices, integrating thousands of valves
while minimizing the number of external ports and incorporating strategies for parallelization,
metering and multistep processing.
The modularity of many high-throughput devices such as MITOMI allows for easy adjust-
ments of the total capacity of the array to host more unit cells by adding more ore less rows
/ columns to the design or varying the size and therefore the volume within each unit cell.
Prototype MITOMI designs hosted 16 flow rows with 40 chambers each, allowing the device
to be programmed with 640 different samples. A scale-up to 2,400 unit cells, controlled by
7,233 valves, was used for many of the published applications [36, 10, 11]. Obviously, a larger
version allows for a higher throughput of larger libraries but also for investigating replicates
on the same chip to control for variations in sample preparation and external conditions.
However, depending on the application and process feasibility in mind, the geometry has
to respect certain design rules, such as pitch size (between unit cells), channel routing as
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well as channel and valve geometry. Increasing the number of unit cells on a similarly small
footprint may impede functionality or ease of handling.
In 2010 Fordyce et al. published a paper featuring a second-generation MITOMI device
(MITOMI 2.0), which contained 4,160 unit cells and ∼12,555 valves. Several design changes
were implemented compared to the first scale-up to ensure function at this scale [13], such
as the homogenous flow across the chip and efficient bonding of the chip to the glass slide.
To address these aspects, they changed the geometry of the flow channels and increased
the pitch between individual unit cells, respectively. In addition, an alternative channel routing
and input tree provided more space for the printed array on the slide.
Very recently, Araci and Quake [146] launched the era of microfluidic very large scale integra-
tion (mVLSI) devices by integrating up to a million valves as small as 8 x 6 µm2 on a footprint
of 1 cm2 using a MSL design with three layers instead of two. Reducing the valve dimensions
by more than a magnitude allowed them to increase valve density by more than two orders
of magnitude compared to the current state of the art microfluidic MLSI devices. Arguably,
mVLSI devices would be favorable for single-cell assays of prokaryotic cells, as the channel
dimensions get closer to the size of these cells.
However, programming several thousand to over a million of unit cells/chambers with different
sample solutions might be another question to be addressed. Currently, programming high-
throughput microfluidic devices for large-scale screens is typically accomplished by depositing
samples on a glass slide either via contact printing using pins, inkjet printing [147, 148] or
droplet formation technologies (non-contact printing). Despite their experimental variability
spotted microarrays have been the most popular due to wide availability, high flexibility and
relatively low cost [149]. Using small pen-like devices or pins the sample solution is picked
up from a reservoir such as a microwell plate and transferred to a glass slide, where the
deposited liquid remains as a spot. Spot diameters can vary and depend on the diameter of
pin, its geometry (pointed or blunt end, solid pin tip or pin with cavity), the viscous properties
of the sample solution as well as the surface chemistry of the glass slide. However, the
resolution of pin-aided contact printing is limited and precision at the submicron to nano-scale
might be better achieved with technologies like the direct-write dip-pen-nanolithography
(DPN) [150], which allows feature sizes of less than 15 nm by molecular self-assembly.
3.2.3 Modular scale-up of MITOMI
In view of future experiments another scale-up of MITOMI is desirable to accommodate entire
fusion protein libraries for full-proteome scale interaction studies on a single device. Building
on previous efforts, a larger device was designed in 2009 with 7,200 unit cells covering an
array size of 54 mm x 18 mm (Figure 3.3 A). The scale-up therefore contained an order of
magnitude more unit cells than the most commonly used MITOMI chip (768 unit cells) in the
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Maerkl lab at only a 4.5 times larger footprint, which still allowed the use of arrays printed
on a regular 3 x 1 inch glass slide (76 x 26 mm). However, increased unit cell density came
at a price: difficulties associated with such small delicate features rendered chip fabrication
impractical (Figure 3.3 B). Moreover, high feature density called for smaller pitches (distance
between unit cells), which reduced the surface area available for bonding the chip to a glass
slide and hence may result in poor adhesion. Increasing the number of unit cells may also
result in decelerated response times in the control layer with longer fluid channels to be
filled and actuated. Longer channels will result in higher resistance at the same flow rate,
compromised mass transfer and longer surface modification times. The implementation of
additional fluid control components such as separated modules with individual fluid input trees
and multiplexer elements can avoid overly prolonged operation times for on-chip experiments
and allow more control. However, increasing the feature density to ∼740 unit cells/cm2 and
∼2,200 valves/cm2 requires some practice in aligning the features of the device and might
therefore be less suitable as a tool for common biology labs.
2 mmValve controlchannels
A
B DC
button
membrane
sandwich 
valve
neck
valve
sample
chamber
SampleInlets
Figure 3.3: (A) Drawing of a device with 7,200 unit cells. (B) Picture of three unit cells from the same device,
showing the challenges when aligning small control elements with detailed structures. Simpler feature geometries
(C), (D) will overcome the shortcoming of the previous large-scale design but still require a lot of practice to
manually align a microfluidic device of this capacity.
Revised versions of the scale-up favored simple feature geometry (Figure 3.3 C, D), a modular
design, and an inlet tree multiplexer, which allowed individual addressing of each of the
4 sub-arrays with 1,800 unit cells as well as each row within it. The 7,200 unit cells are
controlled by ∼21,720 valves on a footprint of 9.72 cm2 (54 mm x 18 mm array size), which
was to our knowledge the highest valve density (2,235 valves/cm2) on a functional microfluidic
chip at that time. Challenges with such a high feature density include programming the device
with samples and control of valves. The latter one can be addressed by implementing
31
Chapter 3. Microfluidic devices in biology
computationally controlled valves [151, 97].
However, reducing the size of the chamber volume also limits the initial seeding density of
samples, which might be critical for (live) cell arrays, where deposition of multiple layers
using pins with a small diameter is not an option due to time constraints. In addition,
decreasing the chamber size by 20% requires a precise technology for depositing sufficient
biological material. While well-established methods are available for generating microarrays
of homogenous solutions such as bacteria, DNA, proteins and other small molecules, spotting
larger cells may require some adjustments to the spotting procedure, which will be discussed
in section chapter 4. Additionally, higher flow channels and unit cells as well as a modified
sample chamber shape can help to accommodate larger volumes.
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4 Yeast cell arrays
4.1 Abstract
Protein arrays have been the gold standard to study the binding activity and specificity of
proteins with other molecules in large-scale functional assays. Depositing purified proteins
on glass slides was used to array the entire yeast proteome [5], analyze their activity in
interaction studies [6] and obtain quantitative networks [7]. However, large-scale mapping
of interactions using these classical protein arrays has two main drawbacks: the extremely
laborious protein purification process and a bias towards strong binding proteins due to a
lack of advanced detection mechanisms. This chapter describes an alternative approach
to generate a protein array on a microfluidic chip from an array of whole yeast cells, each
expressing a different protein, which are purified and detected in situ.
4.2 Introduction
The budding yeast Saccharomyces cerevisiae has been used by human kind since ancient
times, first in the processes of winemaking, brewing and baking; and with the beginning of
the biotechnology era as a cell factory for the production of fuel, chemicals, pharmaceuticals
and more. Today, Saccharomyces cerevisiae is one of the most intensively studied eukaryotic
model organisms in molecular and cell biology. Many genome-wide technologies were first
established in yeast before they were applied to other organisms. A number of regulatory
pathways are conserved between this yeast and humans, and thus yeast has served as a
model organism for detailed molecular studies. Direct parallels between the two organisms
allowed conclusive studies in lipid metabolism [152], prion development and neurodegen-
erative diseases such as Alzheimer’s [153, 154], mitochondrial metabolism [155] or aging
[156]. Within the emerging field of systems biology, Saccharomyces cerevisiae has been
successfully used for mapping complex regulatory networks and resolving the dynamics of
signal transduction pathways.
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The Saccharomyces Genome Database (SGD) lists 6,717 genes, of which 5,818 are known
or putative protein-coding ORFs and ∼75% thereof characterized. Several yeast fusion
libraries with different affinity tags and knockout strains have been constructed to facilitate
protein analyses on a proteome-wide scale for a growing research community. The ORF can
be either genomically integrated in its intrinsic chromosomal location or encoded separately
on a plasmid. In an enormous effort the labs of O’Shea and Weissman generated two
genomic collections by systematically inserting a tag and a selectable marker gene (His)
at the C-terminus of each ORF. They are tagged with green fluorescence protein (GFP) for
protein localization [157] and tandem affinity purification (TAP) [158], respectively. Both ORF
collections comprise ∼75% of the entire yeast proteome and are now commercially available.
Detected levels of fusion proteins in genomic libraries correspond to the physiological abun-
dance of that protein in the cell as protein expression is under the control of a native promoter.
In order to yield higher and constant protein quantities, a number of plasmid-based fu-
sion libraries were designed using high-copy number, inducible vectors with an integrated
selection marker that enables robust protein over-expression. Two commercially available
plasmid-based collections were considered for the generation of protein arrays from cells: the
glutathione-S-transferase (GST)-tagged ORF-fusion protein collection [6] and a moveable
ORF collection (MORF), where each ORF is fused to a versatile tandem fusion tag that allows
a range of detection and affinity purification strategies [159]. Both collections contain more
than 80% of all S. cerevisiae ORFs and protein expression is under control of a GAL-promoter,
inducible by adding galactose to the yeast cells. Most of the described yeast ORF collections
were interrogated in extremely labor-intense large-scale screens using laborious techniques
such as purifications for the production of protein microarrays [6, 159, 160] and Western
blot analysis [158, 159] or more technologically advanced approaches, such as imaging
[157, 160] and FACS-based sorting [161, 160]. Clearly, these large-scale screens had two
main shortcomings: array production and limitation of detection methods.
To overcome these limitations, we generated protein arrays directly from deposited yeast
cells. Coupling this cell array to a microfluidic device allowed cell lysis and protein extraction,
pull-down and sensitive detection based on the MITOMI principle. The in situ generated
protein arrays in can be used to perform protein interaction studies at high-throughput on a
very small footprint with minimal reagent consumption.
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4.3 Material and Methods
4.3.1 Yeast cell culture
Cells from the yeast GFP clone stock collection (Invitrogen, Switzerland), containing 200 µl
yeast peptone dextrose (YPD) medium (Sigma-Aldrich, Switzerland) supplemented with 15%
glycerol were inoculated into 96-well plates with 150 µl fresh YPD medium using a 96-floating
pin tool replicator (V&P Scientific). Plates were covered with Breathe-Easy sealing mem-
branes (Sigma-Aldrich, Switzerland) and cultured overnight at 30°C in an orbital incubator
shaker (Gyromax 737R, Amerex Instruments, Inc.) to an OD600 of around 0.8-1.2, before
centrifuging them at 2400 rpm for 3 minutes to obtain a compact cell pellet for spotting.
The full collection of GST-tagged yeast, created by the Andrews lab is now distributed
by Open Biosystems (now Thermo Scientific, Switzerland) in 76 microwell plates (96-well),
containing CM broth (chopped meat) with glucose minus uracil (SD-ura/0.5% glucose) with
15% glycerol. Plates were replicated by inoculating cells into 150 µl fresh selective growth
medium (SD-ura/0.5% glucose) with a 96-pin replicator tool, covered with Breathe-Easy
sealing membranes and grown for 2 days in an orbital incubator shaker at 30°C and approxi-
mately 250 rpm. Plates were then either supplemented with 65 µl of a 50/50 glycerol/growth
medium mixture (total glycerol 15%) for maintenance at -80°C or re-inoculated into 100 µl
SC-ura/2% raffinose to grow cells in a glucose-free medium before induction. Confluent
overnight cultures were re-inoculated into fresh 100 µl SC-ura/2% raffinose and grown at
30°C (250 rpm) to an OD600 between 0.6 and max. 1.0. Cells were then induced by adding
50 µl 3x YP + 6% galactose (2% total galactose) induction medium (50 µl SC-ura/2% raffinose
was added to a negative control plate), grown for another 3-5 hours at 30°C while shaking
and centrifuged at 3,000 rpm for 10 min at 4°C before washing the pellets with 100 µl cold
water. Resuspended cells were spun again at 3,000 rpm for 10 min at 4°C and resuspended
in 100 µl YPD for spotting. Alternatively, blotted pellets of induced cells could be either directly
frozen at -80°C or resuspended in YPD medium containing 25% glycerol before storing them
at -80°C.
Cells from the MORF yeast collection (distributed by Open Biosystems, now Thermo Fisher,
Switzerland) were also maintained in 96-well flat bottom plates filled with SD-ura/0.5% glu-
cose containing 15% glycerol and grown overnight at 30°C in growth medium (SD-ura/0.5%
glucose) before re-inoculation into SC-ura/2% raffinose. Overnight cultures were diluted
1:25 into 100 µl fresh SC-ura/2%raffinose medium (start OD600 = 0.3) and grown to OD600
0.8-1.2 for induction with 50 µl induction medium (3x YP + 6% galactose, total 2% galactose),
while 50 µl SC-ura/2% raffinose was added to another plate, serving as negative control
(non-induced). Cells were induced for 6 hours at 30°C while shaking, then harvested and
washed like the GST cells for spotting or storage of induced cell plates.
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4.3.2 Microfluidic device fabrication an glass slides preparation
Microfluidic chip design and fabrication as well as coating of glass slides with epoxysilane
were performed as described in Appendix A [162].
4.3.3 Spotting of yeast cells and device alignment
The fabrication of a yeast cell arrays for in situ protein pulldown is illustrated in Figure 4.1.
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Figure 4.1: Workflow of fabricating a protein array from yeast cells: Grown yeast cells are spotted on glass slides,
aligned and bonded to a MITOMI microfluidic device and then lysed in situ for protein extraction. Pulled down
protein is detected using an antibody immobilized. Cells from the GFP collection can be printed directly from
the growth plate, while the GST yeast cells have to be re-inoculated to synchronize cell growth before inducing
protein expression with a galactose-containing medium. A secondary antibody is used to label GST protein
pulldown for detection.
Yeast cells were pelleted, resuspended in low-sugar medium or PBS, and then spotted
onto epoxy-coated microscope slides with 373 µm column and 746 µm row spacing using
a QArray2 microarrayer (Genetix) and metal pins of different geometries (ArrayIt). Spotted
yeast arrays were manually aligned to microfluidic PDMS devices containing 768 unit cells
using a Nikon SMz1500 stereoscope and bonded for at least 2 hours at 40°C.
4.3.4 On-chip experimental procedures for yeast cell arrays
The surface area was modified by depositing layers of BSA-biotin and NeutrAvidin/PBS
as described in Appendix A [162]. The glass slide surface modification was finished by
immobilizing biotinylated antibody in PBS (see Appendix D) to the area beneath the button
membrane, followed by washing with PBS.
In situ cell lysis was initiated by first introducing an enzymatic solution of 10 mg/ml Zymolyase
(amsbio, Switzerland), 1% BME (2-Mercaptoethanol), in 0.1 M Tris-HCl, which breaks down
the cell walls. Following a 30 min incubation period at room temperature, a detergent solution
containing Y-PER (Pierce, now Thermo Scientific, Switzerland), 1 µM PMSF (phenylmethyl-
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sulfonyl fluoride), 1 protease inhibitor cocktail tablet (Roche, Switzerland) was loaded into the
chamber and allowed to lyse the cell spheroblasts within 2 hours with the chambers closed.
A variation of this 2-step (cell wall degradation and lysis) lysis protocol was to combine the
two solutions and load them together into the cell chamber by dead-end filling, i.e. with
the outlet closed. The button membrane was kept closed during the loading of the lysis
solutions to prevent a) degradation of the antibody underneath the button membrane and b)
cross-contamination by cells that were flushed from the chamber. After complete cell lysis
at ∼4°C, extracted molecules were allowed to diffuse from the chamber to the immobilized
antibodies, while the sandwich valves were kept closed. After 30 min incubation at room
temperature the glass surface was blocked with a solution of PBS containing 1% milk and
1% BSA, opening the button membrane at the end, and followed by a PBS wash. The
button membrane was collapsed for imaging of the device on a modified ArrayWoRx (Applied
Precision) microarray scanner, when using the GFP collection. In experiments with the
GST and MORF library, protein pull-down was detected flowing a Penta-His Alexa Fluor 647
conjugate (see Appendix D) on chip. After a final PBS washing step, devices were scanned
with the button membrane closed. If not otherwise noted, chemicals and reagents were
purchased from Sigma-Aldrich, Switzerland.
4.3.5 Data acquisition and analysis
Slides were scanned on an ArrayWorx scanner after the final PBS washing step with 1.0 s with
the following wavelengths: 488 nm for GFP-tagged yeast proteins and 685 nm for antibody-
labeled GST-tagged proteins. A reference image was taken with 0.1 s at the reflective channel
and at 488 nm to detect cell spots in the chamber before cell lysis. For detection of surface
bound protein a microarray grid was aligned to each button membrane area. For correlation
of spotted cell density local backgrounds were subtracted for all channels by moving the
grid just next to the chamber, outside the channels. Unit cells with bad features or signal
intensities below the background signal were excluded from further analysis, which was done
with a code written in Mathematica (Wolfram Research). Graphs were plotted with Prism 5
(GraphPad Software).
4.3.6 Protein purification (off-chip)
For protein purification, cells were grown as described above for on-chip experiments in
either 96-deep well plates (1 ml/well) or in 10-ml microvials. Alternatively, individual strains
were streaked from the yeast glycerol stock onto agar plates containing SD-ura/0.5% glucose,
incubated at 30°C for until visible colonies (2 mm) had formed (∼24 h) and then parafilm
sealed kept at 4°C until they were inoculated into glucose free medium (SC-ura/2% raffinose).
Inoculated cultures were grown overnight at 30°C under agitation. Confluent overnight
cultures were re-inoculated into fresh SC-ura/2% raffinose, grown at 30°C (250 rpm) to an
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OD600 between 0.6 and max. and then induced by adding 3x YP + 6% galactose (2% total
galactose) induction medium (SC-ura/2% raffinose was added to a negative control plate).
Induction was quenched after 3-5 h (GST-tagged strains) and 6 h (MORF), respectively, by
washing the cell pellets (centrifugation: 4,000 rpm, 10 min, 4°C) with ice-cold water. Pellets
of induced and non-induced cells were kept at -80°C until lysis.
Proteins from GST and MORF yeast strains were purified under native and denaturing
conditions using Ni-NTA spin columns (Qiagen) for the purification of His-tagged proteins,
with adaptations to yeast cells. Buffers and reagents for protein purification can be found in
Appendix C.
4.3.6.1 Cell lysis and protein purification
Thawed cell pellets were resuspended in 1 ml lysis buffer, 0.5 ml transferred into a 2 ml
Eppendorf tube and spun at 3,000 rpm for 4 min at 4°C. The pellet was resuspend in 0.5
ml lysis buffer and 0.5 ml Y-PER and sonicated with added zirconium beads (diameter 0.5
mm, Sigma) 5 times for 40 seconds with 2 minutes intervals on ice in between sonication
rounds. Sonicated lysates were centrifuged at 4,000 rpm for 45 min at 4°C and 0.6 ml of clear
lysate (L) was loaded onto a Ni-NTA spin column (Qiagen), which had been pre-equilibrated
with 0.6 ml lysis buffer. The flow through (FT) after centrifugation (2000 rpm, 2 min, room
temperature (RT)) was collected for SDS-PAGE analysis. The Ni-NTA column was washed
twice with 0.6 ml wash buffer and centrifuged (2000 rpm, 2 min, RT). Both wash fractions
(W1, W2) were saved for SDS-PAGE analysis. The bound protein was eluted twice from
the Ni-NTA column by centrifugation (2000 rpm, 2 min, RT) with 0.2 ml elution buffer and
the eluate collected after each step (E1, E2). All samples collected during the purification
process (L, FT, W1, W2, E1, E2) were visualized by loading them on 13.5% acrylamide gels
and running a SDS-PAGE and stained with Coomassie Brilliant Blue 250.
4.3.6.2 Western blotting
SDS-PAGE gels were washed with deionized water and transferred to a PVDF membrane
using the standard settings (7 min at 20-25 V) of the iBlot Dry Blotting system (Invitrogen).
The membrane was washed twice with deionized water for 5 minutes, blocked with a blocking
buffer (TBST with 5% non-fat dry milk powder) overnight at 4°C, incubated with a 1:2,000
dilution of primary biotinylated antibody (see Appendix D) for 2 h on a shaker at room
temperature and washed four times with TBST for 10 minutes. The membrane was then
incubated in a 1:50,000 dilution of streptavidin-horseradish peroxidase conjugate in TBST
with 1% non-fat dry milk powder while shaking. The reaction was stopped with cold water
when bands were sufficiently visible. The membrane was washed thrice with cold water for 2
minutes and scanned.
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4.3.6.3 InVision His-Tag In-Gel Stain
The InVision His-tag In-gel Stain (Invitrogen, Switzerland) contains a fluorescent dye (Ex
560 nm / Em 590 nm) conjugated to Ni2+: nitrilotriacetic acid (NTA) complex, which binds
specifically to the oligohisitidine domain of His-tagged fusion proteins. All incubations were
performed at room temperature and on an orbital shaker set to low agitation, following a
modified version of the suppliers’ manual. After electrophoresis, the gel was fixed for 1-2
hours in a fixing solution (50% methanol, 40% ultrapure water, 10% acetic acid), washed
twice for 10 minutes each with ultrapure water to remove the fixative, stained with the ready-
to-use solution of InVision His-tag In-gel Stain for at least 1 hour, washed twice for 10 minutes
each with PBS and then visualized at a fluorescence scanner (Typhoon).
4.4 Results and Discussion
In a proof-of-principle experiment we programmed a MITOMI device with 192 randomly
chosen strains from the yeast GFP library and successfully detected more than 80% of 192
GFP fusion proteins with a signal intensity of at least 20 relative fluorescence units (RFU),
which represented the signal threshold for non-specific detection (2 s.d. above mean of
signal for cell-free chambers). However, we noted a considerable variation of the amounts of
cells printed on the glass slide across the chip and between different batches of spotting. The
inhomogeneous depositing of cell spots eventually contributed to an even larger variation of
detected protein signals between on-chip experiments from different spotting batches. There
are many interlinked factors that play into the final spotting outcome, mainly (1) the spotting
solution or suspension, (2) the settings for the spotting procedure and (3) the parameters of
the metal pin, which transfers the suspended cells from the source plate to the glass slide.
4.4.1 Spotting efficiency and reproducibility
Obviously, spotting yeast cells differs from spotting a molecular solution. Many factors, such
as cell density, pellet quality, viscosity and sugar content of the suspension medium have an
impact on the spotting result. Obtaining sufficient protein pull-down for interaction studies
requires a critical number of cells per spot. To pick up enough cells from the source, GFP
strains were initially spotted with a slit pin, which exploits the mechanisms of surface tension
and adhesion to transfer the sample from the source plate to the glass slide. Yeast cell
suspension are loaded into the pin channel (slit) by capillary forces and form a thin layer at
the end of the flat tip, which then contacts the glass slide surface to expel the suspension
(Figure 4.2 B).
Gently releasing small volumes of the loaded cell suspension with this ink stamping mecha-
nism allows printing multiple spots from one sample-loading step. However, multiple stamping
deposited varying number of cells in consecutive spots and usually only the first stamp pro-
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duced a spot of sufficient cell density. Washing the pin after each deposition step increases
the arraying time considerably. This is particularly an issue for large-scale spotting (the whole
yeast library consists of 48 plates) because cells in the plate as well as on the glass slide
start to dry out. On the other hand, re-inking into the cell suspension tended to clog the pin
channel, which led to inconsistent spotting patterns and the pin was subsequently difficult to
clean. Finally, using a solid pin with a larger blunt tip diameter produced spots of consistent
size and sufficient cell density, as shown in Figure 4.2 A.
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Figure 4.2: Spotting tests with yeast cells from the GFP collection with pins of different geometries. (A) Spot
reproducibility: Each pin was loaded once with yeast cell suspension (same strain) and spotted on a glass slide
ten times without re-loading. Fluorescence intensity of cell spots was detected with a scanner and is plotted as a
function of spot number. (B) Principle of depositing solutions with a metal pin.
To account for the differences in signal intensity due to varying cell-seeding numbers, we
sought to normalize the detected protein signal to the number of cells that gave rise to
it. However, while the fluorescence signal of the protein detected by an antibody, which
is immobilized on the glass surface, can be easily correlated to the protein concentration,
correlating the signal of deposited cells or counting cell numbers on the chip would assume
a monolayer of cells, yet the printing resulted in several stacked cell layers. Thus inferring
the total number of cells per chamber from the detected signal is not a reasonably sensible
correlation and can only serve as a rough indicator. A more sensitive normalization might
be to measure the signal of the GFP-fusion protein in solution after cell lysis. However, this
approach only works for yeast strains with an intrinsic label.
Besides the obvious advantage of an intrinsic fluorescence signal, the GFP yeast collection
has a major drawback: In response to a native promoter GFP yeast strains express protein at
physiological levels, which naturally vary. These signal variations render analysis of detected
protein from GFP fusion strains difficult and impractical to study protein interactions. Thus
quantitative analysis of protein pull-down requires normalization of the spotted cell numbers
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to the detected signal intensity after protein pull-down and correlation to measured in vitro
concentrations derived from Western blots of the TAP-tagged yeast fusion library [158]. The
correlation of a protein array, generated from 384 different GFP strains (4 plates), to the
protein concentrations derived from the TAP-library was only moderate (Figure 4.3 C). A
correlation of our protein signals to the GFP abundance measured by fluorescence activated
cell sorting (FACS) using the same GFP fusion strains [161] showed a considerably more
linear trend (Figure 4.3 D). The observed plateau for proteins of higher abundance could have
two reasons: First, the antibodies used to pull-down proteins were saturated with excessive
proteins in solution and second, the protein intensity was outside of the dynamic range of
the fluorescence scanner. Experimental effects, such as a low number of deposited cells
or incomplete cell lysis may contribute to the detection of weak GFP signals (outliers in the
lower left field) despite its physiological higher abundance. In any case, correlation would
benefit from a more sensitive normalization of on-chip protein intensity to the number of cells
giving rise to it.
Nevertheless, Figure 4.3 B demonstrates that the method is very well reproducible (average
goodness of the linear regression fit r2=0.94) if yeast cells were spotted under optimized
conditions. We detected most of the selected strains at levels that are considered reasonable
to study protein interactions (Figure 4.3 A).
Admittedly, low or no expression of certain proteins under the given conditions makes on-chip
experiments with deposited GFP fusion strains extremely difficult. Promising alternatives are
plasmid-based collections where the ORF is fused to a versatile tandem-tag (MORF library)
or GST- and His-tag (GST library). Over-expression of these libraries can be induced in the
presence of galactose, giving rise to higher protein yields. First test experiments showed
pull-down of proteins from a subset of both libraries, albeit slightly better results were obtained
from the GST collection, which was chosen for most of the following experiments. A critical
point was the relatively low robustness of the method, which could be traced back to the
induction procedure and spotting efficiency. On-chip protein pull-down results from yeast GST
cell arrays, generated under the same conditions, showed poor reproducibility. In addition,
some yeast strains expressed much more protein. Thus, before moving on to quantitative
interaction studies, the following parameters had to be optimized for reliable protein binding
data: (i) spotting efficiency, (ii) on-chip cell lysis, and (iii) labeling and detection strategies.
Last but not least, a more robust protocol for off-chip induction of protein over-expression
needed to be elaborated.
Even though inducible yeast ORF libraries overexpress the protein of interest, the seeding
cell number on the array influences largely the success of protein detection after pull-down of
the overexpressed and extracted protein. Just as with the GFP strains, the initial arraying of
induced strains of the GST and MORF collection showed heterogeneous spotting patterns
with a large strain-to-strain variability across experiments. Crucial parameters for efficient
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Figure 4.3: Detection of protein pull-down of 384 yeast GFP-fusion proteins extracted on-chip from yeast cells. (A)
Pull-down efficiency: The percentage of clones giving rise to a minimal RFU (relative fluorescence units) value
of 50, 100, and 500 is plotted. Signals detected in unit cells without spotted cells served as negative controls.
(B) Reproducibility of pull-down between two on-chip experiments. Dotted gray lines indicate the background
threshold (2 s.d. above the mean of the negative control). (C,D) RFU signals from on-chip protein expression
were compared to values of molecular abundance of the same protein, which was determined by (C) Western
blotting TAP-tagged fusion strains [158] and (D) FACS measurements of the GFP-tagged fusion strains [161],
respectively.
cell deposition, namely pin geometry, resuspension medium and the washing procedure of
the pin are addressed in the following section.
Spotting tests with different pin geometries revealed, that a solid pin, delivering one spot of
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cells at a time, produced the most homogeneous yeast cell array with a rather consistent cell
spot size and density (Figure 4.4 A, left). However, cell spots were very small, contained very
few cells and the throughput remained low even with altered spotting routines (multiple pins
and multiple prints on the same cell spot). Cells in the source wells started to dry up during
the long spotting routine, which proofed to be uneconomical for spotting larger batches of
arrays covering the entire library. More efficient cell transfer was observed for pins with a
cavity (Figure 4.4 A, center).
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Figure 4.4: Spotting tests with yeast cells from the GST collection with pins of different geometries. (A) Print
pattern after spotting different strains with pins of different geometry. Spot size differences after multi-stamping of
one GST without re-inking (B) and after printing 96 different strains on an array with a single stamp (C). (Scale
bar for all spotting images: 500 µm)
Although having a tip diameter (print area) comparable to their solid pin or slit-pin counter-
parts, they are capable of taking up more than double the volume in the bubble-shaped cavity
(0.6 µl vs. 0.25 µl in the slit) and delivering almost 30% more volume per spot (between
0.7 and 1.4 nl). However, with increasing uptake and delivery capacity of the pin, spots
became more irregular-shaped due to sudden releases of large cell agglomerations, leading
to merging of cell spots (Figure 4.4 A, right).
Consequently, three issues were addressed in spotting tests: (i) a more stringent washing
routine of the pin to overcome congestion of the channel, (ii) different spotting routines/pro-
cedures and (iii) various buffers to resuspend the cells in after induction in order to avoid
agglomeration of cells. Ideally, pins with a bubble-shaped channel should stamp several
spots of cells before reloading the pin at the source well. Practically, consecutive spots
contained fluctuating cell numbers (Figure 4.4 B) and were poorly reproducible for the entire
array (Figure 4.4 C). Reloading after each stamp increased the probability of congestion in
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the pin cavity. Hence, while being less efficient, pins were washed after each spot. Multiple
rounds of wash-dry with water for several seconds improved the washing effect but proofed
again too time-consuming and uneconomical. Rigorous washing procedures with a mild
detergent (0.05% Tween-20 in PBS or water) eventually helped to clean adhesive cells from
the pin cavities.
Figure 4.5: Spotting test with different blocking reagents added to the cell media before printing an array of 48
induced GST and MORF strains using a slit pin and a bubble pin, respectively.
To reduce the agglomeration of cells, induced cells were washed several times with cold
water or PBS and finally resuspended in different blocking solutions. The results after can
be seen in Figure 4.5: Neither buffer showed sufficient improvement when spotting several
strains, although induced yeast cells seemed to agglomerate and thus block the pin less.
Analysis of protein pull-down reproducibility of serially spotted slides (with cells from the
same plate) after freezing pre-assembled chips would be an advantage for screening varying
conditions through the entire proteome to avoid batch-to-batch variations of spotted cells
and moreover to reduce total handling time in bulk fabrication. However, we observed only
moderate reproducibility for protein pull-down experiments on cell arrays, which had been
spotted from the same plates, aligned to the microfluidic device and kept at -80°C in order to
maintain the yeast cell protein integrity (Figure 4.6 A) when compared to frozen GFP strains
(Figure 4.6 B).
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Figure 4.6: Reproducibility of protein pull-down for arrays kept at -80°C for 6 weeks with 96 yeast strains from the
(A) GFP and (B) GST collection.
Another possible scenario to improve on-chip performance would be to grow spotted cells
on the device, which has several advantages: 1. The total amount of expressed protein to
be purified increases with growing cell numbers. 2. The viability and morphology of cells
can be monitored. Assuming that only healthy cells produce functional proteins in sufficient
quantity, detected protein signal intensity could be correlated to number and growth rate of
the cells. 3. In situ induction of plasmid-encoded collections reduces loss of cells that is
typically associated with washing and pelleting in a 96-well plate. However, observing cell
density and behavior is critical to induce expression during the right stage of cell growth as
well as a fast and complete media exchange after over-expression.
4.4.2 On-chip cell lysis and protein purification
On-chip yeast cell lysis involved two steps: Cell wall disintegration by an enzyme (Zymolyase)
followed by lysis of the remaining spheroblasts using detergent-based solution (Y-PER).
The two-step cell lysis could be potentially combined. However, we noted that cells in
chambers closer to the fluid inlet tree degraded faster and more efficiently than those located
in chambers towards the outlet, which contained almost intact cell walls even after long time
incubation with the lysis mix. The observed gradient effect was almost completely avoided by
re-loading the enzyme cocktail after 10 minutes. However, in the case of a one-step lysis
procedure, re-loading of the lysis cocktail may wash the already lysed cells (closer to the
inlet tree), out of the chamber and could potentially contaminate adjacent chambers. In
addition, if cell lysis is carried out at room temperature, the integrity and functionality of some
proteins may be disturbed. Consequently, the whole chip was transferred to ice water for cell
lysis and protein pull-down. However, cell wall disintegration with Zymolyase works best at
37°C. Keeping the two lysis steps separated, cell walls were broken down efficiently at room
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temperature, before complete lysis and protein extraction was allowed to occur at 4°C.
4.4.3 Labeling and detection strategies
With exception of the GFP collection, detection of on-chip purified protein is only possible by
introducing a second antibody conjugated to a fluorescence marker. However, implementing
two or more antibodies to immobilize and detect interacting proteins may affect the sensitivity
of detection as a result of crowding and steric hindrance of the molecules.
To detect interactions several approaches could be considered. First, using chemically or
intrinsically labeled TFs or proteins, which are bench-top purified. This provides a reliable
labeling method and avoids incubation with another antibody on-chip. A drawback is that
labeling proteins in solution often requires several purification steps. Moreover, potential
binding sites might be blocked by the chemical dye. Thus, to ensure accessibility of binding
sites, the protein interaction could be captured using an antibody binding to the affinity tag
of the non-immobilized protein. This second approach may even circumvent constraints of
detecting both proteins with a fluorescence-labeled antibody. However, sufficient and reliable
protein pull-down is an essential pre-condition, which had not been established at that stage
in the project. Therefore, applying purified proteins from the GFP fusion library would be the
method of choice for proof-of-principle interaction detection in the future.
4.4.4 Optimization of induction process
One of the advantages of the chosen plasmid-based fusion libraries is the possibility to
induce protein over-expression independently from intrinsic gene regulation, as each ORF
is under the control of a GAL1 promoter, which initiates transcription of the gene of interest
only in the presence of the sugar source galactose. To induce robust protein expression, the
yeast cells have to be depleted of any glucose in the medium because glucose acts as a
repressor of ORF-fusion protein expression.
Most culturing and downstream conditions of previous large-scale protein induction and
purification studies were setup in a 96-well box (2 ml/well) with a minimum volume of 1 ml
[6, 159]. However, to facilitate the generation of yeast cell arrays, our yeast cell cultures
needed to be compatible with the spotting routine, which required regular 96-well microplates
with a maximum volume of 300 µl/well. Consequently, we inoculated cells using a slit 96-pin
tool replicator (with slot/channel), which delivers on average 1 µl of liquid in a liquid-to-liquid
transfer. However, similar to the slit spotting pins, pelleted yeast cells can congest the channel
and this makes the delivery volume of a yeast suspension much more variable. Inoculating
yeast cells into small volumes of media thus lead to different cell densities within one 96-well
plate, which makes it difficult to induce in the recommended OD600 range (Figure 4.7 A).
Repeated re-inoculation of confluent yeast cell cultures into fresh medium using a solid
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pin 96-replicator tool (0.4 µl/transfer) was optimal to obtain synchronized growth, with an
induction window of 1h, the time in which most GST strains were in the recommended range
of OD600 0.6 and 1.0 (Figure 4.7 B).
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Figure 4.7: Variability of cell growth between different GST yeast strains in the same 96-well plate (A) after
inoculation from glycerol stock into growth medium (B) and with synchronized growth after double-inoculation.
Indicated in the blue boxes are the intervals, in which yeast strains reached the recommended cell density (OD600
0.6-1.0) for induction.
Knowing the optimal induction time for protein expression is crucial, as over-expressed
protein can be toxic to the cells. In order to determine the most robust induction variables, two
GST fusion strains were selected, whose optical density 7.5 hours after double-inoculation
was at the upper (SYN8, OD600 0.98) and lower end (ACS1, OD600 0.62), respectively. The
two strains were grown to four different cell densities ranging from OD600 0.6 to 1.2, before
induction and then allowed to express the protein of interest for 3, 4 and 5 hours, respectively.
Figure 4.8 shows that detected protein expression levels were higher for cell cultures, in
which expression was induced at lower optical densities (OD600 = 0.6 and 0.8) and allowed
to last for 4 or 5 hours, whereas those cultures induced at higher cell densities (OD600 = 1.0
or 1.2) cease protein expression over prolonged induction periods. This indicates, that cells
are not as efficient in protein expression, once they have reached a critical growth phase.
Interestingly, very high cell seeding numbers (10-times concentrated) are not reflected in the
intensity of the detected protein signal, particularly, when detected pull-down is normalized to
cell numbers. This effect is probably due to incomplete cell lysis, which had been observed
before for very dense cell spots.
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Figure 4.8: Parameter study to optimize on-chip protein pull-down. Yeast cells from two different GST fusion
strains (SYN8: 55.1 kDa; ACS1: 105.1 kDa) were grown to different cell densities (OD600) before expression
was induced. Induction was quenched after 3, 4 and 5 hours, respectively. A MITOMI chip was then programmed
with normally resuspended and 10-times concentrated cell spots (high cell density) and proteins extracted in situ.
Protein pull-down was normalized to the number of cells spotted and is plotted for all parameters studied.
To summarize, we demonstrated that it is possible to generate a protein array on-chip
from spotted induced GST-fusion yeast cells in a large-scale format that is compatible with
micro-arraying conditions. Several changes in array production resulted in improved on-chip
reproducibility and increased protein detection to levels, which are considered sufficient for
future protein interaction studies (Figure 4.9).
The most significant improvements were observed with the following parameters:
1. Yeast cell cultures from a glycerol stock should be transferred at least twice into 150
µl/well fresh growth medium (glucose-free) in a regular 96-well plate (300 µl/well) with
a solid 96-pin replicator tool and grown to stationary phase (OD600 ∼ 4.0)
2. Cell density should be between OD600 0.6-0.8 and not exceed 1.0 for induction with
induction medium (containing galactose). Cell cultures in a 96-well plate may need to
be monitored with a plate reader to ensure synchronized cell growth.
3. Longer induction times (up to 5 hours) yield higher protein expression levels.
4. Cells are to be washed three times with PBS or cold water after induction to remove
any remaining induction medium.
5. Cell pellets should be resuspended in PBS or sugar-free medium for spotting and
pelleted by short low-impact centrifugation (for max. 1 min at max. 1000 rpm).
6. A solid spotting pin (no cavity) results in a cell array with the most reproducible cell
number/spot. Using pins with a larger tip diameter (pin tip > 125 µm) will increase
cell numbers transferred to the array. Note: Initial seeding cell numbers do not signifi-
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Figure 4.9: On-chip detection of protein expression from 96 yeast GST fusion strains after optimization of array
generation. Protein pull-down was detected with a secondary antibody and plotted over the intensity of cell
density after spotting (ref. channel).
cantly affect protein pull-down on-chip. Instead, very high cell numbers per chamber
on the array can impede cell lysis and protein extraction. Nevertheless, a sensible
normalization of detected protein pull-down to the cell number given rise to it should be
considered for quantitative analysis.
7. Two-step cell lysis is more efficient than combining the enzymatic break down of cell
walls, which works better at room temperature, and lysis of the yeast spheroblasts with
a detergent. In situ protein extraction should be performed at ∼4°C (in iced water) to
ensure protein integrity.
8. Washing the chip with blocking solution (BSA/milk) after protein pull-down for 45 min
helps to reduce non-specific binding of the fluorophore-labeled detection antibody.
Arguably, synchronized growth of all strains in a 96-well plate in order to induce them at the
right time seemed to be one of the biggest challenges to generate GST-tagged yeast cell
arrays. Precise monitoring of cell growth on-chip is very difficult. Therefore, the option of
on-chip growth and induction was not pursued.
Instead, successfully induced plates could be frozen to circumvent the issues of repeatedly
monitoring and synchronizing cell growth after inoculation from frozen plates into fresh
medium. For that, thoroughly washed pellets were either shock-frozen directly or resus-
pended in glucose-free medium containing 15% glycerol and then stored at -80°C. Thawed
plates were pelleted, washed and resuspended in sugar-free medium or PBS for spotting.
However, spotting of thawed plates with resuspended cells produced a very low cell density
compared to spotting from freshly processed plates. Alternatively, non-viscous cryoprotectant
such as DMSO could be added to the yeast cell plate directly before spotting if protein yields
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per device drop significantly after storage at -80 °C.
Reliably expressing and detecting proteins in situ from a large collection of yeast strains
is crucial to perform protein interaction studies on-chip, which can be accomplished in two
different ways using our MITOMI device: First, flowing off-chip purified proteins or cell lysate
over the protein array, generated from lysed yeast cells, and second, co-spotting different
yeast cell strains. Both approaches will be discussed in more detail in the following two
sections.
4.4.5 Protein immunopurification for flow deposition
Generating a protein array to study protein-protein interactions generally requires large-scale
bench-top protein purifications. For this purpose, engineered recombinant proteins with
a specific affinity tag are expressed and purified using affinity chromatography methods.
Affinity tags such as glutathione-S-transferase (GST) and hexahistidine (6xHis) bind with
high affinity to immobilized glutathione agarose and nickel or cobalt ions, respectively, and
are then displaced with excess competing compounds during a process called elution.
His-tagged proteins from selected GST and MORF library strains were purified using com-
mercially available affinity columns based on nickel-nitrilotriacetic acid (Ni-NTA) metal affinity
chromatography matrices. Native conditions with mild lysis conditions and enzymatic in-
hibitors were preferred to reduce binding of contaminants and prevent protein degradation,
respectively. The results of protein purification and detection of the common 6xHis-tag and a
library-specific affinity tag with antibodies are shown in Figure 4.10.
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Figure 4.10: Bench-top protein purification from two strains (A) of the GST (expected protein size: 74 kDa
for DEP1 and 68 kDa for PRP45) and (B) the MORF (expected protein size: 30 kDa for SAE3 and 68 kDa
for ATG17) collection. Protein expression of induced cells (ind) was detected with His-antibody (left, InVision
His-staining), (A) GST-antibody (right, Western blot) and (B) Protein A-antibody, respectively. Black annotations
indicate detected bands at the expected protein size, red the size of the respective fusion tag. Non-induced cell
served as negative control (ctrl).
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Contaminants visible as additional bands on the electrophoresis gels and Western blots
remained in the purified product even after adding reducing reagents (beta-mercaptoethanol)
and mild detergents (Tween 20 and Triton-x). A co-purified protein of ∼26 kDa was repeatedly
detected for GST-tagged proteins (Figure 4.10 A, red dotted box), indicating that expression
terminated prematurely after the N-terminal fusion-tag or proteins were degraded. Contam-
inants of ∼60 kDa were pronounced for MORF-fusion proteins detected by His-straining
(Figure 4.10 B, left). Western blotting with a specific antibody against another affinity tag
detected the right antigen, but also indicated that the eluate contained a mixture of full size
proteins as well as fragments of the affinity tags. Nickel columns seldom return a pure protein
and non-specific bands in His-tag stained gels can be an indicator of highly basic proteins
and divalent metal binding proteins, which cross-react with the stain producing non-specific
bands. Eukaryotic cells are known to contain proteins with neighboring histidines as well as
endogenous proteins with metal-binding sites that also bind to the Ni-NTA matrix to a consid-
erable extent, which is then detected in the eluate as high background. In addition, yeast
cells may acidify the culture medium and both the cells and the medium may contain certain
compounds that influence binding of 6xHis tags to Ni-NTA matrices. Therefore, eukaryotic
proteins may require a tandem affinity purification using two affinity tags to yield higher
purity [163]. To that end, glutathione sepharose columns are available to purify GST-tagged
strains and IgG sepharose for protein A fusion proteins in MORF strains, respectively, but
this possibility was not further investigated.
While immunopurification of tagged fusion proteins requires an antibody or other capturing
reagent, crude lysate could be used, which contain a mixture of proteins, including the protein
of interest. This option is particularly attractive to obtain GFP fusion protein cause most
current GFP purification methods yield low concentrations. However, complex formation,
non-specific binding or interactions with other proteins in the lysate may hinder detection of
the protein of interest, potentially of low-expressing proteins.
Synthesizing proteins can be seen as an alternative approach to obtain the protein of
interest. However chemical synthesis of proteins is expensive and laborious. Expressing
proteins from a DNA expression template using a cell-free in vitro transcription/translation
(ITT) system can overcome many of the current limitations inherent to conventional protein
production and is described in more detail in chapter 5. Generally, flowing samples over
the array, limits the combinatorial possibilities and throughput of the interaction study on the
current MITOMI device as no more than one sample can be flown at a time. Alternatives are
the integration of a multiplexer, as shown in Figure 3.2 E, which allows applying m different
samples consecutively in different rows.
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4.4.6 Co-spotting
Admittedly, the investigation of protein-protein interactions using purified proteins on a pro-
tein array platform remains suboptimal for the analysis of dynamic and short-lived protein
interactions, such as those between enzymes and their substrates. Additionally, optimiz-
ing the entire procedure of protein purification from induced cell strains is a tedious and
time-consuming process, which could be easily circumvented by co-spotting yeast strains
with different affinity tags. Co-spotting allows the device to be programmed in a variety of
combinations by depositing multiple solutions on the same microarray spot. Furthermore,
there is no need to stabilize purified proteins as in situ extracted proteins from different source
cells can interact directly on-chip.
Cell arrays of induced 96 GST strains and a single clone from the GFP collection showed
high cell density. We detected pull-down for GST-tagged proteins, visualized by a secondary
antibody, but no signal for GFP proteins for any of the tested strains. Arguably, some of the
presented GFP strains were expressed in low numbers and therefore may have not reached
a critical level to be detected in interactions. However, using GST and GFP-antibodies in
different parts of the chip for protein pull-down detected sufficient GFP signal for two tested
GFP strains. To further assess the integrity of this approach, well-studied protein-protein
interactions will have to be selected in future experiments.
An alternative to generating protein arrays from whole yeast cells is in situ synthesis of
proteins from DNA templates by cell-free expression. For this path the existing plasmid-
based yeast cell libraries may be used to obtain the DNA templates, which is described in
chapter 5.
4.5 Conclusions, potential pitfalls and future directions
In this project, an alternative approach to generate a protein array was investigated, that can
potentially overcome limitations of conventional technologies and which involves processing
of the generated microarray on a microfluidic device with controllable valves, which allow
surface modification and mechanical trapping based on the MITOMI principle [36].
Whole yeast cells were deposited and proteins purified in situ by cell lysis. We tested
two different types of commercially available yeast ORF-fusion libraries for the generation
of a protein array that would allow interaction measurements: The GFP-tagged collection
with the ORF integrated in its intrinsic chromosomal location and two plasmid-based libraries
(GST, MORF). We repeatedly detected protein pulldown for more than 78% of the studied
GFP strains with an expression level that significantly higher than negative controls. However,
quantitative studies would require normalization of the intrinsically varying GFP signals to
cellular abundance of the expressed protein. Unfortunately, we observed only moderate
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correlation, particularly for proteins with a low GFP signal, even after normalization to the
number of cells giving rise to the protein expressed on chip. Weak GFP signal from proteins
that are normally expressed at high or moderate levels in the cell could result from initial low
cell seeding numbers on chip, incomplete cell lysis or the effect that the GFP-tag may have
on protein synthesis, transport and function.
As a consequence of these limitations when working with a fusion library with protein
expression at a physiological level, we focused the project on the generation of a protein
array from plasmid-based yeast cell collections, where all strains express proteins at high
levels after induction with a galactose medium. More than 95% of the induced GST strains
expressed proteins at levels significantly higher than non-induced control cells, regardless of
the number of cells giving rise to this expression. However, on-chip protein expression was
not very robust, which could be due to variable cell seeding numbers, incomplete cell lysis
and unsynchronized growth of different strains at the time of induction. The conditions for
most efficient protein expression were optimized. Nevertheless, large-scale production of
yeast cell arrays with the GST collection for protein interaction studies remains difficult. In
addition to problems related to array fabrication, the yeast GST library contains numerous
non-transformed strains as well as duplicates throughout the 96-well plate collection and
several strains repeatedly failed to grow or grew only minimally. The low reproducibility of the
library on the level of replication probably also contributed to the overall low reproducibility of
the yeast cell arrays. In view of future protein interaction studies, the entire GST collection or
a sub-collection of targeted strains should be re-arrayed, as done for all known yeast TFs, to
facilitate array production.
For on-chip protein-protein interactions two approaches were envisioned: interaction with
purified proteins as well as co-spotting of different yeast strains. Although considered as
the gold standard, protein purification has several disadvantages: despite the availability
of more convenient purification spin columns and possibilities to automate the procedure,
protocol optimization is time-consuming and the process of purification remains laborious
as well as challenging for certain proteins. Moreover, purified proteins are instable and
their integrity/functionality may be compromised. Given the low performance rate as well
as questionable quality (contaminants and truncated proteins) of purified proteins from the
MORF and GST collection proteins, we considered co-spotting of yeast cells expressing
different fusion proteins as a more promising path. Different strategies were discussed and
should be tested with selected strains of well-studied protein interaction sub-networks.
In conclusion, problems for the generation of whole yeast cell array were encountered
on the level of cell culture, array fabrication and on-chip purification, which could be mostly
solved through step-wise parameter optimization. Challenges included homogeneity of the
cell array and reproducibility of on-chip protein expression, especially in large-scale studies
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involving several hundred different yeast fusion strains. In particular, the use plasmid-based
fusion libraries requires strenuous monitoring of cell growth and synchronization to establish
robust conditions prior to induction of protein expression.
In addition to array fabrication, other factors can influence the detection of protein inter-
action with the described method: Obviously, after on-chip protein extraction an abundance
of other cellular proteins, genomic and plasmid DNA diffuses through the unit cell, which
may bind to the protein of interest. These binding events can mask the antigen-binding site
for protein pull-down or even the potential protein-binding site of the target protein, which
is probably present at lower concentrations. In the future, both experimental approaches to
generate a protein array are attractive alternatives to study protein-protein or protein-DNA
interactions. The re-arrayed yeast GST-fusion collection containing all known TFs can be
used to study protein interactions on a yeast TF-array, before moving on to a larger scale
covering the yeast proteome.
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5.1 Abstract
Producing proteins from pre-arrayed DNA or RNA directly on-chip using cell free expression
systems has been a promising approach to overcome issues of conventional protein arrays
such as protein on-chip stability, protein purification and efficient expression. However, gen-
eration of expression-ready DNA templates often involves multiple cloning, amplification and
purification steps. Here we developed a simple one-step PCR-based approach to generate
linear DNA templates directly from cell cultures to synthesize proteins on a microfluidic device,
suitable for large-scale protein interaction studies.
5.2 Introduction
Cell-free protein synthesis or in vitro transcription/translation (ITT) has been established
as a technique to rapidly and efficiently express virtually any protein outside the cellular
environment from an existing DNA template. Because in vitro expressed proteins do not
require cell culture and protein purification, it is considerably faster than in vivo expression of
recombinant proteins in cellular hosts, such as E. coli or S. cerevisiae. Thus, potentially all
types of protein can be generated and analyzed by cell-free protein expression, including
those which are toxic to a host cell, normally produced in low abundance, difficult to transport
across membranes or prone to proteolytic degradation. Cell-free systems can be used to
express a single gene or a DNA library and to investigate affects of single point mutations by
rational DNA template design. ITT also offers many advantages over chemical synthesis of
proteins as it is not limited by protein size and can be easily scaled to proteomic throughput.
Applications range from structural proteomics such as basic understanding of the molecular
principles of mRNA translation into functional proteins [164], high-throughput functional
proteomics in protein interaction studies [36, 10, 13] and the experimental determination of
regulatory and evolutionary plasticity of proteins [12, 165, 96], or drug target discovery [11],
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diagnostics and therapeutics (reviewed in [166]).
Cell-free protein expression is based on two main ingredients: the genetic template (DNA or
mRNA), which encodes the target protein, and the transcriptional and translational molecular
components, which are usually provided by cell extracts from various cell sources. Systems
based on cell lysates of E. coli, wheat germ and rabbit reticulocytes are most common, but
cell-lysate-free systems with individually purified and reconstituted components become more
popular for highly controlled reaction conditions and easy purification of untagged proteins
[167]. Choosing the appropriate system depends on the origin and nature of the protein as
well as required yields and downstream applications. Although generally lower in yields than
E. coli based systems, eukaryotic systems provide better platforms to study post-translational
modifications. Transcription and translation in ITT systems are by definition coupled and
provide a cost-, time- and resource-efficient tool for high-throughput protein synthesis, which
is suitable to on-chip screening applications. Cell-free systems can be easily supplemented
with further components, including labeling for downstream protein detection, reagents to
improve protein folding and post-translational processing, or modified tRNA to incorporate
non-natural or chemically modified amino acids in the protein.
Expressing proteins with cell-free protein synthesis systems requires expression-ready
DNA templates of the open reading frame (ORF), either in the form of plasmids or linear
DNA fragments generated by PCR, which contain a promoter (typically T7, SP6 or T3) and a
translation initiation signal such as the Shine-Dalgarno (prokaryotic) or Kozak (eukaryotic)
sequence. A transcription and translation termination region can be incorporated to increase
expression levels. Cloning the ORF of interest into plasmids involves PCR steps, digestion
by restriction enzymes, ligation and transformation into a suitable host, ideally followed by
sequencing to ensure that the insert is correct. Obviously, this laborious procedure makes
plasmid-based templates unfeasible for large-scale applications. Although plasmids provide
a more robust template, generating linear expression templates is generally the method of
choice.
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5.3 Material and Methods
5.3.1 Linear template generation
Linear expression templates were generated by two PCR methods: from purified plasmids of
the yeast MORF fusion collection or directly from liquid cell culture of the same collection,
hosted in S. cerevisiae and E. coli, respectively (all distributed by Open Biosystems, now
Thermo Fisher, Switzerland).
5.3.1.1 Plasmid purification from MORF-fusion strains
This procedure was adapted from the suppliers protocol for isolation of plasmid DNA from
Saccharomyces cerevisiae strains using the QIAprep Spin Miniprep Kit. Selected strains
were inoculated from the frozen glycerol stock into 5 ml growth medium, grown overnight
(16-24 h) at 30°C with low agitation, harvested by centrifugation (4,000 rpm, 10 min, 4°C),
washed with 250 µl PBS and pelleted again (4,000 rpm, 10 min, 4°C). Cells were lysed in
either of the following two procedures: In the first one, following the instruction manual, the
pellet was resuspended in 250 µl buffer P1 containing 0.1 mg/ml RNase A and vortexed for 5
min with 100 µl sterile glass beads (diameter 0.5 mm, Sigma). In the alternative procedure,
the pellet was resuspended in 50 µl Lyse-and-Go PCR Reagent (Pierce) and incubated for
5 min at 95°C. Suspensions of both methods were transferred to another tube containing
250 µl lysis buffer P2 and inverted gently 4-6 times to mix. After 5 min incubation at RT 350
µl neutralization buffer N3 was added to the tube and inverted immediately but gently 4-6
times. The lysate was centrifuged (14,000 rpm, 10 min, RT) and the supernatant transferred
to a QIAprep Spin Column inside a 2 ml collection tube, centrifuged (14,000 rpm, 60 sec,
RT) and the flow-through discarded. The spin column was washed with 0.75 ml of Buffer PE,
centrifuged (14,000 rpm, 60 sec, RT) and the flow-through discarded. Residual wash buffer
was removed by additional centrifugation for 1 min. The spin columns were transferred to
a fresh tube before plasmids were eluted by adding 25 µl of Buffer EB (10 mM Tris-Cl, pH
8.5) to the center of each spin column, letting it stand for 1 min and a final centrifugation
for 1 min. The quality of the purified plasmids was then assessed by running 2 µl sample
on a 1% agarose gel and measuring their concentration and purity with a NanoDrop 1000
spectrophotometer (Wileg AG, Switzerland). Purified plasmids were stored at -20°C for
further processing.
5.3.1.2 Linear template synthesis by two-step PCR
Initially, linear expression templates were generated by a slightly modified version of the
two-step PCR method described by Maerkl et al. [36], in which the first step amplifies the
target sequence and the second step adds the required 5’UTR and 3’UTR components for
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efficient ITT as well a fluorescence label through a third set of primers. The first step PCR
reaction contained 0.45 µM of each gene specific primer in 25 µl ready-to-use High Fidelity
PCR Master mix (Roche). Template was added by pipetting 20 ng/µl purified plasmid or by
transferring cell template from a glycerol stock (OD600=4.0) with a 96-well metal solid pin
replicator tool (V & P Scientific). The reaction mix was cycled for 2 min (plasmid template)
or 10 min (cell template) at 94°C, followed by 10 cycles of 10 sec at 94°C, 70 sec at 50°C
(annealing) and 2 min at 72°C (elongation), then another 20 cycles of 15 sec at 94°C, 30
sec at 50°C (annealing) and elongation for 2 min + 5 sec for each successive cycle at 72°C,
followed by a final extension at 72°C for 7 min. The second PCR contained 25 nM of each
extension primer in 23.5 µl ready-to-use High Fidelity PCR Master mix, to which 1 µl of the
unpurified product from the first PCR step was added as template. The reaction was cycled
for 2 min at 94°C followed by 10 cycles of 10 sec at 94°C, 70 sec at 50°C and 2 min at 72°C
followed by a final extension of 72°C for 7 min. After extension 0.5 µl of final primer mix (0.5
µM final concentration for 5’finalCy5 and 3’final in dH2O) was added to each reaction tube. In
a 96-well plate setup, products of the extension PCR were transferred to another PCR plate
containing 0.5 µM of each final primer in a 25 µl or 50 µl ready-to-use High Fidelity PCR
Master mix (Roche) with a 96-well metal solid pin replicator tool (V & P Scientific). Cycling
was then continued immediately for 2 min at 94°C, followed by 10 cycles of 10 sec at 94°C,
70 sec at 50°C (annealing) and 2 min at 72°C (elongation), then another 20 cycles of 15 sec
at 94°C, 30 sec at 50°C (annealing) and elongation for 2 min + 5 sec for each successive
cycle at 72°C, followed by a final extension at 72°C for 7 min. Unpurified products of each
reaction step were assessed by running 0.5 µl sample on a 1% agarose gel.
The same settings for the extension and final PCR were used to generate expression
templates directly without the first PCR. In this 1.5-step PCR 0.5 µl plasmid (20 ng/µl final
concentration) or 1 µl yeast cells served as template for the extension PCR.
5.3.1.3 Linear template synthesis by single-tube colony PCR
Linear expression templates were generated by single-tube PCR in a 96-well plate format
by transferring cell template from a glycerol stock (OD600=4.0) with a 96-well metal solid pin
replicator tool (V & P Scientific) to 50 µl ready-to-use High Fidelity PCR Master mix containing
0.45 µM of each extension primer (as used for the 2-step PCR). The mix was heated at 94°C
for 10 min, followed by 10 cycles of 10 sec at 94°C, 70 sec at 50°C (annealing) and 2 min at
72°C (elongation), then another 20 cycles of 15 sec at 94°C, 30 sec at 50°C (annealing) and
elongation for 2 min + 5 sec for each successive cycle at 72°C, followed by a final extension
at 72°C for 7 min. Unpurified products were assessed by running 0.5 µl sample on an 1%
agarose gel.
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5.3.2 DNA spotting and device alignment
Solutions of unpurified expression-ready DNA templates were spotted onto epoxy-coated
microscope slides with 373 µm column and 746 µm row spacing using a QArray2 microarrayer
(Genetix) and 946MP2 slit-pins (ArrayIt). Sample solutions contained 2(w/v)% BSA/dH2O to
prevent covalent linkage of DNA to the epoxy surface and to visualize DNA spots for alignment
to the microfluidic device. Spotted DNA arrays were manually aligned to microfluidic PDMS
devices containing 768 unit cells using a Nikon SMz1500 stereoscope and bonded overnight
at 40°C.
5.3.3 On-chip experiments for linear template arrays
The surface area was modified by depositing layers of BSA-biotin and NeutrAvidin/PBS
as described in Appendix A [162]. The surface derivatization was finished by immobilizing
biotinylated Penta His-antibody or HA-antibody in PBS (see Appendix D) to the area beneath
the button membrane, followed by washing with PBS.
Expression of linear templates was first tested by setting up a test tube containing 12
µl of either TNT T7 Coupled Wheat Germ Extract System (Promega) or TnT SP6 High-
Yield Wheat Germ Protein Expression System (Promega) with 0.5 µl tRNA-Lysine-Bodipy-Fl
(Promega) to which 0.5 µl unpurified expression template from the 1.5-step PCR were added.
The ITT mix was incubated for 90 minutes in a PCR cycler (BIO-RAD) at 30°C (T7) and 25°C
(SP6), respectively, before flowing them on the prepared chip surface.
For on-chip protein expression, an in vitro transcription-translation (ITT) mix containing
12 µl TnT T7 Coupled Wheat Germ Protein Expression System, spiked with 0.5 µl tRNA-
Lysine-Bodipy-Fl was loaded into the chambers of the device to solubilize the linear DNA.
The outlet valve and the button membrane were kept closed during the loading of the ITT mix
to protect the antibody underneath the button membrane and to prevent cross-contamination
by DNA samples that were flushed from the chamber. After complete resuspension of the
DNA in the chamber, the neck valve was closed again and the channels washed with ITT mix
for 5 min to remove potentially flushed out DNA. The reaction then incubated for 2 h at room
temperature with the sandwich valves closed and the neck valve and button membrane open
to allow the expressed proteins to diffuse to the antibody. A final washing step with 1% BSA
in PBS for 45 min with the button membrane and neck valve closed removed excess ITT mix
from the channels for both experimental approaches (on-chip and off-chip ITT), after which
the device was imaged on a modified ArrayWoRx (Applied Precision) microarray scanner
with 1.0 s at 488 nm.
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5.4 Results and Discussion
5.4.1 Template generation
We applied a PCR-based approach to generate linear DNA templates from the yeast MORF-
fusion library, described in chapter 4. Compared to the GST-fusion library, which was the
library of choice for the yeast cell arrays, the MORF collection offers several advantages:
ORFs were tagged at their C-terminal with a versatile triple affinity tag unlike the N-terminal
GST-6x-His-tag in the GST collection, which could result in the detection of truncated proteins
(detection of tag without ORF). Moreover, the quality of the commercially available GST
yeast library was lower than the MORF library, with respect to cell library and data base
maintenance.
Wheat germ ITT (Promega) was chosen over E. coli-based systems for this study on yeast
proteins for two reasons. Multi-domain proteins, often found in eukaryotes, tend to fold
into their correct conformations much better in eukaryotic rather than prokaryotic translation
systems [168]. In addition, PCR-generated DNA templates are generally transcribed and
translated less efficiently in E. coli systems because mRNA and DNA-degradation enzymes
from the cells decrease the stability of the templates and this reduces yields. Moreover,
wheat-germ-based expression was optimized for higher yields using a PCR-based approach
developed by Sawasaki et al. [169]. Although PCR is the fastest way to generate linear DNA
templates, most approaches involve a time-consuming multi-step PCR. On the other hand,
they are extremely flexible and modular; and linear templates can be generated from genomic
DNA, cDNA clones and other plasmid-based ORFs. Nevertheless, optimization of the PCR
and usually purification of the PCR products are required to minimize the presence of contami-
nants, such as primer dimers, in the final template. To easily generate linear expression-ready
DNA templates from genomic DNA, Maerkl et al. developed a two-step PCR method, in
which the first step amplifies the target sequence and the second step adds elements to
the 5’UTR and 3’UTR (untranslated region) for efficient in vitro transcription/translation [36].
With the short gene-specific primers in the first PCR they added the translational initiation
sequence (start codon and a Kozak sequence in the case of eukaryotes) and a double-stop
codon to the template as well as overhang sequences, which allowed downstream priming
in the second PCR using a set of extension primers. The 5’ extension primer contained the
required promoter sequence and a beta-globin sequence to increase expression. A Poly-A
tail and a terminator were added to the 3’ extension primer to enhance mRNA stability and
transcription. After 10 cycles of extension PCR, a set of short final primers was added, which
not only amplified and labeled the already functional linear templates but should also reduce
the chance of primer dimer formation.
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5.4.1.1 Template generation by single-step PCR using purified plasmids
One of the goals of this project was to find faster, less expensive and more direct ways to
generate large scale protein arrays to enable protein interaction studies on a proteome-wide
level. However, the 2-step PCR still required numerous handling steps, like transferring
PCR products and adding the final primer set, which were impractical for the generation of
templates from a library consisting of almost 6,000 ORF-fusion strains. Even with the aid
of facilitating tools, such as a 96-replicator tool and liquid dispensing systems, the entire
process would become rather laborious, reagent consuming and prone to manual errors in a
large-scale 96-well-microplate format.
Therefore, the set out to design a new streamlined PCR to overcome these limitations,
if possible as a one-tube, one-step reaction. Critical points addressed in the original 2-step
PCR were still considered, such as a highly modular PCR design, which uses commercially
available primer sets with a maximum length of 135 bp. Additionally, linear templates should
be compatible with on-chip processing without the need of spin column based purification
steps. Two methods were developed and compared to the 2-step PCR results. In a first
approach, the 5’UTR and 3’UTR elements were added to the target gene/region of interest
during the first round of PCR using long extension primers (between 88 and 123 bp), as
shown in Figure 5.1.
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Figure 5.1: Primer design to generate a linear DNA template by colony PCR from a plasmid-based cell collection.
Primers were designed, which contained all the required elements for efficient cell-free protein expression
using a commercial in vitro transcription-translation system: a T7 promoter and a T7 terminator were added to
be compatible with commercial in vitro transcription systems using bacterial RNA polymerase to initiate gene
transcription. In addition, a beta-globin sequence was added to increase the translational rate as well as a Poly-A
tail to stabilize the mRNA after transcription. The translational initiators, Kozak sequence and Start codon were
already present in the plasmid, but a double stop codon was added after the HA-tag. The blue-colored 5’- and
3’-overhangs can be used for further amplification of the resulting linear template in another PCR step to add a
fluorescence tag to the sequence and reduce the chance of primer dimer formation in the PCR mix, if needed.
The resulting linear DNA product was then amplified and labeled with a Cy3 fluorescence tag
in a final PCR by adding a short primer set. The fluorescence label allows visualizing the
linear DNA template on a microarray after spotting onto a glass slide. In a proof-of-principle
experiment using purified plasmids from the MORF yeast library all templates were amplified
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Figure 5.2: Protein expression levels of templates generated by one-step plasmid PCR. Two proteins of similar
size (protein size: 34 kDa for HMRA1 and 37 kDa for POP6) were synthesized off-chip using the SP6 and the T7
ITT expression system, respectively, from linear DNA templates generated by a double-step plasmid PCR. The
protein-ITT-mix was then flown on-chip and detected by either anti-HA antibody or Penta-His antibody.
at the correct size in sufficient quantity for downstream processing (dilution for spotting).
On-chip detection of two proteins (HMRA1 and POP6) synthesized showed slightly similar
signals for proteins expressed off-chip with the SP6 and T7 system, respectively (Figure 5.2).
Although, skipping the gene-specific PCR amplification saved one transfer step, it still required
adding 0.5 µl of final primer to each well in a 96-well plate or copying into another plate.
The final PCR serves three functions: (i) the amplification of the generally low number of
extension PCR product due to the length of the primer set, (ii) reducing the chance of primer
dimer formation (iii), and the possibility to incorporate a fluorescence tag with a shorter primer
pair, which is much cheaper than adding the tag to the long extension primers. However,
in principal the PCR products are already functional after the extension step and thus the
final PCR is not strictly required. Running the linear template on a gel showed that most
samples were already sufficiently amplified after the extension PCR step without significant
primer dimer contamination. In a second approach, the PCR conditions were modified to
enable a one-step, one-tube PCR by using only extension primers. In addition, a single-step
PCR reduces the total number of PCR cycles and therefore the risk of accumulating point
mutations due to the error rate of the DNA polymerase.
5.4.1.2 Template generation by colony PCR
To further optimize the PCR conditions, templates ought to be generated directly from liquid
cell culture, which circumvents the need of plasmid purification. Commercially available spin
column systems generally facilitate plasmid purification from liquid cell culture or colonies.
Although the yield and purity of plasmids purified from yeast cells was only moderate, it proved
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sufficient for PCR amplification. Arguably, if very low plasmid concentrations allowed the
generation of linear expression DNA templates, it would be worthwhile to test the amplification
after lysing yeast cell cultures. In order to keep handling steps to a minimum, boiling yeast
cells for 10 min before PCR was the preferred cell lysis method over adding detergents as a
heating step can be easily implemented in the PCR cycler without additional transfer of lysed
yeast cells. DNA band signals on the gel after single-step PCR from lysed yeast cells were
weaker than after single-step PCR from purified plasmids, probably due to lower plasmid
concentrations after cell lysis. PCR failed repeatedly for 20-33% of the lysed yeast strains,
even though plasmid PCR had worked for some of them. This high failure rate during colony
PCR could indicate too low cell numbers as starting material or incomplete cell lysis. The
first hypothesis was ruled out as it proved that highest DNA yields were obtained in PCR
reactions using the lowest cell numbers, which had been transferred with a 96-pin replicator
tool. Cell lysis with detergent or enzymatic reagents, such as Y-PER, Lyse-and-Go PCR
Reagent or Zymolyase even seemed to impair the quality of the PCR. The MORF plasmids
were also transformed in E. coli cells, but the library format/setup differed from the yeast
collection, which made plate-to-plate comparison difficult. Single-step PCR from lysed E.
coli cells instead of yeast showed an overall higher success rate (always more than 85%).
However, when comparing PCR results between the same transformants, E. coli was only
slightly better than yeast. Figure 5.4 A shows that DNA fragments were amplified equally
well for a DNA length ranging from 369 to 1400 bp.
5.4.2 On-chip protein expression
Linear DNA templates can be easily transferred to a microfluidic device and converted into
a protein array by introducing a cell-free expression system, without the need of further
purification (Figure 5.3).
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Figure 5.3: Workflow of cell-free protein synthesis on-chip: Products from the one-step colony PCR were printed
on a glass slide and aligned to a MITOMI device. An in vitro transcription-translation (ITT) mix was then loaded
into the chamber to drive protein expression. The mix also contained a tRNA carrying a BODIPY-labeled lysine
amino acid, that is incorporated into the final protein, allowing its detection once it is bound to the detection
antibody.
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As a proof-of-principle on-chip experiment, 16 MORF-fusion proteins were expressed from
spotted expression templates, which had been generated by single-step colony PCR of yeast
and E. coli cells using a wheat-germ in vitro transcription/translation (ITT) system. In a
scale-up experiment the MITOMI device was programmed with 64 linear templates, which
were obtained by a single-step colony PCR in a 96-microwell plate. The device was then
loaded with T7 wheat germ ITT mix and incubated for 2 hours to allow protein synthesis
and pull-down to an immobilized HA-antibody. Protein expression signals were detected
for almost 70% of the 51 samples, for which a correct PCR product was observed on the
electrophoresis gel, with protein sizes ranging from 153 to 496 amino acids (6.3-44.1 kDa)
as shown in Figure 5.4 B. The relatively high signals of spots programmed with incorrect
PCR products (no or very weak signal, double band, too small fragments) could be caused
by non-specific binding or by samples with a dubious DNA template. Moreover, wheat germ
extracts contain endogenously biotinylated proteins, which may bind non-specifically.
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Figure 5.4: On-chip protein expression from DNA templates generated by single-step PCR from lysed yeast cells:
Expression levels as a function of protein size for 64 MORF-fusion strains (o = correct size PCR product, x = no
or incorrect size of DNA product detected on gel). The signal of almost 70% of expressed proteins was higher
than the average signal of the spots without a PCR product (— negative control cutoff).
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5.5 Conclusions and Future Directions
In this project, the MITOMI device was charged with linear DNA templates encoding an ORF,
from which proteins were synthesized by a cell-free in vitro transcription/translation system.
Linear expression templates were generated from a plasmid-based cell library. The PCR
was designed as a single-step, one-tube reaction that allows amplification and tagging of
ORFs as well as incorporating all the 3’UTR and 5’UTR elements necessary for transcription
and translation through appropriate primer design. By optimizing the PCR conditions the
method was used to generate linear DNA expression templates from cell cultures of yeast
and E. coli cells. The circumvention of any purification steps renders this approach very
useful for large-scale applications. Spotted linear templates were successfully expressed
in situ using the wheat germ ITT system and proteins detected on-chip. However, using
only a single set of primers increases the risk of primer dimer formation, which contain all
the necessary 3’UTR and 5’UTR elements and therefore could compete for ITT resources
during cell-free protein expression. In the presented study, primer dimer formation was not
observed at detectable levels. Undoubtedly, cell-free ITT systems offer a fast, convenient
and simple approach to synthesize proteins from DNA. However, wheat germ expression
systems contain cellular debris, which include necessary molecular components for protein
synthesis. These particles tend to block the microfluidic channels when the ITT mixture is
loaded into the chambers with spotted expression templates. Clogging might be a bigger
problem when a scale-up version of MITOMI with more unit cells is used, as proposed in
3.2.3 for high-throughput, large-scale studies because the channel dimensions are even
smaller. A possible solution is a chip design with higher flow channels, which would allow
more efficient purging of fluids in the device.
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6 Drosophila transcription factor array
6.1 Abstract
Mapping gene regulatory networks (GRNs) is a significant challenge in systems biology,
yet only a few methods are currently capable of systems-level identification of transcription
factors (TFs) that bind a specific regulatory element. We developed a microfluidic method
for integrated systems-level interaction mapping (iSLIM) of TF-DNA interactions, generating,
and interrogating an array of 423 full-length Drosophila TFs. With iSLIM it is now possible to
rapidly and quantitatively map GRNs of higher eukaryotes.
6.2 Introduction
The fruit fly, Drosophila melanogaster, has been instrumental as a model organism in bio-
logical research, particularly in genetics and developmental biology, and today it is one of
the most widely used and genetically best-known organisms among eukaryotes. Its genome,
released in 2000 [170], contains more than twenty times less base pairs (139.5 Mbp) than the
human genome (3,200 Mbp) on only four chromosomes, coding for more than 15,000 genes.
Many basic processes are shared between Drosophila and human, which has made it a great
genetic model system to study human diseases, including the neurodegenerative disorders
Parkinson’s, Huntington’s and Alzheimer’s disease, as well as developmental defects and
other malfunctions [171]. Today, 77% of all known human disease genes were found to have
a fly homologue, which can be searched in an online database (http://homophila.sdsc.edu)
[172]. Drosophila is also being used to study mechanisms underlying aging and oxidative
stress, diabetes, immunity, and cancer, as well as drug addiction. Moreover, studying fly
homologs of various human genes provides new insight into fundamental aspects of protein
function. The importance of these studies for human health was recognized with the Nobel
Prize in 1995.
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Despite the considerable progress in elucidating the function of each gene in the fly genome,
we still know little about the regulatory sequences and corresponding gene regulatory net-
works (GRNs), which control gene expression. This lack of knowledge results from the
complexity of GRNs and the difficulties associated with studying them. GRNs consist primar-
ily of transcription factors (TFs), which can bind to many DNA sequences as well as to other
TFs or proteins. However, while only 20% of all fly TFs have currently been associated with
target genes, most of them were found to bind to multiple cis-regulatory modules on the DNA
(source: REDfly database). The sheer number of combinatorial possibilities seems infinite,
given the number of TFs encoded by the genome and the potential TF binding sites (TFBS)
on target genes. Moreover, TF regulation is often dependent on higher-order interactions:
many TFs require dimer formation to bind to their respective target DNA sequence. To
complicate matters even more, expression levels are often mediated by the recruitment of
transcriptional co-factors (co-regulators) and concentration-dependent binding affinities and
dynamics multiply the quantitative impact on regulation of gene expression. Understanding
the full regulatory repertoire will be a considerable and tedious task. It would first require
identifying all binary TF-TF interactions and their regulatory interaction partners as well as
determining their transcriptional properties. This implies a need to measure affinities of
individual interactions at varying conditions and integration of all regulatory interactions with
their dynamic properties into a multidimensional GRN. Mapping all interactions that constitute
a GRN to elucidate central regulatory mechanisms is one of the challenges of systems
biology. Experimental and computational methods can help to generate complex regulatory
models, but they require large-scale quantitative measurements of TF-DNA interactions.
However, the growing information on interaction networks remains predominantly qualitative
and binary in nature.
MITOMI is a versatile platform capable of mapping and characterizing 768 independent
molecular interactions through physical confinement of individual interactions and a trapping
mechanism that eliminates stringent washing steps. This avoids cross-contamination and al-
lows the detection of low-affinity and transient binding, typically found in TF-DNA interactions.
MITOMI was shown to be able to map interactions between 43 prokaryotic proteins and
generate a small-scale protein-interaction network [10]. Quantitative measurements allowed
a TF-centered mapping of binding energy landscapes of 4 eukaryotic TFs to short oligos
[36] and determination of binding specificities and affinities of 28 yeast TFs to various DNA-
binding domains (DBDs), presented as an oligonucleotide array, which covered the entire
genomic DNA sequence space [13].
However, mapping and characterizing all TF-DNA interactions of an organism using the same
platform would provide a rapid and inexpensive approach to generate a comprehensive and
quantitative regulatory network. The nearly complete repertoire of 755 sequence-specific
Drosophila melanogaster TFs is ideal to (i) assess the capacity of MITOMI to synthesize
hundreds of functional eukaryotic TFs from expression-ready DNA in situ, (ii) investigate
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its ability to detect specific interactions on a systems level and (iii) measure their binding
specificity and affinity in order to map and characterize TF interactions in a GRN.
6.3 Material and Methods
6.3.1 Plasmid purification
Plasmids from overnight E. coli cultures were isolated for microvials (5 ml) and 96-well
plates following exactly the suppliers’ protocols QIAprep Spin Miniprep Kit and Plasmid
DNA Purification using the QIAprep 96 Turbo Miniprep Kit, respectively (both Qiagen, see
Appendix F).
6.3.2 Construction of a linear DNA template library
A collection of open reading frames (ORFs) coding for all known Drosophila melanogaster
TFs was previously cloned into Gateway compatible destination vectors [74] with a C-terminal
GST-tag.
A universal set of primers (IDT) was designed framing the Gateway cassette on the pF3A-
WG-GST plasmid with a 5’ primer (see Appendix B) located 10 bp upstream of the SP6
promoter and a Cy3-labeled 3’-primer (see Appendix B) located 24 bp downstream of the T7
terminator. We performed colony PCR in standard 96-well PCR plates for 575 samples (for
which plasmids had been successfully transformed into E. coli). About 0.4 µl cell template
from a glycerol stock were transferred into 50 µl of a ready-to-use High Fidelity PCR Master
reaction mix (Roche) with a 96-well metal solid pin replicator tool (V & P Scientific). The
reaction mix was cycled for 2 min at 94°C, followed by 10 cycles of 10 sec at 94°C, 70 sec
at 54°C (annealing) and 2 min at 72°C (elongation), then another 20 cycles of 15 sec at
94°C, 30 sec at 54°C (annealing) and elongation for 2 min + 5 sec for each successive cycle
at 72°C, followed by a final extension at 72°C for 7 min. Following the High Fidelity PCR
Master manual, two PCR cycling protocols with different elongation times and temperatures
(2 min at 72°C and 4 min at 68°C, respectively) were used for each clone to cover most of
the expected PCR fragment sizes ranging from 1.5 kb to 7.2 kb.
Correct size of the PCR products was checked on E-Gel 96 1% agarose gels (invitrogen). A
MatLab-based image analysis program automatically detected and analyzed PCR product
bands. The readout listed the number of detected DNA fragments (number of peaks) per gel
lane, their size and intensity. PCR products for the final TF library were selected based on
expected transcription size (+/- 33% from expected size), band intensity (Inti > 300 a.u.), and
purity of the PCR product (P = Inti∑ Inti > 0.8), as shown in Figure 6.1. Selected PCR products
were diluted 1:3 with 2(w/v)% BSA/dH2O without previous purification and transferred into
two 384-well plates using a liquid handling robot (Tecan).
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Figure 6.1: PCR read-outs, which did not match our selection criteria for size (+/- 33 % from expected size), band
intensity and purity of the PCR product, were excluded from the candidate pool. For samples with successful
PCR products in both methods we selected the sample with the higher intensity value on the electrophoresis gel.
We double-checked for false negatives within the pool of size-excluded candidates for samples without a positive
read-out from both methods.
6.3.3 Synthesis of Target DNA (Klenow
Single-stranded Cy5-labeled DNA oligo sequence templates for 12 TFs from the even-skipped
GRN (bcd, D, gt, kni, Kr, Mad, Med, pan, prd, tin, ttk, twi) [173] were ordered from IDT (see
Appendix B). To synthesize double-stranded DNA target sequences, we prepared a 20 µl
primer mix containing 2 µl of 150 µM target DNA sequence, 0.4 µl 5’ Comp Cy5 primer (see
Appendix B), 2 µl 10x NEBuffer 2 (NEB) and 15.6 µl PCR-grade water. The primer mix was
denatured for 3 minutes at 94°C and then slowly cooled down (0.1°C/sec) to 37°C before
adding 10 µl of a Klenow-fragment-nucleotide mix containing 1 µl Klenow Fragment (3′ → 5′
exo-, NEB), 3 µl dNTP (10 mM PCR nucleotide mix, Roche), 1 µl 10x NEBuffer 2 (NEB), and
5 µl PCR-grade water. The final 30 µl mix was then incubated for 60 minutes at 37°C and 20
minutes at 72°C before slowly cooling it to 30°C at a rate of 0.1°C/sec.
6.3.4 De Bruijn DNA library design and synthesis
De Bruijn sequences have essentially been designed and generated as previously de-
scribed [174]. All possible 8mer DNA sequences (a total of 65536) were computationally
assembled into a DNA library of 1523 individual 68-mer oligonucleotides and one 72-mer
oligonucleotide. Oligonucleotides with five or more consecutive guanines were replaced by
its reverse complement to avoid problems during primer extension. Each oligonucleotide
contained multiple, overlapping 8-bp sequences, a 5’-CGC-3’ clamp at the 5’ end, and a
5’-CTCCGGCGGTATGAC-3’ sequence at the 3’ end for hybridization to fluorophore labeled
extension primer. Double stranded target DNAs were essentially generated as outlined above.
However, instead of using only one Cy5-labeled extension primer, we used an additional Cy-
3-labeled primer. DNA library was split into equal size of 762 oligonucleotides and extended
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with either Cy3- or Cy5-labeled primer. Following completion of extension a pair of Cy3- and
Cy5-labeled double-stranded DNAs were pooled and diluted in 1% BSA for spotting.
6.3.5 Microfluidic device fabrication and glass slides preparation
Microfluidic chip design and fabrication, as well as coating of glass slides with epoxysilane,
were performed as previously described (see Appendix A) [162]. All experiments were
performed with a MITOMI device containing 768 unit cells and a microfluidic multiplexer
capable of controlling each flow channel row individually (see Figure 3.2 E).
6.3.6 DNA spotting and device alignment
DNA sequences were spotted onto epoxy-coated microscope slides with 373 µm column
and 746 µm row spacing using a QArray2 microarrayer (Genetix) and 946MP2 slit-pins
(ArrayIt). Samples with expression-ready DNA templates sample solutions contained 2(w/v)%
BSA/dH2O to prevent covalent linkage of DNA to the epoxy surface and to visualize DNA
spots for alignment to the microfluidic device. Target DNA dilutions and the De Bruijn library
contained only 1% BSA. Spotted DNA arrays were manually aligned to microfluidic PDMS
devices using a Nikon SMz1500 stereoscope and bonded overnight at 40°C.
6.3.7 On-chip experimental procedure
MITOMI experiments were performed with flow and control channel pressures set to 3 and
17.5-22.5 psi, respectively. All control lines were filled with water. The surface area was
modified by depositing layers of BSA-biotin and NeutrAvidin/PBS as previously described
[162]. The surface derivatization was completed by immobilizing 1 µg/ml biotinylated GST
antibody (ab71283, abcam, see Appendix D) in 1% BSA/PBS to the area beneath the button
membrane and blocking the surface using a blocking solution of 0.5% non-fat dried milk
powder, 1% BSA in PBS and 0.1 mg/ml sheared salmon sperm DNA (Sigma).
All TFs were produced using an in vitro transcription-translation (ITT) mix containing 5 µl
TnT SP6 High-Yield Wheat Germ Protein Expression System (Promega), 0.25 µl tRNALys-
Bodipy-Fl (Promega) and 3 µl of nuclease-free water (Promega). The channels were first
equilibrated with the ITT-mix before solubilizing the DNA spots in the chamber by opening the
neck valve without flow. Neck valves were closed again and the channels flushed with the
remaining ITT mix to remove DNA molecules that diffused out of the chamber. All ITT-loading
steps were performed with the button membrane activated (closed) to protect the antibody.
On-chip protein synthesis was incubated for 3 h at room temperature with the sandwich
valves closed, which allowed the expressed GST-tagged TFs to diffuse to the antibody. The
device was imaged on a modified ArrayWoRx (Applied Precision) microarray scanner with
the button membrane open and closed before and after a final wash step, respectively.
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6.3.7.1 Detection of TF-DNA interactions
For interaction studies, we pooled all 12 synthesized target DNA and diluted them 1:10 in
PCR-grade water. The ITT mix was prepared containing 5 µl TnT SP6 High-Yield Wheat
Germ Protein Expression System (Promega), 0.25 µl tRNALys-Bodipy-Fl (Promega), 0.8 µl
of pre-diluted pooled target DNA mix, 0.32 µl sheared salmon sperm DNA (Sigma) and 1.63
µl of nuclease-free water (Promega). Loading of the ITT-DNA mix, incubation and image
acquisition were the same as in the above procedure.
6.3.7.2 Correlation of signal detection from BODIPY lysine
For the experiment in which we correlated the amount of BODIPY-labeled lysines that were
incorporated into the proteins to the amount of detected proteins, we let a second GST-
antibody bind to the BODIPY-labeled surface immobilized TFs. A monoclonal fluorescently
labeled GST-antibody (Hilyte Fluor 647, ab64370, see Appendix D) was diluted 1:200 in
1% BSA/PBS to a final concentration of 5 µg/ml and loaded on chip for 5 min with the
button membrane closed. After closing the sandwich valve again and re-opening the button
membrane the antibody solution was allowed to diffuse and bind to the GST-tagged proteins
for 30 min, after which the device was washed once more for 5 min with the membrane
buttons closed and the sandwich valves open and scanned a third time.
6.3.7.3 Concentration-dependent binding measurements (Klenow)
For the concentration-dependent binding measurements, we printed 6 serial dilutions in
1% BSA for each target DNA on epoxy-coated glass slides, aligned and bonded them
to the MITOMI device. Surface chemistry was as described for the TF detection studies.
Transcription factor proteins were produced off-chip by adding 0.5 µl linear DNA template
(unpurified PCR product) to 5 µl TnT SP6 High-Yield Wheat Germ Protein Expression
System (Promega), 0.25 µl tRNALys-Bodipy-Fl (Promega) and 1.75 µl of nuclease-free water
(Promega) and incubating the ITT-TF mix for 2 h at 25°C.
DNA binding was measured in two different modes: For the monomeric measurements, the
supernatant of the ITT-TF mix was perfused over the chip, allowing the TFs to bind to the
GST-antibody beneath the button valve. Excess protein was washed off with 1%BSA/PBS
and the button membrane collapsed before solubilizing the DNA spots in the chamber by
opening the neck valve without flow. DNA was allowed to diffuse to the TF underneath the
button area, where we captured interactions by collapsing the button membrane after 60
minutes. For the measurements in dimer mode, the area beneath the button membrane
was protected by collapsing the membrane before equilibrating the channels with ITT-mix.
DNA spots were solubilized by passive diffusion of the ITT-mix into the chambers. Neck
valves were then closed again and the channels flushed with remaining ITT mix to remove
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DNA molecules that diffused out of the chamber. During the 1-hour incubation period, TFs
were allowed to interact with the resuspended target DNA in the chambers before binding to
the immobilized antibody underneath the button membrane. The device was imaged on a
modified ArrayWoRx (Applied Precision) microarray scanner with the button membrane open
and closed before and after a final wash step, respectively.
6.3.7.4 8-mer library (De Bruijn) on-chip experimental procedure
We programmed the MITOMI device with a library of 1524 oligonucleotides. Surface chemistry
and modification as well as off-chip TF production were prepared as described above. The
supernatant of the ITT-TF mix was loaded into the chambers with button membranes and
outlet valve closed, which allowed the DNA to interact with the TFs. The neck valves were
then closed again and the channels flushed with ITT mix, before closing the sandwich valves
and allowing the solution to diffuse to the area beneath the button. After 1 hour of incubation,
the button membrane trapped surface-bound TF-DNA-complexes and a final PBS wash
removed unbound TFs and DNA from the channels.
6.3.8 Data acquisition and analysis
For each experiment, slides were scanned on an ArrayWorx scanner with 0.5 s and 1.0 s
exposure times before and after the final wash step at the following wavelengths: 488 nm for
BODIPY-labeled proteins, 685 nm for Cy5-labeled target DNA (or anti-GST antibody Hilyte
Fluor 647, see Appendix D) and 595 nm for the Cy3-labeled in the De Bruijn experiments.
For each experiment two images were analyzed with GenePix6.0 (Molecular Devices). The
first image (before washing) determined the available DNA concentration in solution, the
second (after washing) the amount of surface bound DNA and protein (see Figure A.5 A).
The parallel recording in the DAPI channel allowed a quick detection of the area below the
button membrane, which had been labeled with NeutrAvidin Alexa Fluor 350 conjugate. For
detection of surface bound protein and DNA a microarray grid was aligned to the stained
circular NA spots and used as a template for the detection of protein pull-down and DNA
binding events. Local backgrounds were subtracted for all channels by moving the grid just
next to the chamber, outside the channels. We excluded unit cells with bad features or
insufficient signals from further analysis, which was done with a code written in Mathematica
(Wolfram Research).
6.3.8.1 Kd determination for concentration-dependent binding
The concentration of available target DNA for binding in each unit cell was determined
by measuring the Cy-5 fluorescence in the chamber after incubation. For this purpose we
generated a calibration curve, for which we filled the device with serial dilutions of Cy5-labeled
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target DNA in 1% BSA at 8 concentrations (1.25 µM, 0.625 µM, 0.156 µM, 0.078 µM, 0.039
µM, 19.5 nM, 9.8 nM and 4.9 nM) and scanned the device at 635 nm with 0.5 s and 1.0 s
exposure time, respectively.
Measured Cy5 chamber intensities were converted to concentrations using the calibration
curve described above (see Figure A.5 B). For each protein, measured fluorescence ratios r
(r=DNA-Cy5 intensity/protein-BODIPY-FL intensity) were fitted as a function of total available
DNA concentration ([D] n RFU) to a single-site binding model to determine the equilibrium
binding constant (Kd ) using Prism 5 (GraphPad Software):
r = Bmax · [D]
[D]+Kd
(6.1)
For each protein, we performed a global nonlinear regression fit for all target sequences over
all concentrations with the same Bmax , because this maximum intensity ratio, at which all
binding sites are occupied, should be the same for all sequences.
6.3.8.2 De Bruijn Analysis and Motif Discovery
The de Bruijn analysis was performed essentially as described by Fordyce et al. with the
exception that MEME was used for the initial motif discovery instead of fREDUCE [13]. We
first normalized the background adjusted Cy3 and Cy5 DNA pull-down signals by dividing
each data point by the mean of each dataset. The combined datasets (Cy3 and Cy5 channels)
were rank ordered and all oligos above the mean plus two standard deviations were used in
an initial MEME search. The MEME search was conducted using the standard MEME tool
(v. 4.8.1) using a maximum motif width of 14 bps and the remaining standard settings (zero
or one motif per sequence, min motif width 6, max number of motifs to find: 3). If MEME
returned a statistically significant motif it was used as a seed motif for MatrixREDUCE [175].
We then ran MatrixREDUCE (REDUCE Suite v2.0) on the dataset using standard settings
and the seed motif derived from MEME. In some instances REDUCE could be used directly
to provide a seed motif by running the algorithm first without providing a seed motif. The
motifs returned by REDUCE and MEME were plotted using LogoGenerator (included with
REDUCE Suite v2.0).
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6.4 Results and Discussion
6.4.1 Gene-centered approach for the detection of TF-DNA interactions on
an on-chip Drosophila TF-array
The efficiency/versatility of cell-free protein synthesis from expression-ready DNA templates
has been demonstrated in a broad range of biomolecular interaction studies using the MITOMI
platform, including protein-protein [10], protein-DNA [36, 13], protein-RNA and protein-small
molecule [11].
Expression-ready DNA templates for in vitro protein synthesis can be provided as plas-
mid or linear cDNA containing of the open reading frame (ORF), an appropriate promoter
(typically T7, SP6 or T3), a translation initiation sequence (Kozak for eukaryotes) and op-
tionally a transcription and translation termination sequence. For that a collection of 722
Gateway-compatible Entry vectors containing the open reading frame (ORF) for 96% of all
755 predicted Drosophila TFs had been generated by incorporating existing cDNA and de
novo cloning [74]. The 647 sequence-verified clones were then transferred into a pF3A-WG-
GST vector by Gateway cloning, containing an SP6 as well as a T7 promoter, a T7 terminator,
the Kozak sequence and a GST-affinity tag. More than 75% of TF-ORFs (575 of 755) had
been successfully transformed in E. coli, which allows replication and plasmid purification to
generate an expression-ready DNA template.
6.4.1.1 TF-array from plasmid DNA
Plasmids containing the TF-ORF purified from 96-well plate bacterial cultures using com-
mercial purification systems (QIAprep 96 Turbo Miniprep Kit) yielded low concentrations,
even when pooled from cell cultures grown to saturation in up to three plates containing 200
µl/well (20-40 ng/µl) or 96-deep-well plates (max. 1 ml/well). We failed to observe protein
expression on-chip using the TNT SP6 High-Yield Wheat Germ Protein Expression System
(Promega) for in situ synthesis from spotted templates as well as for ITT reactions set up in
larger volumes in a test tube and captured on-chip. Indeed, the SP6 ITT instruction manual
recommends at least 10 times higher template concentrations for efficient protein synthesis.
Using the same experimental setup we detected concentration-dependent signals from 10
mouse TFs and two human receptor proteins, which were expressed on-chip from plasmids.
However, the ORF sequences had been cloned into a different vector, which yielded much
higher plasmid concentrations after purification (∼ 200 ng/µl).
It should be noted that purification of plasmids from clones containing the pF3A-WG-GST
vector would require large bacterial culture volumes to yield sufficient DNA concentrations.
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6.4.1.2 Construction of a linear DNA template library of TFs
Considering that large-scale plasmid purification under the given conditions was uneconomic
and too labor intensive, we decided to apply an alternative approach by amplifying the ORFs
by colony PCR using a universal Cy3-tagged primer pair for the pF3A-WG-GST vector (Figure
6.3 A). We used two PCR cycling protocols for each clone to efficiently amplify the large
range of ORF sizes (1.5-7.2 kb). All PCR reactions were validated by gel electrophoresis
and automatically assessed for quality using a MatLab-based image analysis program, which
returned the number of detected DNA fragments for each PCR product, its size and intensity
on each 96-well PCR gel. PCR performance was assessed based on expected transcription
size (+/- 33% of expected size), band intensity and purity of the PCR product. We successfully
amplified 454 of 575 ORFs (79%), spanning the entire size range of up to 7.2 kb (Figure 6.2
A) and distributed uniformly among all major TF families (Figure 6.2 B).
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Figure 6.2: PCR performance of generated linear DNA templates after quality assessment. Histograms of PCR
success rate of (A) expected DNA fragment size, and (B) DNA-binding protein domains within the Drosophila
TFs.
The linear template library generated by PCR is sufficient to spot dozens of arrays from
PCR products in BSA. The PCR reactions can be used directly for array generation without
requiring additional purification steps, which further streamlines the approach. In addition,
spotted template arrays can be easily visualized because of the Cy3-fluorophore that was
added to the PCR product via the reverse primer.
6.4.1.3 Generation of an on-chip Drosophila TF-array
We programmed the MITOMI device consisting of 768 unit cells with the linear template
library (Figure 6.3 B) and expressed proteins in situ using the SP6 ITT kit.
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Protein expression levels were characterized by relating BODIPY intensities under the button
valve area to the number TFs carrying a lysine-BODIPY-charged tRNA, which were bound
to the surface-immobilized antibody. This correlation was confirmed when additionally de-
tecting protein pull-down with a secondary Hilyte Fluor 647 labeled GST-antibody (Figure
6.4). Detected protein signals (in relative fluorescence units, RFU) can thus be correlated to
expression levels after normalization to their lysine counts (Figure 6.7).
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Figure 6.4: Correlation between signal intensities of protein pull-down labeled with a lysine-BODIPY-charged
tRNA and a secondary GST-antibody (Hilyte Fluor 647) on the same TF array.
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The sensitive detection of different BODIPY signals allows a quantitative analysis of the
amount of protein present for each TF, unlike in Y1H methods were TF expression levels are
not assessed.
Detection of TF expression was considered positive for BODIPY signals that showed 2
s.d. above average noise level of negative controls (only BSA spotted). We detected protein
expression that was significantly higher than the negative controls (only BSA) on average for
more than 90% of the DNA templates with very good reproducibility (r2=0.85) as shown in
Figure 6.5.
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Dotted gray lines indicate the background threshold (2 s.d. above the mean of the negative control).
Overall, we successfully detected 423 full-length drosophila TFs on-chip (Figure 6.5), which
constituted 56% of all 755 predicted fly TFs. Protein expression was uniformly detected
among all major TF families (Figure 6.6 B). We expressed 93.2% of the 454 linear DNA
template library with protein sizes ranging from 317 to 2078 amino acids (37-231 kDa) (Figure
6.6 A). By comparison, in a previous study 43 S. pneumonia proteins were detected ranging
in size from 35-757 amino acids (4-83 kDa) on a microfluidic device [10]. The protein array
generated in this study thus increases throughput by an order of magnitude and consists of
large eukaryotic proteins.
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Contrary to the study on 43 prokaryotic proteins, we repeatedly observe a correlation
between protein size and expression levels (Figure 6.7), which could have several reasons:
Larger proteins take longer to synthesize and their size may prevent more proteins to bind
to the surface-immobilized antibody. In addition, the accessibility of the GST-tag may be
compromised for binding to the antibody.
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Figure 6.7: Correlation of protein expression levels and expected protein size: protein expression levels were
normalized to the number of lysine residues per protein and plotted as a function of protein size for all 454 TF
(error bars: standard deviation; n=6).
6.4.1.4 Detection of TF-DNA interactions on chip
After obtaining quantitative protein expression levels, the TF-array was assessed for the
ability to detect TF-DNA interactions. Recent interrogations of TF binding specificities by
ChIP-seq and in vitro methods suggest that TFs exhibit considerable cross-reactivity and
that promiscuous binding can be of functional significance [176]. To investigate the extent of
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TF promiscuity on a systems-level, we used the MITOMI platform to measure the binding of
12 DNA consensus motifs for TFs involved in the well-studied even-skipped GRN (bcd, D,
gt, kni, Kr, Mad, Med, pan, prd, tin, ttk, twi) [173] against all 423 TFs present on our array.
The 12 double-stranded DNA motifs were synthesized by isothermal primer extension of
single-stranded Cy5-labeled oligonucleotide sequences. We loaded all 12 DNA sequences
as a pool together with the ITT mix into the chambers containing linear DNA templates
to synthesize TFs. Adding the target DNA motifs as a pool to the ITT resembles closer
the situation inside the cell, where TFs have to discriminate between an abundance of
genomic DNA. The detected Cy5 intensity of TF-bound DNA correlates to the number of
DNA molecules bound to surface immobilized TF, which is reflected by the BODIPY intensity
in the same area. Interrogating all 12 DNA motifs as a pool allowed us to test a total of 5,076
interactions in a single experiment (423 TFs x 12 DNA motifs). For 11 of these 12 motifs, the
targeted TF was present on our array. We observed DNA binding by 4 TFs (Kr, gt, prd, D),
while 7 TFs failed to bind DNA above background (bcd, kni, ttk, tin, Mad, twi, pan) as shown
in Figure 6.8.
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Figure 6.8: Gene-centered detection TF-DNA interactions on the Drosophila TF-array: scatter plot showing the
DNA binding as a function of protein expression of all 423 TFs on the array to a pool of 12 DNA consensus motifs
for TFs involved in the even-skipped gene regulatory network (GRN). Interactions are represented as grey circles.
Highlighted are targeted TFs expressed on the array (blue) and additional TFs that interacted with the consensus
sequences (black).
Amongst these 7 TFs, twist (twi) is known to require dimerization with another basic helix-
loop-helix (bHLH) domain for efficient DNA binding [177], and Mad was shown to bind DNA
only in a truncated form [178]. Given that Mad and twi were not expected to be functional
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we arrive at 4 out of 9 TFs (44%) that functionally bound to DNA in the context of this
particular set of proteins. This relatively low detection rate still compares well to a recent
large-scale Y1H study, based on the same ORF library [74], which identified 26% of the
control interactions, as well as other Y1H screens on C. elegans (25-33%) [86, 69].
6.4.2 TF-centered approach to characterize TF-DNA interactions
6.4.2.1 Affinity and specificity measurements
Interestingly, in addition to previously known interactions, we also identified 11 TFs (gsb-n,
gsb, Pdp1, slbo, z, Sox21a, Sox102F, Gsc, Ets65A, bun, CG15696) that reproducibly bound
to one or more of the 12 consensus motifs on the TF-array (Figure 6.8). Three of these TFs
(Pdp1, Sox21a, bun) had no prior PWM associated with them. As we initially interrogated the
12 consensus sequences as a pool, we next set out to determine the binding specificities and
affinities of each of the 11 TFs individually. For these quantitative measurements we took a
TF-centered approach by programming the MITOMI device with known concentrations of the
12 target DNA motifs and detecting the binding preferences to the selected TF. We obtained
saturating binding curves for each TF-DNA sequence combination by fitting the measured
DNA/protein ratio signals over available consensus DNA (in solution) to a single-site binding
model (Figure 6.9 A, B, left panel). The ratio of DNA fluorescence intensities to BODIPY
intensities was used as a dimensionless factor of how strongly DNA was bound by protein as
the number of protein and DNA molecules beneath each button can differ due to fluid flow
variations in the channels. Binding affinities to each consensus motif were then plotted as Kd
value (Figure 6.9 A, B, right panel).
Overall we obtained Kd values for 228 TF-DNA interactions from binding curves consisting
of 6,192 data points. The detailed affinity analysis showed that all 11 TFs were able to
bind DNA, indicating that the false positive rate of on-chip TF-DNA interaction detection with
MITOMI is low. Out of these 11 TFs, 8 TFs bound specifically and with high affinity to one of
the 12 consensus motifs: i) gsb, and gsb-n bound the prd motif, ii) slbo, and Pdp1 bound
the gt motif, iii) Gsc bound the bcd motif, iv) Ets65A bound the Mad motif, and v) Sox21a
and Sox102F bound the D motif. Z bound to both the bcd and prd motif with high affinity.
CG15696 binding was weak but showed a slight preference for the gt motif, while bun was
entirely non-specific.
81
Chapter 6. Drosophila transcription factor array
gs
b-
n r2 = 0.82   
r2 = 0.58   
r2 = 0.79   
r2 = 0.67   
r2 = 0.43   
r2 = 0.33   
r2 = 0.96  
r2 = 0.70
gs
b
slb
o
Gs
c r2 = 0.79
r2 = 0.86
 
r2 = 0.97
r2 = 0.85
CG
15
69
6
Et
s6
5A
z
r2 = 0.40
Pd
p1
0.01 0.01
0.1
1
10
K d
 (µ
M
)
r2 = 0.92
r2 = 0.85
r2 = 0.92
So
x2
1a
r2 = 0.65
So
x1
02
F
bu
n
0.2
0.4
0.6
DN
A/
Pr
ote
in
0.1
1
10
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
0.1
1
10
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
0.1
1
10
0.1
1
10
0.1
1
10
0.1
1
10
0.1
1
10
0.1
1
10
0.1
1
10
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
0.1
1
10
0.1
1
10
0.1
1
10
0.1
1
10
0.1
1
10
0.1
1
10
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
0.1
1
10
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
0.1
1
10
K d
 (µ
M
)
0.2
0.4
0.6
0.80.8
DN
A/
Pr
ote
in
0.01
0.1
1
10
K d
 (µ
M
)
0.2
0.4
0.6
DN
A/
Pr
ote
in
bcd D g
t kni KrMa
d
Me
d
panprd tin ttk tw
i0
0
0.1 0.2 0.3 0.4 0.5
Free DNA (µM)
bcd D g
t kni KrMa
d
Me
d
panprd tin ttk tw
i0
0
0.1 0.2 0.3 0.4 0.5
Free DNA (µM)
monomer dimerA B
r2 = 0.57
r2 = 0.53
Figure 6.9: Binding specificities and affinities of TFs for which binding was observed were measured for all
12 DNA consensus motifs in two different modes: (A) For monomer-DNA binding, target DNA could bind
only to surface-immobilized TFs. (B) In the second mode, TFs were allowed to interact with DNA consensus
sequences in solution prior to antibody binding and detection, which potentially allowed for TF binding to DNA.
Concentration-dependent binding curves are derived from fitting the measured DNA/protein ratio signals over
available consensus DNA (in solution) to a single-site binding model (left); binding affinities to each consensus
motif is plotted as Kd value with standard errors (right). Specificity and affinity measurements of TFs to DNA
sequences for all 11 newly identified TFs, which bound to one or more of the 12 DNA consensus motifs (bcd, D,
gt, kni, Kr, Mad, Med, pan, prd, tin, ttk, twi).
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To account for the fact that some TFs are known to require multimerization or dimer formation
for efficient binding to DNA, we measured saturation binding curves in two distinct modes for
8 TFs: the first mode favoring monomer-DNA binding, in which the target DNA was presented
to a surface bound TF (Figure 6.9 A). In a second, the TF was loaded into the chamber, which
allowed the formation of homodimers while binding to a target DNA (Figure 6.9 B). Several
TFs indeed showed increased binding affinities when allowed to interact in a dimer-like
manner (Figure 6.9 B). Binding specificity was more pronounced for zeste (z) when multiple
recognition sites were presented, which is also known to require a much longer DNA binding
sequence (16 bp) for efficient binding than its consensus sequence would suggest [179].
Interestingly, although almost the same DNA binding motif had been discovered for both
gooseberry TFs in a bacterial one-hybrid study (B1H) [180], they do not display the same
binding preference. This seems to be supported by the fact that different non-overlapping
control elements drive the specific expression of gsb and gsb-n [181]. The only candidate
that showed non-specific binding was bunched (bun), which had been reported to contain
a leucine zipper dimerization domain and as such may require other proteins to bind DNA
efficiently [182].
6.4.2.2 Assessment of TF integrity
To further estimate how many of the expressed TFs could functionally bind DNA, we randomly
selected 8 TFs spanning the entire size range and tested each TF against a library of
particular DNA sequences. This De Bruijn library contains all 65,532 8mer sequences
computationally segmented into 1,524 double-stranded target DNAs [13]. Labeling the 70
bp oligonucleotides with a Cy5- and a Cy3-fluorophore, respectively, allowed us to harbor
all of the 1,524 DNA fragments on one MITOMI device with 768 unit cells by programming
each unit cell with two different sequences. ITT mix with the selected TF was loaded into
the chambers and allowed to interact with the DNA sequences before trapping the TF-DNA
complexes bound to the surface area under the button valve.
Of the 8 TFs tested, 3 TFs bound strongly and specifically to DNA allowing us to determine
position weight matrices (PWMs) for these TFs. An additional 2 TFs showed DNA pull-down,
but the quality of the data was not sufficient to derive PWMs, and 3 TFs failed to bind to
DNA (Figure 6.10). Based on this analysis we estimate that 38-63% of TFs on the array can
functionally bind DNA. This is a conservative estimate, as TFs may be folded correctly, but
require a co-factor for functional DNA binding. Nevertheless, it compares well with a previous
estimate of 35-41% of functional TFs derived from a protein array generated by expression
of human proteins in yeast, followed by large-scale purification, and microarraying [8].
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Figure 6.10: Binding ability of randomly chosen TFs was assessed on an oligonucleotide array containing all
possible 65,532 8mer sequences (de Bruijn library). The table summarizes plots of measured Cy3 and Cy5
intensities after background correction for each oligonucleotide and a supporting scan image for each channel for
detected TF-DNA binding.
We thus could establish that protein arrays generated by in vitro transcription-translation
perform as well as classical protein arrays, but drastically reduce cost and labor associated
with array generation. A similar comparison to Y1H assays is difficult, as parameters such as
TF expression, and ability to bind DNA have not been assessed in Y1H assays. Although,
a recent Y1H study identified only 26% of control interactions on previously characterized
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cis-regulatory modules, the authors claim that this number should be treated with caution
because of missing high-confidence protein-DNA interaction to validate the assay [74].
6.4.2.3 Determination of DNA binding motifs
We completed our TF characterization by determining the position weight matrices (PWMs)
for 8 TFs, including Kr, prd, CG15696, Rel, achi, and gt, and de novo PWMs for the unchar-
acterized TFs Pdp1 and Sox21a (Figure 6.11). We adopted and streamlined the method
of Fordyce et al. [13], permitting the same 8mer measurement depth using 768 unit cells
instead of the 4,160 unit cell device previously required. The motifs for Kr, prd, CG15696,
Rel and achi determined in our analysis were in good agreement with motifs found in the
database of Drosophila TF DNA-binding specificities (http://pgfe.umassmed.edu/TFDBS/).
A motif for gt could not be reproduced with confidence, which is reflected by the variety of
published motifs [183]. However, applying a multiple-motif model may reveal a secondary
model as shown for many TFs (especially with motifs longer than 10 nucleotides) using the
Seed-and-Wobble algorithm [80].
Our determined motif and the novel motifs found for Pdp1 and Sox21a reflected known
motifs of other members of the bZip (Pdp1) and HMG-box (Sox21a) family of transcription
factors. In particular, Pdp1 had shown strong preference for the gt target DNA in the affinity
measurements. This preference was supported by a high similarity between the gt consen-
sus sequence and the motif found for Pdp1, with a very high correlation (r2=0.98) between
experiments performed on different days.
6.5 Conclusions
Current approaches to study TF-DNA interactions at a systems level for GRN mapping usually
involve rather insensitive high-throughput screens, which can be susceptible to a high false
positive/negative rate and thus require validation by additional methods. In this project, we
developed a high-throughput gene-centered approach for integrated systems-level interaction
mapping (iSLIM) of TF-DNA interactions. iSLIM uses a single microfluidic platform based
on the MITOMI principle for qualitative detection of TF-DNA interactions as well as their
quantitative characterization. To demonstrate the versatile applicability of iSLIM for studying
regulatory networks, we generated an in situ synthesized protein array, on which we detected
protein binding to specific DNA sequences and determined the binding affinity and specificity
of detected binding events.
We successfully expressed 423 full-length Drosophila melanogaster TFs (93%) in situ from
DNA templates, which is, to our knowledge, one of the most comprehensive fly TF collections
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Figure 6.11: Determination of DNA binding motifs by de Bruijn analysis of 7 TFs. The binding specificity of
selected TFs was assessed on an oligonucleotide array containing all possible 65,532 8mer sequences (de
Bruijn library). The library consisted of 1524 double-stranded oligonucleotides, labeled with Cy3 and Cy5 in equal
parts. The motifs found with iSLIM platform are shown in comparison to previously known motifs (if any), listed in
the database of Drosophila TF DNA-binding specificities (http://pgfe.umassmed.edu/TFDBS/).
produced on a microfluidic chip. Between 38 and 63% of these TFs are estimated to be
functional based on the analysis of binding preferences of 9 randomly selected TFs to 1,524
individual DNA sequences. We further confirmed the TF integrity by simultaneously interro-
gating our TF array with 12 specific DNA sequences, which allowed us to measure 5,076
(12 DNA x 423 TF) interactions in a single experiment. In measurements with specific DNA
sequences known to bind to TFs from a well-characterized GRN we were able to detected at
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least 44% of the expected TF-DNA interactions, supporting the previous estimate. However,
this is probably a conservative number given that many of these TFs potentially form dimers
with other proteins or require co-factors for efficient DNA binding and compares well with other
in vitro approaches under similar conditions. Moreover, 11 additional interactions, previously
unreported within this GRN, were confirmed in affinity and specificity measurements using
the same platform, asserting a very low false positive/negative rate for our approach and
giving rise to 228 Kd values from binding curves with a total of 5,472 data points. We further
demonstrated the versatility of iSLIM by determining DNA binding motifs for TFs with known
and unknown position weight matrices (PWM).
To conclude, we established a comprehensive methodology for gene-centered mapping
of GRNs by rapidly generating a large-scale TF-array from ORF libraries and detecting thou-
sands of TF-DNA interactions in a single experiment. Unlike other gene-centered methods,
our approach allows quantitative assessing the expression level of each investigated TF and
requires an order of magnitude less time, as a single experiment takes only 1-2 days as
opposed to ∼2 weeks for Y1H screens. Compared to classical protein arrays we reduce
associated costs and labor by circumventing tedious cell-based protein expression, and pu-
rification. Moreover, using the same platform we can fully characterize TF-DNA interactions
including determination of de novo consensus motifs/PWMs and quantitative measurements
of binding energy landscapes, which makes it the only method capable of both gene-centered
and TF-centered approaches to characterize GRN. In a recent publication, we show that it is
even possible to measure the kinetics of TF-DNA interactions in large-scale using a modified
MITOMI device [97].
Given these performance advantages over existing methods, our approach will contribute to
the large-scale mapping of GRNs and provide a detailed quantitative analysis of the interac-
tions constituting GRNs. Finally, since experiments are conducted in vitro and integrated with
a next generation detection method, reaction conditions can be precisely controlled enabling
the analysis of higher-order interactions, which is not feasible with Y1H methods and may be
difficult to achieve using standard protein arrays. iSLIM thus provides a universal tool that
cannot only complement current methods but has the potential to replace other techniques
to systematically map molecular interactions in any given organism, which will aid systems
biology in the quantitative characterization of GRNs.
6.6 Future Directions
In order to further assess the overall integrity of each individual TF on the array we will
measure binding potential of TFs to genomic DNA, and the binding specificity to specific
promoter regions by interrogating the TF array with fragmented DNA sequences covering
the entire Drosophila genome. This will undoubtedly give us a more reliable estimate of how
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many TFs are functional and therefore likely to bind to specific DNA sequences in future
sub-network studies on the array.
Given that our proof-of-principle measurement with iSLIM on the well-studied even-skipped
GRN in Drosophila melanogaster already revealed previously unknown network connections
with high confidence (low false positive/negative rate), we aim to move from highly character-
ized sub-networks to less well characterized global networks to link and better understand
the regulation in a highly interconnected network. These experiments may also provide more
insight into binding site promiscuity, as shown for several consensus motifs in our affinity and
specificity measurements. Coupled with association and dissociation rate measurements
using the novel kinetic MITOMI device [97] we envision extending the informational content
of GRNs significantly. In addition to binary TF-DNA interactions, iSLIM could be used to
investigate homo- and heterodimer formation, which is known to be required for many TFs to
efficiently bind DNA, by implementing co-spotting and multiplexing with different fluorophores.
This strategy will also allow systematic studies with a combination of regulatory and co-
regulatory factors and will facilitate the feasibility of large-scale protein-protein interaction
studies on a proteomic level. In addition, other effects on the binding affinity of TFs, especially
CpG methylation of DNA sequences, to enlighten the consequences of epigenetic regulators
could easily be implemented in on-chip TF characterization as recently shown [144].
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On-chip protein synthesis overcomes a lot of the known limitations of conventional protein
arrays, notable saving time and reagents as well as reducing the risk of protein degradation
during array generation. In this thesis two approaches for on-chip protein synthesis were
investigated in order to study protein interactions in large scale using a microfluidic device.
This work includes a novel method to purify proteins on-chip from yeast cells as well as a new
and improved PCR-based method compatible with large-scale applications for the generation
of linear expression-ready DNA templates directly from yeast cell libraries for cell-free protein
expression. In addition, a microfluidic method was developed for integrated systems-level
interaction mapping (iSLIM) and quantitative characterization of transcription factor (TF)-DNA
interactions.
While classical protein arrays remain extremely time and resource consuming to produce,
this work demonstrates that functional proteins can be retrieved efficiently without the need
for tedious bench-top purifications, when coupled to/integrated with a microfluidic platform
capable to detect protein interactions. The presented methods are faster than other assays: a
single multiplexed experiment takes between 1 and 3 days for cell-free protein synthesis and
in-situ protein extraction from cells, respectively, while actual hands-on times are reduced to
1 to 2 hours. In addition, using a microfluidic platform substantially decreases experimental
costs by minimizing reagent consumption to a few microliters per experiment. On-chip
protein expression from DNA templates runs at a cost of 1-2 cents per synthesized protein.
Consequently, one round of TF-DNA interaction screening on our iSLIM platform costs ∼10
CHF. Protein extraction from deposited yeast cells reduces the expenses by another order of
magnitude. A direct cost comparison to other methods is difficult, as screening assays vary
largely with respect to experimental procedures and detection mechanisms. In addition to
favorable operation times and costs, the problems associated with protein stability for storage
and array production are eliminated when producing a protein microarray on demand from
either DNA templates or cells.
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However, the programmable nature of MITOMI-based devices has been shown to be more
than a screening platform: When coupled to an organism-independent DNA library of compu-
tationally assembled oligonucleotide sequences, it allows detailed quantitative analysis and
full characterization of protein-DNA interactions. At the same time, applying this TF-centered
approach validates detected binding events and verifies that MITOMI shows, unlike other
interaction screening platforms, a very low false positive rate. Finally, since the method is
conducted in vitro and integrated with a next generation detection method, reaction conditions
can be precisely controlled, enabling the analysis of higher-order interactions, which is not
feasible with Y1H methods and may be difficult to achieve using standard protein arrays.
Given these performance advantages over existing methods, pairing MITOMI-based detection
of molecular interactions with alternatives to conventional protein arrays will contribute to the
large-scale mapping of gene regulators networks (GRNs) and provide a detailed quantitative
analysis of the interactions constituting GRNs.
7.1 Limitations and suggestions for the improvement of the cur-
rent approaches
The aim of this work was to investigate different approaches to generate protein arrays to
study protein interactions using a microfluidic device. Here we demonstrate the potential
of an in vitro on-chip cell-based approach and the capacity of an integrated microfluidic
method for systems-level TF-DNA interaction mapping and characterization on an in situ
synthesized protein array. Although performed on a library of yeast ORF-fusion proteins
hosted in Saccharomyces cerevisiae, the cell-based approach described in chapter 4 can
be easily adapted to other protein-fusion cell libraries. It is certainly worthwhile to consider
using E. coli transformants to facilitate on-chip lysis and increase protein yields. On the other
hand, some eukaryotic proteins expressed in bacteria are not functional as a result of missing
post-translational modifications or incorrect folding due to differences in the prokaryotic
enzymatic machinery. Regardless of the host organism, protein (over-)expression in the
wrong spatio-temporal cellular context may be toxic for the cells themselves and trigger a
number of modifications.
While a genomically integrated yeast fusion library was considered impractical for gen-
erating in situ protein arrays from cells, physiological expression levels may be advantageous
for the detection of protein interactions to promiscuous binding sites. However, first and
foremost the possibilities of a cell-based protein array to detect relevant protein interactions
should be assessed to assure array integrity.
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The second study on cell-free in situ protein synthesis using iSLIM investigated 60% of
all known Drosophila melanogaster TFs (454 of 755), of which 93 % (423 of 454) were
considered potential candidates for protein interaction mapping after in situ protein expres-
sion. Arguably, this is one of the most comprehensive fly TF interaction platforms in vitro.
Nevertheless, to get a complete picture of the fly transcriptome, it is indispensable to include
information from potential interaction partners that were not incorporated in the presented
work (∼44 %).
Currently, most in vitro approaches, including those presented in this work, focus on studying
one particular protein interaction at a time, which does not reflect the physiological condition,
where competing binding partners are abundant and the protein needs to find its specific
regulatory site. Moreover, it is well known that many TFs only bind to their target DNA after
dimer formation with another protein or association with other co-regulators. Addressing
this shortcoming would greatly expand the scope of possible interactions and could be
implemented by co-spotting of several proteins or additional co-regulators (e.g. two different
expression templates) as described in chapter 4. Furthermore, binding to a pool of frag-
mented genomic DNA would give a much more realistic picture of functional TFs binding
to their regulatory sequence. Multiplexing with different fluorescence labels would increase
throughput and narrow down the potential genomic binding sequence.
Finally, all approaches in this thesis are performed in vitro in precisely controlled reaction
conditions. On the other hand, one of the main limitations of most in vitro protein interaction
studies is the absence of a cellular environment, which contributes to the complexity of
molecular interactions and GRNs. Mapping post-translational modifications, such as phos-
phorylation or methylation, and other upstream signal transduction pathways is exceedingly
important to elucidate contributors to differential gene expression and complete the current
understanding of protein interaction networks. The kinetics of these usually enzymatically
conveyed modifications could be measured in high-throughput by developing a sensitive
on-chip enzyme assay.
7.2 Future applications of microarrays in the field of molecular
biology
While post-translational modifications on in situ synthesized is relatively difficult to implement,
modifications on the DNA level could be more easily pursued. DNA methylation is crucial
for epigenetic differences between cell types and pathological states, but its effects on TF
binding has not been studied in detail. A recently fabricated microarray of duplex methylated
DNA showed the potential of this platform [184] and could be modified to determine the
binding preferences and affinities of a TF in the presence of methylated sites.
91
Chapter 7. General discussion and outlook
In this work, the iSLIM approach was successfully demonstrated on a TF array consist-
ing of more than 400 Drosophila TFs. This approach can be easily adapted to cover all TFs
of other organisms, such as mouse or yeast. It would be also interesting to compare the
iSLIM approach to the human transcriptome study, performed on a classical protein array
with ∼ 4,200 purified human proteins [8].
The protein-centered and gene-centered approach of iSLIM can also be applied to map
and characterize other specific sub-networks, such as for proteins involved in ribosome
biogenesis. A recent publication on 110 yeast ribosomal protein (RP) promoters uncovered
that mutations in certain DNA sequences reduced promoter activity [185]. Measuring binding
energy landscapes of RP alone or in combination with other protein against a large DNA
library could provide more information on the transcriptional regulation of RP promoters.
Furthermore, a gene-centered screen using the TF library could be applied to discover
proteins that specifically bind to promoter sequences involved in ribosome biogenesis, which
have been much less characterized than RP promoters.
While studies on native promoters provide useful information, defined synthetic promoter
libraries allow studying gene regulation systematically. Characterizing the binding properties
and determining the binding energy landscapes of each promoter sequence from a recently
published library of 128 synthesized eukaryotic promoters [186] will further aid our under-
standing of gene regulation.
Expanding in situ protein synthesis to the entire protein repertoire of an organism on a
MITOMI device with higher throughput as described in chapter 3, would establish a com-
prehensive interaction network on a proteome level. As already outlined in the previous
section, screening the proteome array with fragmented genomic DNA will be advantageous
to assess the array integrity. In addition to characterizing other sub-networks with selected
DNA sequences a library of native and synthetic promoter sequences (see above paragraph)
could detect previously unknown proteins with regulatory activity.
Another interesting biological question to be addressed with the iSLIM approach is how
microRNA (miRNA) binding to mRNA transcripts affects the level gene expression. A recent
screen set out to identify 40% of all Drosophila genes that are involved in the miRNA pathway
[187].
Although in this work we primarily focused on characterizing TFs that associate directly
with the genes they regulate, the MITOMI principle has been used to measure other molecu-
lar interactions, involving single-stranded RNA and drug molecules [11]. A similar approach
could be applied to investigate pathways that affect gene regulation further downstream, for
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example, to identify genes that are involved in the mircroRNA (miRNA) pathway and measure
how miRNA binding to mRNA transcripts affects gene regulation. Another example is to
identify the role of regulatory sequences in untranslated regions or non-coding RNAs using a
comprehensive library of cDNA complementary to RNA transcripts.
Mapping of molecular interactions and their full characterization has been long tackled
by opposing approaches. However, when coupled to next-generation sequencing and de-
tailed kinetic measurements [97], the microfluidic approach based on the MITOMI principle
has the potential to characterize the entire transcriptome of any given organism and con-
tribute substantially to our current understanding of the regulatory network and its underlying
mechanisms.
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A MITOMI - A microfluidic platform for
in vitro characterization of transcrip-
tion factor-DNA interactions
.
A.1 Abstract
Gene regulatory networks (GRNs) consist of transcription factors (TFs) that determine
the level of gene expression by binding to specific DNA sequences. Mapping all TF-DNA
interactions and elucidating their dynamics is a major goal to generate comprehensive models
of gene regulatory networks (GRNs). Measuring quantitative binding affinities of large sets of
TF-DNA interactions requires the application of novel tools and methods. These tools need
to cope with the difficulties related to the facts that TFs tend to be expressed at low levels in
vivo, and often form only transient interactions with both DNA and their protein partners. Our
approach describes a high-throughput microfluidic platform with a novel detection principle
based on the mechanically induced trapping of molecular interactions (MITOMI). MITOMI
allows the detection of transient and low-affinity TF-DNA interactions in high-throughput.
A.2 Introduction
Transcription factors (TFs) are proteins that bind to specific DNA sequences and regulate
the level of gene expression by either promoting or blocking the transcription of specific
genes. These specific TF-DNA interactions are part of a dynamic gene regulatory network
(GRN), which is beginning to be understood by generating complex models from data of both
experimental and computational methods [188, 189].
The comprehensive characterization of GRNs requires large-scale quantitative measure-
ments of TF-DNA interactions in a high-throughput format. However, conventional experi-
mental methods to study molecular interactions are limited by being either non-quantitative
[77, 190] or relatively low-throughput [191]. Generating microarrays of immobilized double-
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stranded DNA sequences and probing them with off-chip purified proteins has been widely
used for the detection of TF-DNA interactions.
The more recent introduction of microfluidics in the field of protein and DNA microarrays
is a promising approach to scale-down and parallelize biological assays and study individ-
ual molecular interactions in a miniaturized format. The use of microfluidics platforms has
many advantages: samples can be detected with high-precision and sensitivity while at
the same time decreasing the amount of consumables, and time needed, as compared to
more conventional methods [192]. With the development of multilayer soft lithography for
the rapid prototyping of microfluidic systems [193, 194] and microfluidic large-scale inte-
gration (MLSI) [114] microfluidic technology has become appealing to the field of biology.
These MLSI devices are generally fabricated from elastomeric materials such as PDMS
(polydimethylsiloxane) and harbor micron-sized channels with thousands of integrated mi-
cromechanical valves. Among the increasing number of applications in biology, microfluidic
platforms emerged as powerful screening tools to study molecular interactions, which show
the potential of realizing high-throughput and high-precision measurements [36, 12].
With the highly integrated microfluidic device described in this protocol a novel detection
method has been established based on the mechanically induced trapping of molecular
interactions (MITOMI). MITOMI allows the capture of transient and low-affinity interactions
between DNA sequences and TFs at equilibrium, and thus the measurement of absolute
binding affinities. In short, picoliter-sized reaction chambers within the array of the microfluidic
chip are aligned to spots of dsDNA sequences printed onto an epoxy-coated glass slide
using standard DNA microarray instruments. After loading an in vitro transcription/translation
(ITT) mixture together with genomic DNA coding for the TF, the TF of interest is synthesized
on-chip and can bind to freely diffusing target DNA. These binding events are separated by
micromechanical valves and thus will be detected independently by MITOMI.
95
Appendix A. MITOMI - A microfluidic platform for in vitro characterization of
transcription factor-DNA interactions
A.3 Materials
A.3.1 Mask & Wafer Fabrication
A.3.1.1 Instruments for mask & wafer fabrication
1. Mask writing on Heidelberg DWL200 laser lithography system (Heidelberg Instruments
Mikrotechnik GmbH)
2. Mask and wafer development using DV10 (Süss MicroTec AG)
3. Wafer cleaning with oxygen plasma before processing using Tepla300 (PVA Tepla AG)
4. MA6 Mask Aligner (Süss MicroTec AG) for exposure of wafers
5. Sawatec LMS200, programmable coater for negative resist and Sawatec HP401Z,
programmable hot plate for soft bake (Sawatec AG)
6. Süss RC-8 THP, manual coater and hotplate for positive resist (Süss MicroTec AG)
A.3.1.2 Materials for mask & wafer fabrication
Chemicals used in mask and wafer fabrication are from Rockwood Electronic Materials,
Gréasque, France, and of Metal-Oxyde-Semiconductor (MOS) quality, unless otherwise
stated.
1. Masks: square blank 5" Nanofilm SLM 5 (Nanofilm)
2. Silicon wafers (diameter: 100 ± 0.5 mm, thickness: 525 ± 25 µm, conductivity type: P,
dopant: Boron, resistivity range: 0.1-100 Ωcm; Okmetic)
3. Photoresists: AZ9260 positive photoresist (MicroChemicals GmbH); SU-8 negative
photoresist GM1060 and GM1040 (Gersteltec)
4. Chrome etching of masks: CR7 consisting of (NH4)2 Ce(NO3)6; HClO4
5. Developers: MP 351 for mask and AZ 400K for AZ9260 coated wafers (AZ Electronic
Materials); PGMEA (1-methoxy-2-propyl-acetate) for manual development of SU-8
wafers;
6. Solvents: Remover 1165 composed of 93% NMP (N-methyl-2-pyrrolidone; Sotrachem
Technic) and 7% PGMEA for masks; isopropyl alcohol (IPA); acetone for wafers
A.3.2 MITOMI device fabrication by multilayer soft lithography
1. PDMS (Polydimethylsiloxane) resin: heat curable silicone elastomer (Dow Corning
Sylgard 184)
2. TMCS (trimethylchlorosilane) (Sigma-Aldrich)
3. Mixing and degassing of PDMS: Thinky Mixer ARE-250 equipped with adaptor for 100
ml disposable PP beakers (C3 Prozess- und Analysentechnik GmbH)
4. Degassing of PDMS control layer: vacuum desiccator (Fisher Scientific AG)
96
A.3. Materials
5. Spin coating of PDMS flow layer: programmable spin coater SCS P6700 (Specialty
Coating Systems Inc.)
6. Stereomicroscope, SMZ1500 (Nikon AG)
7. Manual hole punching machine and pin vises, 21 gauge (0.04" OD) (Technical Innova-
tions, Inc.)
A.3.3 Epoxy slide preparation
Chemicals for epoxy-coating of glass slides are from Sigma-Aldrich.
1. Standard (76 x 26 x 1 mm) microscope glass slides (VWR)
2. Milli-Q water
3. Ammonium hydroxide (30%)
4. Hydrogen peroxide (30%)
5. Solvents: acetone, toluene, isopropyl alcohol (IPA)
6. 3-Glycidoxypropyl-trimethoxymethysilane (3-GPS; 97%)
7. Nitrogen gas supply
A.3.4 DNA synthesis
A.3.4.1 Synthesis of linear template DNA
All chemicals used for synthesis of DNA are from Sigma-Aldrich. For DNA primer sequences
see Table A.1.
1. DNA primers (Integrated DNA Technologies, IDT)
2. dNTPs (Roche Diagnostics AG)
3. Yeast genomic DNA (Merck Chemicals Ltd.)
4. Polymerase enzyme, Expand High Fidelity PCR system (Roche Diagnostics AG)
5. Elution buffer: 10 mM TrisCl, pH 8.5
A.3.4.2 Synthesis of target DNA
1. Primers, 5’CompCy5, (Integrated DNA Technologies, IDT)
2. dNTP (Roche Diagnostics AG)
3. Klenow fragment (3′ → 5′ exo-) (Bioconcepts)
4. Dithiothreitol (DTT)
5. Magnesiumchloride (MgCl2)
6. Buffer: Tris-HCl, pH7.9
7. 0.5% BSA in dH2O
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Table A.1: Primer sequences used to generate ITT linear templates and target DNA library.
 19 
 
Name 
(Comment)  Sequence 
5’CompCy5 
(Extension primer for target DNA 
synthesis) 
 5'-[Cy5]GTCATACCGCCGGA-3' 
Target DNA 
(Design of target DNA library. 
Variable binding sites of interest 
are bracketed by constant linker 
sequences. 3' ends consist of 
reverse complementary sequence 
of CompCy5 extension primer) 
 5'-[5'LINKER]-[BINDING SITE OF INTEREST]-
[3'LINKER]-TCCGGCGGTATGAC-3' 
Forward-ORF-HIS 
(Design gene specific sequence 
to Tm of 60°C. Start codon is 
underlined. First 5 codons code 
for 5xHis-tag. Alternatively 5xHis-
tag can be added to 
Reverse_ORF primer) 
 5'-
CTCGAGAATTCGCCACCATGCACCACCACCACC
AC-[GENE SPECIFIC]-3' 
Reverse-ORF 
(Design gene specific sequence 
to Tm of 60°C. Stop codon is 
underlined) 
 5'-GTAGCAGCCTGAGTCGTTATTA-[GENE 
SPECIFIC]-3' 
Forward extension 
T7 promoter sequence and 
transcription start site is indicated 
in italic and bold, respectively 
 5'-
GATCTTAAGGCTAGAGTACTAATACGACTCACTA
TAG 
GGAATACAAGCTACTTGTTCTTTTTGCACTCGAG
AATTC GCCACC-3' 
Reverse extension 
(Poly(A) track is underlined) 
 5'-
CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCC
AAG 
GGGTTATGCTAGTTTTTTTTTTTTTTTTTTTTTTTT
TTTTTT GTAGCAGCCTGAGTCG-3' 
Forward final  5'-GATCTTAAGGCTAGAGTAC-3' 
Reverse final  5'-CAAAAAACCCCTCAAGAC-3' 
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A.3.5 Microarraying / Spotting
1. QArray2 microarrayer (Genetix GmbH) equipped with a NanoPrint microarray printer
printhead and a 946MP3 micro spotting pin (Arrayit Corporation)
2. Bovine serum albumin (BSA; Sigma-Aldrich) re-suspended in DI water to 2 mg/ml
3. Synthesized target DNA templates (see A.3.4.2)
4. Epoxy-coated microscope glass slides (see A.3.3)
A.3.6 Microfluidic control elements
A.3.6.1 Pressure regulation and control
1. Precision pressure regulator, BelloFram Type 10, 2-25 psi; 1/8" port size (part. no.
960-001-000; Bachofen SA)
2. Bourdon tube pressure gauges, 0-30 psi (0-2.5 bar), G 1/4 male connection (part. no.
NG 63-RD23-B4; Kobold Instruments AG)
3. Custom-designed manual manifolds (rectangular metal casing: 14.5x1x1") for con-
trol line regulation with 16 detented toggles and barbs for 1/16" tubing ID; 1/4 NPT
connection (Pneumadyne Inc.)
4. Fittings to connect regulators to gauges and to luer manifolds (Serto AG): tee union
(SO 03021-8), male adaptor union (SO 01121-8-1/8)
5. Tubing: Tygon 1/4" OD x 1/8" ID (Fisher Scientific AG)
6. Polycarbonate luer fittings (Fisher Scientific AG): multi-port luer manifolds for flow inlet
regulation (e.g. part. no. Cole Parmer 06464-87); male luer to luer connector (part. no.
Cole Parmer 06464-90)
A.3.6.2 Fluidic connections
1. Disposable stainless steel dispensing needles to connect to syringe 23 gauge, 1/2"
long, ID 0.33 mm (part. no 560014; I & Peter Gonano)
2. Tubing (Fisher Scientific AG): for liquid/gas; flexible plastic tubing for fluidic connections,
Tygon S54HL, ID 0.51 mm;
3. Steel pins for chip-to-tube interface: tube AISI 304 OD/ID x L 0.65/0.30 x 8mm, cut,
deburred, passivated (Unimed S.A.)
A.3.7 MITOMI
A.3.7.1 Surface Chemistry
1. Biotinylated bovine serum albumin (Sigma-Aldrich), reconstituted to 2 mg/ml in DI
water (referred to as: BSA-biotin)
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2. Neutravidin (Thermo Scientific Pierce), reconstituted to 0.5 mg/ml in PBS (referred to
as: NA/PBS)
3. 1:1 solution of biotinylated Penta-histidine antibody (Qiagen AG) in 2% BSA
A.3.7.2 Transcription Factor Synthesis
1. TNT T7 coupled wheat germ extract mixture (Promega AG)
2. FluoroTect GreenLys-tRNA (Promega AG)
3. Linear template DNA coding for transcription factor (see A.3.4.1)
A.3.8 Data acquisition
1. Modified ArrayWorx scanner (Applied Precision) for detection and softWoRx software
2. Axon GenePix (Molecular Devices) for analysis
A.4 Methods
The entire process involves seven distinct steps that will be described in details (see Figure
A.1). Molds for the two-layer microfluidic device are fabricated on silicon wafers patterned
from laser-written chrome masks in a class 100 clean-room environment. A set of control
and flow molds is used to produce a double-layer device by multilayer soft lithography [36].
Libraries of Cy5-labeled target DNA sequences are synthesized and spotted onto epoxy-
coated microscope slides. The DNA arrays are aligned to the microfluidic device containing
768 unit cells and bonded overnight. Assembled chips are mounted on a microscope stage
and connected to a pneumatic setup. Each unit cell of the device can be controlled by three
individually addressable micromechanical valves, which allow compartmentalization of each
unit cell, control of DNA chamber access and the detection area. A circular button membrane
is used to mask a precisely defined area during surface derivatization and for the mechanical
induced trapping of molecular interactions (MITOMI).
Upon surface derivatization the device is loaded with a mixture of wheat germ in vitro
transcription/translation (ITT) extract and the linear DNA template coding for the TF of inter-
est. Spotted target DNA and the synthesized TF localize to an antibody deposited underneath
the circular button area. MITOMI is performed by actuating the button membrane and trap-
ping bound complexes in equilibrium. These complexes can subsequently be visualized
by scanning the device with a DNA array scanner. Binding affinities are determined by
quantifying the detected signals.
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Figure A.1: (1) Molds for the two-layer microfluidic device are produced on silicon wafers reproduced from chrome
masks. (2) A double-layer device is fabricated of PDMS (polydimethylsiloxane) by multilayer soft lithography
using a control and flow mold as template. (3) Microscope glass slides are surface modified with an epoxysilane
coating. (4a) Short, fluorescently labelled target DNA sequences are synthesized and (5) spotted onto the
epoxy-coated glass slides using a microarrayer before aligning and bonding them to microfluidic chip generated
in step (2). (6) After surface derivatization of the glass slide a mixture is loaded containing wheat germ in vitro
transcription/translation (ITT) extract and the synthesized linear DNA template (4b) coding for the TF of interest.
On-chip synthesized TFs are pulled down by immobilized antibody pulls down and can bind spotted target DNA
sequences. TF-DNA interactions are captured by a mechanism based on mechanically induced trapping of
molecular interactions (MITOMI) and (7) binding affinities quantified from detected interactions after scanning.
Note for researchers without clean-room and/or PDMS fabrication facilities: the MITOMI
devices may also be obtained directly for a nominal fee from the California Institute of
Technology (http://kni.caltech.edu/foundry/) and Stanford Microfluidic Foundries (http://www.
stanford.edu/group/foundry/index.html). Up-to-date protocols and microfluidic design files
can be found on our laboratory homepage (http://microfluidics.epfl.ch).
A.4.1 Mask & Wafer Fabrication
All processes in this section are performed in a class 100 clean room.
A.4.1.1 Mask fabrication
1. The two layer device is designed in CleWin4 (WieWeb software).
2. Each layer is reproduced as a chrome mask using a Heidelberg DWL200 laser lithogra-
phy system with a 10 mm writing head and a solid state wavelength stabilized laser
diode (max. 110mW at 405 nm).
3. For the development of masks, first the dispenser arm within the DV10 development
chamber is purged for 10 sec, then a developer mixture (MP 351:DI water 1:5) is
applied twice to the mask (15 sec), agitated for 45 sec and drained, before rinsing and
drying (50 sec).
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4. Developed masks are chrome etched for 110 sec, rinsed, cleaned twice 15 min in 1165
remover bath, quick rinsed and air dried.
A.4.1.2 Flow mold fabrication
1. A 3" silicon wafer is cleaned in a plasma stripper (Tepla 300) with 400 ml/min oxygen
gas at 500 W and a frequency of 2.45 GHz for a period of 7 min.
2. A 1-2 µm thin layer of GM1040 negative resist is deposited on the oxygen plasma
cleaned silicon wafer by spin coating first for 10 sec at 500 rpm (ramp 100 rpm/sec),
then for 46 sec at 1100 rpm (ramp 100 rpm/sec), followed by a short quick spin for 1
sec at 2100 rpm, and finally for 6 sec at 1100 rpm.
3. The pre-coated wafer is baked for 15 min at 65°C and 15 min at 105°C with a ramp of
4°C/min, and allowed to cool down to room temperature.
4. The wafer is exposed for 2 sec in flood exposure mode with an alignment gap of 15
µm, using a lamp with a light intensity of 10 mW/cm2 (further settings: WEC type: cont,
N2 purge: no, WEC-offset: off).
5. The exposed wafer is baked on a hotplate for 35 min at 100°C.
6. Positive resist AZ9260 is spin coated on the pre-coated wafer for 10 sec at 800 rpm,
followed by 40 sec at 1800 rpm (ramp 1000 rpm/sec) to yield a substrate height of
around 14 µm.
7. The coated wafer is then baked on a hotplate for 6 min at 115°C.
8. The soft-baked positive resist is allowed to rehydrate for 1 h.
9. The wafer is exposed on a MA6 mask aligner for 2 intervals of 18 sec with 15 sec.
waiting time in photolithography (soft contact) mode at 360 mJ/cm2 with a light intensity
of 10 mW/cm2 (broad band spectrum lamp). The alignment gap is set to 15 µm (further
settings: WEC type: cont, N2 purge: no, WEC-offset: off).
10. Following 1 h relaxation time the wafer is developed in a development chamber (DV10)
for 8-12 min based on visual observation after each cycle of the following routine with
a total time of 4 min: A development mixture (AZ 400K:DI water 1:4) is dispensed and
agitated on the wafer in three cycles, drained, rinsed (total time: 3:15 min), and finally
dried.
11. In a final step, channels of the flow mold are annealed and rounded at 160°C for 20
min to create a geometry that allows full valve closure.
A.4.1.3 Control mold fabrication
1. Negative photoresist SU-8 GM1060 is spin coated on an oxygen plasma cleaned silicon
wafer (see step 1 in A.4.1.2) first for 10 sec at 500 rpm (ramp 100 rpm/sec), then for 50
sec at 1500 rpm (ramp 100 rpm/sec), followed by a short quick spin for 1 sec at 2500
rpm, and finally for 6 sec at 1500 rpm to yield a height of ∼14 µm.
2. The coated wafer is baked for 30 min at 130°C and 25 min at 30°C on a hotplate.
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3. The wafer is exposed on a MA6 mask aligner for 3 intervals of 20 sec with 15 sec.
waiting time (all other settings see step 9 in A.4.1.2).
4. The exposed wafer is developed manually for 2 x 5 min in PGMEA, rinsed with IPA and
dried with an air gun.
A.4.2 MITOMI device fabrication by multilayer soft lithography
1. The control layer mold is placed in a glass petri dish lined with aluminum foil to facilitate
easy removal. Care must be taken that the aluminum foil lining doesn’t contain any
holes.
2. To generate a hydrophobic surface, both flow and control mold are exposed to vapor
deposits of TMCS for 30 min by placing them into a sealable plastic container with 1 ml
TMCS filled into a plastic cap. TMCS treatment is repeated for 10 min each time prior
to PDMS chip fabrication.
3. For the control layer, 60 g of a 5:1 Sylgard mixture (50 g Part A : 10 g Part B) is
prepared, mixed for 1 min at 2000 rpm (∼400 x g) and degassed for 2 min at 2200 rpm
(∼440 x g) in a centrifugal mixer.
4. The mixture is poured onto the control layer mold and degassed in a vacuum desiccator
for 10 min.
5. For the flow layer, 10.5 g of a 20:1 Sylgard mixture (10 g Part A : 0.5 g Part B) is
prepared, mixed for 1 min at 2000 rpm (∼400 x g) and degassed for 2 min at 2200 rpm
(∼440 x g) in a centrifugal mixer.
6. The mixture is spin coated onto the flow layer with a 15 sec ramp and a 35 sec spin at
2200 rpm.
7. After removing the control layer mold from the vacuum chamber any residual surface
bubbles are destroyed by blowing on top of the PDMS layer. Any visible particles on
top of the control channel grid are carefully removed using a toothpick.
8. Both layers are cured in an oven for 30 min at 80°C.
9. Following polymerization, both molds are taken from the oven and allowed to cool for 5
min.
10. The control layer is then diced with a scalpel and holes (1-8 and B, S, C, O in Figure
A.2 A) are punched at the control input side using a hole puncher or an 21 gauge luer
stub.
11. The channel side of the control layer is thoroughly cleaned with Scotch Magic Tape.
12. The cleaned control layer is then aligned to the flow layer on the stereomicroscope.
13. The device is bonded for 90 min at 80°C in an oven.
14. Bonded devices are removed from the oven and allowed to cool for 5 min.
15. Following the outline of the control layer each individual device is cut with a scalpel and
peeled off the flow layer.
16. Holes are punched for the sample inlet and outlet (S1-S7 and O in Figure A.2 A) using
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a hole puncher.
17. The flow channel side is cleaned thoroughly with tape before aligning the device to a
spotted glass slide (see A.4.5).
18. The flow mold is cleaned of any residual polymerized PDMS either by peeling off the
thin layer of PDMS using a pair of tweezers or by an additional PDMS layer. For the
latter, 11 g of a 10:1 Sylgard mixture (10 g Part A : 1 g Part B) is mixed for 1 min at
2000 rpm (∼400 x g), degassed for 2 min at 2200 rpm (∼440 x g), poured on the flow
mold cured in the oven for 30 min at 80°C, and peeled off after cooling down to room
temperature. The control mold is cleaned with a nitrogen air gun of any PDMS debris
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Figure A.2: MITOMI chip: (A) Drawing of a MITOMI device with 768 unit cells in the flow layer (blue) which
are controlled (red) by 2388 valves. Resistance equalizers towards solution inlets and outlet ensure equal flow
velocities and even derivatization in each row of the channels. (B) The magnified view shows two single unit cells
each controlled by 3 different micro-mechanical valves: the chamber in each dumbbell-shaped unit cell hosts
a different target DNA sequence and is isolated with the chamber valve during surface modification steps for
subsequent pull-down to an immobilized antibody in the detection area under the button membrane. For diffusion
of samples to the immobilized antibody chamber valves are opened while sandwich valves between individual
unit cells are closed in order to prevent cross-contamination between different samples. (C) Tygon tubing is
loaded with different sample solutions and connected to a metal pin that is plugged into a hole at the end of each
channel within the sample inlet tree (also see magnified insert of Fig. 2 B). Loading of the device with samples
via the inlets (S2-S7) is controlled by opening and closing the corresponding control valves. (D) A cross-section
of one of the unit cells is shown to illustrate the detection mechanism based on mechanically induced trapping of
molecular interactions (MITOMI). A thin deflectable membrane can be pushed down by actuating the water-filled
control channel and consequently physically trap any material under this area in the flow channel.
A.4.3 Glass slide preparation
A.4.3.1 Cleaning procedure
1. All glassware is prepared by rinsing with Milli-Q water.
2. 750 ml Milli-Q water and 150 ml ammonium hydroxide are heated to 80°C in a staining
bath.
3. 150 ml hydrogen peroxide is carefully poured to the ammonium solution.
4. Glass slides are added into the staining bath and incubated for 30 min.
5. After removal from the staining bath the glass slides are allowed to cool for 5 min.
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6. Glass slides are then rinsed with Milli-Q water in the staining bath.
7. Clean glass slides are dried with nitrogen and stored in a dust free box.
A.4.3.2 Epoxysilane deposition
1. Before epoxysilane deposition all glassware is rinsed with acetone and dried at 80°C.
2. Cleaned glass slides are incubated for 20 min in 891 ml toluene with 9 ml 3-GPS.
3. After rinsing with fresh toluene to remove unbound 3-GPS the glass slides are dried
with nitrogen.
4. Glass slides are baked at 120°C for 30 min.
5. Following sonication in toluene for 15 min glass slides are rinsed with fresh IPA.
6. Coated glass slides are dried with nitrogen and stored in a dust free box under oxygen
free conditions until usage.
7. In case of systematic PDMS chip delamination: Prior to DNA spotting, glass slides are
rinsed with toluene and dried with nitrogen.
A.4.4 DNA synthesis
A.4.4.1 Synthesis of linear template DNA
Generation of linear templates from genomic DNA or cDNA (see Note 1) of the TF of interest
by a two-step polymerase chain reaction (PCR) method in which the first step amplifies the
target sequence and the second step adds required 5’UTR and 3’UTR for efficient ITT.
1. For the first PCR step a mixture of the following components is prepared in a final
volume of 50 µl:
 1 
   
   
1    µM forward-ORF primer 
1 µM reverse-ORF primer 
100 ng yeast genomic DNA 
200 µM of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
   
(a) Denaturation 94°C for 4 min 
(b) Annealing 53°C for 60 sec 
(c) Elongation 72°C for 90 sec 
 
   
5    nM forward extension 
5 nM reverse extension 
1 µl PCR product (from previous step) 
200 µM of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
   
6.7   µM 5’CompCy5 
10 µM library primer  
5 units Klenow fragment (3’→5’ exo-) 
1 mM of each dNTP of a nucleotide mix  
1 mM Dithiothreitol (DTT)  
50 mM NaCl  
10 mM MgCl2 
10 mM Tris-HCl, pH 7.9 
 
       
 
2. After initial denaturation for 4 min at 94°C, the first PCR amplification is performed with
30 cycles as follows:
3. The correct product of this step should be ascertained on a 1% agarose gel.
4. For the second PCR step a mixture of the following components is prepared to yield a
final volume of 100 µl:
5. After initial denaturation for 4 min at 94°C, the second PCR amplification is performed
with 10 cycles as follows:
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 1 
   
   
1    µM forward-ORF primer 
1 µM reverse-ORF primer 
100 ng yeast genomic DNA 
200 µM of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
   
(a) Denaturation 94°C for 4 min 
(b) Annealing 53°C for 60 sec 
(c) Elongation 72°C for 90 sec and finish 
with a final extension at 72°C 
for 7 min 
 
   
5    nM forward extension 
5 nM reverse extension 
1 µl PCR product (from previous step) 
200 µM of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
   
6.7   µM 5’CompCy5 
10 µM library primer  
5 units Klenow fragment (3’→5’ exo-) 
1 mM of each dNTP of a nucleotide mix  
1 mM Dithiothreitol (DTT)  
50 mM NaCl  
10 mM MgCl2 
10 mM Tris-HCl, pH 7.9 
 
       
 
 1 
   
   
1    µM forward-ORF primer 
1 µM reverse-ORF primer 
100 ng yeast genomic DNA 
200 µM of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
   
(a) Denaturation 94°C for 4 min 
(b) Annealing 53°C for 60 sec 
(c) Elongation 72°C for 90 sec 
 
   
5    nM forward extension 
5 nM reverse extension 
1 µl PCR product (from previous step) 
200 µM of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
   
6.7   µM 5’CompCy5 
10 µM library primer  
5 units Klenow fragment (3’→5’ exo-) 
1 mM of each dNTP of a nucleotide mix  
1 mM Dithiothreitol (DTT)  
50 mM NaCl  
10 mM MgCl2 
10 mM Tris-HCl, pH 7.9 
 
       
 
 1 
   
   
1    µ  for ard-ORF primer 
1 µ  reverse-ORF primer 
100 ng yeast genomic DNA 
200 µ  of each dNTP of a nucleotide ix  
2.5 units HiFi polymerase enzyme mixture 
 
   
(a) Denaturation 94°C for 4 min 
(b) Annealing 53°C for 60 sec 
(c) Elongation 72°C for 90 sec and finish 
with a final extension at 72°C 
for 7 min 
 
   
5    nM forward extension 
5 nM reverse extension 
1 µl PCR product (from previous step) 
200 µM of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
  
6.7   µM 5’CompCy5 
10 µM library primer  
5 units Klenow fragment (3’→5’ exo-) 
1 mM of each dNTP of a nucleotide mix  
1 mM Dithiothreitol (DTT)  
50 mM NaCl  
10 mM MgCl2 
10 mM Tris-HCl, pH 7.9 
 
       
 
6. To each reaction 1 µl of final p imer mix is added (Forward final + Reverse final; each
at 1µM final concentration) and cycling continued for 30 cycles after 4 min at 94°C as
follows:
 1 
   
   
1    µM forward-ORF primer 
1 µM reverse-ORF primer 
100 g yeast genomic DNA 
200 µ  of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
   
(a) Denaturation 94°C for 4 min 
(b) Annealing 50°C for 60 sec 
(c) Elongation 72°C for 90 sec and finish 
with a final extension at 72°C 
for 7 min 
 
   
5    n  forward xtension 
 n  reverse extension 
 µl PCR product (from previous step) 
2 0 µ  of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
  
6.7   µM 5’CompCy5 
10 µM library primer  
5 units Klenow fragment (3’→5’ exo-) 
1 mM of each dNTP of a nucleotide mix  
1 mM Dithiothreitol (DTT)  
50 mM NaCl  
10 mM MgCl2 
10 mM Tris-HCl, pH 7.9 
 
       
 
7. The final product can be used directly in ITT reactions or purified on spin columns and
eluted in 100 µl 10 mM TrisCl (pH 8.5).
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A.4.4.2 Synthesis of target DNA
1. Small Cy5 labeled, dsDNA oligos are synthesized by isothermal primer extension in a
reaction of a total volume of 30 µl containing:
 1 
   
   
1    µM forward-ORF primer 
1 µM reverse-ORF primer 
100 ng yeast genomic DNA 
200 µM of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
   
(a) Denaturation 94°C for 4 min 
(b) Annealing 53°C for 60 sec 
(c) Elongation 72°C for 90 sec 
 
   
5    nM forward extension 
5 nM reverse extension 
1 µl PCR product (from previous step) 
200 µM of each dNTP of a nucleotide mix  
2.5 units HiFi polymerase enzyme mixture 
 
   
6.7   µM 5’CompCy5 
10 µM library primer  
5 units Klenow fragment (3’→5’ exo-) 
1 mM of each dNTP of a nucleotide mix  
1 mM Dithiothreitol (DTT)  
50 mM NaCl  
10 mM MgCl2 
10 mM Tris-HCl, pH 7.9 
 
       
 
2. All reactions are incubated at 37°C for 1 h followed by 20 min at 72°C and a final
annealing gradient down to 30°C at a rate of 0.1°C/sec.
3. After the synthesis, 70 µl of a 0.5% BSA dH2O solution are added to each reaction.
4. The entire volume is then transferred to a 384 well plate and a 6 fold dilution series
prepared with final concentrations of 5’CompCy5 of 2 µM, 600 nM, 180 nM, 54 nM, 16
nM and 5 nM (see Note 2).
A.4.5 Microarraying / Spotting
Spotting target DNA onto epoxy-coated microscope slides is performed by a QArray2 DNA
microarrayer.
1. Before each spotting routine an Eppendorf or Falcon tube filled with DI water and the
spotting pins is submerged in a sonicator water bath to clean the pins. During the
spotting routine a sterilizing loop (1 sec DI water, followed by 1 sec air drying) between
different DNA samples keeps pins clean throughout the spotting procedure.
2. Sample plate(s) of target DNA are placed in an external source plate stacker before
starting the spotting routine (see Note 3).
3. The dilution series for each target DNA sequence is spotted as a microarray with a
column and row pitch of 373 µm and 746 µm, respectively.
4. Spotted arrays are aligned manually to a tape-cleaned PDMS device (see A.4.2) on a
Nikon SMZ1500 stereoscope and bonded overnight in an incubator at 40°C.
5. DNA arrays can be stored in a sealed box protected from light and dust at room
temperature for several weeks.
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Appendix A. MITOMI - A microfluidic platform for in vitro characterization of
transcription factor-DNA interactions
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Figure A.3: Setup of the experiment. (A) Schematic of fluidic control set-up using regulated pressure and
manually controlled manifolds. (B) Photograph of an assembled MITOMI device placed on the stage of a
microscope where flexible tubing (Tygon) is connected via metal pins to the inlets that actuate the control lines on
the device (magnified insert). The tubing is filled with DI water displacing the air in the channels when actuated
with pneumatic pressure that is controlled with manifolds. Each reagent for the on-chip experiment is filled into a
pin-end flexible tube (Tygon) and connected to the flow inlets. The pressure of the flow can be controlled with a
gauge.
A.4.6 On-chip experiment (surface chemistry & MITOMI)
A.4.6.1 Mounting MITOMI device to microfluidic control elements
1. The assembled device is mounted on a light microscope and connected to tubing (for
details see Figure A.3).
2. Control channels are filled with DI water by actuation with ∼5 psi of pneumatic pressure
which forces the air from the dead-end channels into the bulk porous silicone. This
procedure eliminates subsequent gas transfer into the flow layer upon valve actuation,
as well as prevents evaporation of the liquid contained in the flow layer.
3. Devices are actuated with 15 to 20 psi in the control lines and between 5 and 8 psi for
the flow line.
4. Upon actuation button membrane and sandwich valves are opened again; chamber
valves remain closed during the following initial surface derivatization steps to prevent
liquid from entering the sample containing chambers.
A.4.6.2 Surface chemistry
The surface area within the flow channels of the device is modified by depositing layers
of BSA-biotin, NA/PBS, and biotinylated antibody onto the epoxy coated glass slide (see
Figure A.4). Using a syringe the different sample solutions are loaded into short pieces
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(30-40 cm) of clean Tygon tubing which are hooked to a metal pin that is then pushed into
the corresponding flow sample inlet holes (see Figure A.2).
1. Tubing with 30 µl of BSA-biotin is inserted into the sample inlet hole S6. The port on
manifold 2 for flow inlet regulation (see Figure A.3) is actuated and valves are opened
by switching the corresponding toggles on manifold 1 in the following order: valve 6
controlling sample flow inlet S6, equalizer (1), array inlet (8).
2. Once the air in the channels of the array is displaced with liquid, the outlet valve (O) is
opened and the equalizer valve (1) opened.
3. After flowing BSA-biotin for ∼20 min the array inlet valve (8) and the sample valve (6)
are closed again and the port on manifold 2 turned off.
4. The tubing is disconnected from the port of manifold 2.
5. The process of valve and port opening / closing is performed for the following samples.
6. After BSA-biotin derivatization the surface area is washed for 2-3 min with 5 µl PBS
(S7).
7. A 30 µl solution of NA/PBS (S5) is flowed for ∼20 min and washed again for 2-3 min
with 5 µl PBS.
8. The button membrane (B) is closed and PBS washing continued for 1 min (∼2 µl)
making sure button is closed.
9. The remaining surface area is passivated with 30 µl BSA-biotin (∼20 min) and washed
with 5 µl PBS (2-3 min) while button is actuated.
10. 30 µl of a 1:1 solution of biotinylated penta-His antibody in 2% BSA is loaded (S4). To
ensure that all channels are saturated with antibody solution the button membrane is
opened only after flowing 5 µl.
11. After finishing the antibody deposition (total ∼20 min), the surface is washed again with
5 µl PBS for 2-3 min.
12. The surface derivatization procedure is finished with a final 5 µl PBS washing step (see
Note 4).
A.4.6.3 DNA pull-down & detection of interactions on-chip
1. 25 µl TNT T7 coupled wheat germ extract is prepared and spiked with 1 µl tRNALys-
Bodipy-Fl and 2 µl of linear expression ready template coding for the appropriate
transcription factor (TF).
2. The mixture is immediately loaded onto the device (S3) and flushed for 10 µl (around
5-7 min) while the button membrane is closed.
3. Chamber valves (C) are opened and the outlet valve (O) is closed to allow for dead
end filling of the chambers with wheat germ extract.
4. Chamber valves are closed and the outlet valve opened again and flushing is continued
for an additional 10 µl (5-7 min).
5. Sandwich valves (S) that separate each unit cell are closed.
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transcription factor-DNA interactions
Transcription 
Factor 
Penta-His
Antibody
Cy5-labeled
Target DNA
PDMS 
membrane
Epoxy 
glass slide Surface chemistry layers of
BSA-biotin / Neutravidin / BSA -biotin
Microfluidic 
channel
(10-14 µm)
1 Binding in equilibrium state 2 Mechanical Trapping 3 Washing unbound molecules
Figure A.4: Schematic of the MITOMI principle. The gray structure at the top of each panel represents the
deflectable button membrane that can be brought into contact with the glass surface. (1) His-tagged TFs are
localized to immobilized penta-His antibody at the epoxy-coated glass slide. Specific binding between Cy5-labeled
target DNA and TFs are at steady state when (2) the button membrane is actuated and brought into contact with
the surface. Any molecules in solution are expelled while surface-bound material is mechanically trapped. (3)
Unbound material that was not physically protected is washed away, and the remaining molecules are quantified.
6. After ensuring that all sandwich valves are closed the chamber valves and button
membranes are opened.
7. The device is incubated for 90 min at room temperature to allow for protein synthesis
and diffusion of the samples to the immobilized antibody under the button membrane.
8. After the incubation period the device is scanned on a modified ArrayWoRx microarray
scanner.
9. Button membranes are closed to trap bound samples.
10. Chamber valves are closed, sandwich valves opened and the channels washed with
10 µl PBS (5-7 min).
11. The washed device is scanned once more with closed button membranes to detect the
trapped molecules.
A.4.7 Data acquisition & analysis
1. For each experiment two images are analyzed with GenePix3.0 (Molecular Devices):
The first image, taken directly after the 60-90 min incubation period before washing, is
used to determine the concentration of solution phase or total target DNA concentration
(Cy5 channel). The second image, taken after MITOMI and the final PBS wash, is
used to determine the concentration of surface bound protein (FITC channel) as well
as surface bound target DNA (Cy5 channel).
2. Dissociation equilibrium constants can be calculated for each experiment using a
curve fitting software (e.g. Graphpad Prism5 or Mathematica) by performing global
nonlinear regression fits using a one site binding model to the data plotted as surface
bound target DNA (RFU) divided by surface protein concentration (RFU) (or effectively
fractional occupancy) as a function of total target DNA concentration in RFU (see
Figure A.5)
3. Relative Kd (RFU−1) must be transformed into absolute Kd (M−1) using a calibration
curve previously established by measuring known quantities of 5’CompCy5 primer.
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Figure A.5: Steps to analysis of MITOMI experiments. (A) Fluorescence scans of subsequent MITOMI steps.
Scan of immobilized, fluorescence labeled protein (Top), solubilized target DNA (Middle), and surface bound
target DNA after mechanical trapping and washing step (Bottom). (B) The fraction of surface bound target DNA
is plotted against concentration of target DNA in solution. Dissociation constants are determined by performing a
nonlinear regression fit using a one site binding model.
4. The change of free Gibbs energy (∆∆G) with ∆∆G = RT ln(Kd ,re f ) is calculated at a
temperature of 298 K, where the highest affinity sequence serves as the reference.
A.5 Notes
1. Linear expression templates can also be synthesized from bacterial cDNA clones after
lysing them in 2.5 µl Lyse n’Go buffer (Pierce) at 95°C for 7 min. The lysate serves as
template in an Expand High Fidelity PCR reaction (Roche). The first PCR product is
then purified using the Qiaquick 96 PCR purification kit (Qiagen) and eluted in 80 µl of
10 mM TrisCl, pH 8.5.
2. The on-chip DNA concentration can be increased by raising the numbers of repetitive
stamps of sample DNA per spot during the spotting routine (multiple returns of spotting
pin to the same spot)
3. The humidity inside the spotter is set to 65-80% to prevent the samples in the source
plate from evaporating during long spotting routines (> 2 h).
4. An additional passivation step can be included by flowing 5 µl BSA-biotin for 2-3
min after the antibody immobilization, then closing the button, followed by 2-3 min
of 5 µl BSA-biotin. This additional BSA-biotin passivation step was found to reduce
background signal.
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B Primer library
B.1 Primers for Drosophila TF-array
Table B.1: Universal primers for amplification of ORF-GST fragment from pF3A-WG-GST vector.
Name, Length, Sequence
Abbreviation (Comment)
5’-forward, 23 bp 5’-GTATCCGCTCATGGATCTCGATC-3’
sp6-for-10down (primes 10 bp downstream of SP6 promoter)
3’-reverse, 22 bp 5’-CGGTTTTATGGACAGCAAGCGA-3’
sp6-rev-24up (primes 24 bp upstream of T7 terminator)
Table B.2: Gene-specific primer sequences of target DNA.
TF name Sequence (5’-clamp - TF-consensus motif - 5’-extension-3’)
bcd 5’-CGCGGATTAGCTCCGGCGGTATGAC-3’
D 5’-CGCGTCCATTGTTCTCTCCGGCGGTATGAC-3’
gt 5’-CGCGTCCATTGTTCTCTCCGGCGGTATGAC-3’
kni 5’-CGCAAAACTAGAGCAACTCCGGCGGTATGAC-3’
Kr 5’-CGCTAACCCTTTTGCTCCGGCGGTATGAC-3’
Mad 5’-CGCGCTGCCGGCGCGGCCTCCGGCGGTATGAC-3’
Med 5’-CGCAACAGGCGAAACTCCGGCGGTATGAC-3’
pan 5’-CGCCTTTGATCCTCCGGCGGTATGAC-3’
prd 5’-CGCCCAATTTGTCACGCTCTCCGGCGGTATGAC-3’
tin 5’-CGCCTCAAGTGCTCCGGCGGTATGAC-3’
ttk 5’-CGCATTATCCTGGCTCCGGCGGTATGAC-3’
twi 5’-CGCCCCGCATATGTTGCTCCGGCGGTATGAC-3’
5’-CompCy5 5’-[Cy5]GTCATACCGCCGGA-3’
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B.2 Primers to generate linear templates from yeast cells
Table B.3: Yeast cell MORF-plasmid (BG1805) collection
 20 
A Appendix – Primer library 
Primer sequences used to generate ITT linear templates  
Yeast cell MORF-plasmid (BG1805) collection 
  
Name, Abbreviation 
(Comment), Length Sequence 
MORF forward extension 
MORF-WG-SP6-FW 
(used in 2-step, 1.5-step 
and single-step  PCR),  
94 bp 
5’-[GATCTTAAGGCTAGAGTAC][ATTTAGGTGACACTATAGAAGGGG] 
[GAATACAAGCTACTTGTTCTTTTTGCA][gtacaaaaaagcaggcacAAAATG]-3’ 
 
5’-[5’-Final-overhang (19bp)][SP6 promoter with overhang (24bp)] 
[beta-globin(27 bp)][BG1805-plasmid-specific incl. Kozak+Start (24 bp)]-3’ 
MORF forward extension 
MORF-WG-T7-FW 
(used in 2-step, 1.5-step 
and single-step  PCR),  
89 bp 
5’-[GATCTTAAGGCTAGAGTAC][TAATACGACTCACTATAGG] 
[GAATACAAGCTACTTGTTCTTTTTGCA][gtacaaaaaagcaggcacAAAATG]-3’ 
 
5’-[5’-Final-overhang (19bp)][T7 promoter (19bp)] 
[beta-globin (27bp)][BG1805-plasmid-specific incl. Kozak+Start (24 bp)]-3’ 
MORF reverse extension 
MORF-WG-RV 
(used in 2-step, 1.5-step 
and single-step  PCR),  
123 bp 
5’-[CAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGGGTTATGCTAG] 
[TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT][gtagcagcctgagtcg][TTATTAA] 
[GCATAATCAGGAACATCGTATG]-3’ 
 
5-[T7-terminator incl. 3-Final-overhang (48bp)] 
[Poly(A)-track][linker sequence (30bp)][2xSTOP (6pb)] 
[BG1850-plasmid-specific (23bp)]-3’ 
Gene-specific forward  
MORF-attB-FW 
(primes in attB region of 
BG1805 plasmid), 24 bp 
5’-gtacaaaaaagcaggcacAAAATG-3’ 
 
5’-[BG1805-plasmid-specific + KOZAK + START]-3’ 
Gene-specific reverse 
MORF-HA-RV 
(primes after HA-tag in 
BG1805 plasmid), 29 bp 
5’-TTATTAAGCATAATCAGGAACATCGTATG-3’ 
 
5’-[2 x STOP + BG1805-plasmid-specific]-3’ 
Final forward 
5’-Final-FW, 19 bp 
5’-GATCTTAAGGCTAGAGTAC-3’ 
Final reverse 
3’-Final-RV, 18 bp 
5’-CAAAAAACCCCTCAAGAC-3’ 
!
WG primers designed for cell-free protein expression with TNT Wheat Germ ITT kits
(Promega)
113
C Protein Purification
C.1 Buffers
Table C.1: Buffers for protein purification under native conditions.
Buffer Chemicals
Stock buffer 50 mM NaH2PO4; 0.3 M NaCl; pH 8.0
Lysis buffer 10 mM imidazole; 50 mM NaH2PO4; 0.3 M NaCl; pH 8.0
Wash buffer 20 mM imidazole; 50 mM NaH2PO4; 0.3 M NaCl; pH 8.0
Elution buffer 250 mM imidazole; 50 mM NaH2PO4; 0.3 M NaCl; pH 8.0
Add 0.05% Tween 20 (5 ml of a 10% Tween 20 stock solution). All buffers adjusted to pH 8.0
using NaOH.
Table C.2: Buffers for protein purification under denaturing conditions.
Buffer Chemicals
Stock buffer 0.1 M NaH2PO4; 0.01 M Tris-Cl; pH 8.0
Lysis buffer 8 M urea; 0.1 M NaH2PO4; 0.01 M Tris-Cl; pH 8.0
Wash buffer 8 M urea; 0.1 M NaH2PO4; 0.01 M Tris-Cl; pH 6.3
Elution buffer 1 8 M urea; 0.1 M NaH2PO4; 0.01 M Tris-Cl; pH 5.9
Elution buffer 2 8 M urea; 0.1 M NaH2PO4; 0.01 M Tris-Cl; pH 4.5
All buffers adjusted immediately prior to use using NaOH (pH 8.0) and HCl (all other pH).
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C.2 SDS-PAGE
C.2.1 SDS gels
SDS gels were casted using the following protocol for 13.5% gels.
Running gel solution (pH 8.8)
6.0 ml 40% Acrylamide/Bisacrylamide (37.5 : 1 cross-linker ratio)
7.5 ml 1 M Tris/HCl, pH 8.8
0.2 ml 10% SDS
0.1 ml 10% APS
6.1 ml DI water
20.0 ml total
10 µl TEMED (added when ready to cast)
Ammonium persulfate was prepared freshly, and stored at 4°C for max. 1 week.
Acrylamide/bisacrylamide solutions were kept in the dark.
Stacking Gel Solution (pH 6.8)
10 ml 40% Acrylamide/Bisacrylamide (37.5 : 1 cross-linker ratio)
1.25 ml 1 M Tris/HCl, pH 6.8
0.1 ml 10% SDS
50 µl 10% APS
7.6 ml DI water
10.0 ml total
5 µl TEMED (added when ready to cast)
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C.2.2 SDS PAGE - Buffer System (Laemmli)
Sample Buffer (SDS Reducing Buffer) - added to protein pellet
3.55 ml deionized water
0.625 ml 1 M Tris-HCl, pH 6.8 (6 g Tris base in 60 ml DI water)
3.15 ml glycerol
2.0 ml 10% (w/v) SDS (10 g/100 ml)
0.2 ml 0.5% (w/v) Bromophenol Blue
9.5 ml total
50 µl β-mercaptoethanol (BME) was added to 950 µl sample buffer prior to use. Sample
(protein pellet) was diluted at least 1:2 with sample buffer and heated at 95°C for 4 minutes.
10x Electrode (Running) Buffer, pH 8.3 (1 L)
30.3 g Tris base
144 g glycine
10 g SDS
1 L DI water
Kept at 4°C. If precipitation occurred, warmed up to room temperature before use. 50 ml of
10x stock were added to 450 ml deionized water for each electrophoresis run.
Coomassie staining solution
50% MeOH
10% Acetic Acid
0.05% Brilliant Blue R-250 (dissolved in methanol)
Destaining solution 50% MeOH
40% milli-Q water
10% Acetic Acid
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D Antibodies
D.1 Primary antibodies
Table D.1: Primary antibodies (biotinylated) for on-chip protein pulldown used in chapter 4
 1 
antibody name 
(Epitope) 
supplier 
(art. no.) 
isotype 
used for 
yeast 
collection 
on-chip 
dilution 
(conc.) 
Western 
blot 
dilution 
(conc.) 
anti-GFP 
antibody 
(Biotin) 
abcam 
(ab6658) 
IgG goat 
polyclonal GFP 
1:100               
(10 µg/ml)  
anti-GST 
antibody 
(Biotin) 
abcam 
(ab71283) 
IgG goat 
polyclonal GST 
1:100               
(10 µg/ml) 
1:2,000           
(0.5 µg/ml) 
anti-protein A 
antibody 
(Biotin) 
abcam 
(ab18598) 
IgY chicken 
polyclonal MORF 
1:20                 
(50 µg/ml) 
1:2,000           
(0.4 µg/ml) 
anti-HA 
antibody 
(Biotin) 
abcam 
(ab26228) 
IgG rabbit 
polyclonal MORF 
1:100               
(10 µg/ml)  
Penta-His 
Biotin 
Conjugate 
Qiagen 
(34440) 
IgG1 mouse 
monoclonal MORF 
1:50                   
(4 µg/ml) 
1:2,000           
(0.1 µg/ml) 
 
antibody name 
(Epitope) 
supplier 
(art. no.) 
isotype 
used for 
yeast 
collection 
on-chip 
dilution 
(conc.) 
anti-GST 
antibody (FITC) 
abcam 
(ab71283) 
IgG goat 
polyclonal GST  
anti-GST 
antibody (Hilyte 
Fluor 647) 
abcam 
(ab64370) 
IgG2a mouse 
monoclonal GST  
Penta-His 
Alexa Fluor 
488 Conj. 
Qiagen 
(35310) 
IgG1 mouse 
monoclonal 
MORF 
GST 
1:200      
(1 µg/ml) 
Penta-His 
Alexa Fluor 
555 Conj. 
Qiagen 
(35350) 
IgG1 mouse 
monoclonal 
MORF 
GST 
1:200      
(1 µg/ml) 
Penta-His 
Alexa Fluor 
647 Conj. 
Qiagen 
(35370) 
IgG1 mouse 
monoclonal 
MORF 
GST 
1:200       
(1 µg/ml) 
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D.2 Secondary antibodies
Table D.2: Secondary antibodies (fluorescence-labeled) for on-chip protein detection used in chapter 4
 1 
antibody name 
(Epitope) 
supplier 
(art. no.) 
isotype 
used for 
yeast 
collection 
on-chip 
dilution 
(conc.) 
Western 
blot 
dilution 
(conc.) 
anti-GFP 
antibody 
(Biotin) 
abcam 
(ab6658) 
IgG goat 
polyclonal GFP 
1:100               
(10 µg/ml)  
anti-GST 
antibody 
(Biotin) 
abcam 
(ab71283) 
IgG goat 
polyclonal GST 
1:100               
(10 µg/ml) 
1:2,000           
(0.5 µg/ml) 
anti-protein A 
antibody 
(Biotin) 
abcam 
(ab18598) 
IgY chicken 
polyclonal MORF 
1:20                 
(50 µg/ml) 
1:2,000           
(0.4 µg/ml) 
anti-HA 
antibody 
(Biotin) 
abcam 
(ab26228) 
IgG rabbit 
polyclonal MORF 
1:100               
(10 µg/ml)  
Penta-His 
Biotin 
Conjugate 
Qiagen 
(34440) 
IgG1 mouse 
monoclonal MORF 
1:50                   
(4 µg/ml) 
1:2,000           
(0.1 µg/ml) 
 
antibody name 
(Epitope) 
supplier 
(art. no.) 
isotype 
used for 
yeast 
collection 
on-chip 
dilution 
(conc.) 
anti-GST 
antibody (FITC) 
abcam 
(ab71283) 
IgG goat 
polyclonal GST  
anti-GST 
antibody (Hilyte 
Fluor 647) 
abcam 
(ab64370) 
IgG2a mouse 
monoclonal GST  
Penta-His 
Alexa Fluor 
488 Conj. 
Qiagen 
(35310) 
IgG1 mouse 
monoclonal 
MORF 
GST 
1:200      
(1 µg/ml) 
Penta-His 
Alexa Fluor 
555 Conj. 
Qiagen 
(35350) 
IgG1 mouse 
monoclonal 
MORF 
GST 
1:200      
(1 µg/ml) 
Penta-His 
Alexa Fluor 
647 Conj. 
Qiagen 
(35370) 
IgG1 mouse 
monoclonal 
MORF 
GST 
1:200       
(1 µg/ml) 
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E Plasmid Purification Protocols
All plasmid purification steps from E. coli overnight cultures in LB medium were carried out at
room temperature using Qiagen plasmid purification kits.
E.1 Plasmid DNA Purification using the QIAprep Spin Miniprep
Kit
All centrifugation steps were carried out at room temperature with 14,680 rpm in a conven-
tional table-top microcentrifuge (Eppendorf 5424).
1. Pellet 1-5 ml bacterial overnight culture by centrifugation at 10,000 rpm for 3 min at
room temperature (15-25°C).
2. Resuspend pelleted bacterial cells in 250 µl Buffer P1 (with RNase A solution added)
and transfer to a microcentrifuge tube.
3. Add 250 µl Buffer P2 and mix thoroughly by inverting the tube 4-6 times until the
solution becomes clear. Do not allow the lysis reaction to proceed for more than 5 min.
If using LyseBlue (1 to 1000 in buffer P1) reagent, the solution will turn blue.
4. Add 350 µl Buffer N3 and mix immediately and thoroughly by inverting the tube 4-6
times. If using LyseBlue reagent, the solution will turn colorless.
5. Centrifuge for 10 min.
6. Apply the supernatant from step 5 to the QIAprep spin column by decanting or pipetting.
Centrifuge for 30-60 s and discard the flow-through.
7. Wash the QIAprep spin column by adding 0.75 ml Buffer PE (with 96% ethanol added
before use). Centrifuge for 30-60 s and discard the flow-through. Transfer the QIAprep
spin column to the collection tube.
8. Centrifuge for 1 min to remove residual wash buffer.
9. Place the QIAprep column in a clean 1.5 ml microcentrifuge tube. To elute DNA, add
50 µl Buffer EB (10 mM Tris-Cl, pH 8.5) or water to the center of the QIAprep spin
column, let stand for 1 min, and centrifuge for 1 min.
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E.2 Plasmid DNA Purification using the QIAprep 96 Turbo Miniprep
Kit
1. Resuspend pelleted bacterial cells in 250 µl Buffer P1 and transfer to the flat bottom
block (if cells were not harvested in this block) provided with the kit.
2. Add 250 µl Buffer P2 to each sample. Dry the top of the flat-bottom block with a paper
towel, seal the block with the tape provided, gently invert the block 4-6 times to mix,
and incubate at room temperature for 5 min. It is important to mix gently by inverting
the block. Do not shake vigorously, as this will result in shearing of genomic DNA. If
necessary, continue inverting the block until the solution becomes viscous and slightly
clear.
3. Remove the tape from the block. Add 350 µl Buffer N3 to each sample, dry the top
of the flat-bottom block with a paper towel, and seal the block with a new tape sheet.
Gently invert the block 4-6 times.
4. Remove the tape from the block. Pipet the lysates from step 3 (850 µl per well) into the
wells of the TurboFilter plate. Unused wells of the TurboFilter plate should be sealed
with tape. Apply vacuum until all samples have passed through.
5. Switch off vacuum and ventilate the QIAvac 96 slowly. Discard the TurboFilter plate.
Transfer the QIAprep plate containing the cleared lysates to the top plate of the manifold.
Seal any unused wells of the QIAprep plate with tape.
6. Replace plate holder in the base with waste tray. Place the top plate squarely over
the base, making sure that the QIAprep plate is seated securely. Apply vacuum. The
flow-through is collected in the waste tray.
7. Switch off vacuum. Wash QIAprep plate by adding 0.9 ml of Buffer PE to each well
and applying vacuum. Repeat once.
8. After Buffer PE has been drawn through all wells, apply maximum vacuum for an
additional 10 min to dry the membrane. Important: This step removes residual Buffer
PE from the membrane. The removal is only effective when maximum vacuum is used
9. Switch off vacuum, and ventilate the QIAvac 96 slowly. Lift the top plate from the base
(not the QIAprep plate from the top plate), vigorously tap the top plate on a stack of
absorbent paper until no drops come out, and blot the nozzles of the QIAprep plate
with clean absorbent paper to remove residual ethanol from the buffer PE.
10. Replace waste tray with an empty blue collection microtube rack (provided with the
QIAvac 96). Place a 96-well microplate directly on the rack. Place the top plate back
on the base, making sure that the QIAprep plate is positioned securely.
11. To elute DNA, add 100 µl of Buffer EB (10 mM Tris-Cl, pH 8.5) or water to the center
of each well of the QIAprep plate, let stand for 1 min, and apply maximum vacuum
for 5 min. Switch off vacuum and ventilate QIAvac 96 slowly. For increased DNA
concentration, an elution volume of 75 µl can be used.
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Glossary
Antibody Protein produced by certain cells of the immune system as response to a foreign
substance (antigen). Since an antibody binds specifically to only one antigen, engineered or
isolated antibodies can be used to detect or label other proteins or cells.
cDNA (complementary DNA) The DNA complement of an mRNA sequence, synthesized
using reverse transcriptase.
Cell The smallest structural unit of living matter capable of functioning independently; a mi-
croscopic mass of protoplasm surrounded by a semi-permeable membrane, usually including
one or more nuclei and various non-living products, capable - either alone or by interacting
with other cells - of performing all the fundamental functions of life.
Chip A semiconductor device cut from a silicon wafer. Refers also to a microfluidic de-
vice.
ChIP as an abbreviation stands for chromatin immunoprecipitation and is technique used
to determine specific interactions between proteins and DNA in vivo (inside a cell) by fixing
proteins and associated chromatin in the cell lysate and purification of the DNA-protein
complex with a specific antibody.
DamID (DNA adenine methyltransferase identification) Methylation-based chromatin pro-
filing method, in which DNA binding sites are identified by expressing the DNA-binding
protein as a fusion protein with DNA methyltransferase, which transfers a methyl group from
S-adenosyl-methionine (SAM). Since this process does not occur naturally in eukaryotes,
adenine methylation in a fusion protein of interest implies that the region is near a binding site.
DBD DNA binding domains are protein domains containing a specific motif that recog-
nizes a specific DNA sequence. All transcription factors contain at least one DBD. Diffusion
The movement of molecules from a region of higher concentration to a region of lower
concentration.
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DNA (deoxyribonucleic acid) The chain-like molecule, that stores and transmits genetic
information, is composed of two strands running anti-parallel to each other, which are twisted
into a double helical conformation.
DNA footprinting is a laboratory technique used to study where and how proteins and
other ligands bind to DNA.
DNA polymerase Enzyme that catalyzes the synthesis of double-stranded DNA, using
single-stranded DNA as a template.
Drosophila melanogaster The full name of a species of fruit fly that is widely used in
genetic research as a eukaryotic model organism. Of the nearly 300 disease-causing genes
in the human genome, more than half have an analogous gene in the Drosophila genome.
E. coli (Escherichia coli) Bacterium inhabiting the colon of many animal species, including
human. E. coli is widely used as a model of cell biochemical function, and as a host for
cloning DNA.
Electrophoresis A method of separating molecules by their movement within an electric
field. The medium used is usually an agarose or polyacrylamide gel through which the
molecules move.
Eukaryote Organisms that have their DNA in a nucleus enclosed by a membrane.
Exon Part of a eukaryotic gene that is transcribed and translated into a protein.
Gene Conceptually, the unit of heredity transmitted from generation to generation during sex-
ual or asexual reproduction. More generally, the term is used in relation to the transmission
and inheritance of particular identifiable traits. Since the molecular revolution, it is now known
that a gene is a segment of nucleic acid that encodes peptide or RNA.
Gene expression The process by which a gene produces RNA and protein, and hence
exerts its effects on the phenotype of an organism.
Genome The complete set of genetic material (genes and non-coding sequences) of an
organism, virus or organelle, encoded in DNA or in RNA (some viruses) and inherited in its
entirety through a set of chromosomes from the parents.
Genomics Is a discipline that uses molecular characterization to understand the struc-
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ture, function and evolution of genes through.
Genetics (from Greek "genesis" meaning "origin") is the science of genes and heredity.
GRN (gene regulatory network) describes the collection of direct and indirect molecu-
lar interactions between oligonucleotide sequences (DNA and RNA) and other molecules in
a cell, which govern the transcription rate of DNA.
Induction Process that triggers downstream effects such as transcription of a specific
gene or synthesis of a specific protein through a physical or chemical stimuli.
In silico coined in analogy to commonly used Latin phrases in biology (in vitro, in vivo,
in situ), meaning "performed on a computer or by computer simulation" as opposed to in
biological experiments. In silico experiments became an essential part within the emerging
field of systems biology to handle the growing amount of sequence and interaction databases.
In situ (from Latin meaning "in position") In biology and bioengineering it refers to the
examination of an organism, cell, tissue, phenomenon or reaction, where it occurs without
moving it to another location.
In vitro Cells growing in culture as opposed to in an organism (in vivo).
In vivo In an intact cell or organism (antonym to in vitro).
Kd abbreviation for dissociation constant, which characterizes the strength of binding (affinity)
between molecules at equilibrium and is the inverse of the association constant Km .
Klenow fragment A truncated from of the enzyme DNA polymerase I from E. coli, which
lost its 5′ → 3′ exonuclease activity and is therefore used frequently for the production of
synthetic DNA.
Km abbreviation for association constant or Michaelis constant that describes the substrate
concentration at its half maximum reaction rate in a Michaelis-Menten kinetic enzymatic
model. As an inverse of the dissociation constant Kd , the Km value is smaller for tighter
binding of enzymes to the substrates.
Kozak (consensus) sequence nucleotide sequence in eukaryotic mRNA with the con-
sensus, which is recognized by the ribosome as the start side for protein translation.
Lab-on-a-chip Device that integrates one or several laboratory functions on a single chip of
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only millimeters to a few square centimeters in size.
Major groove As the twin helical strands, which form the DNA backbone, are not directly
opposite to each other, the width between the strands, or grooves, are not identical. The
major groove is 10 Å wider than the minor groove and allows better accessibility of binding
proteins, such as TFs.
Mask Typically a transparent substrate with a pattern on its surface defined in an opaque
material (chrome metal or ink) used in photolithography.
Microfabrication Term to describe the fabrication and patterning of structures in the microm-
eter range. Adapted from the semiconductor industry, these methodologies are increasingly
used for bioengineering applications.
Microfluidics Fluidics in micrometers-sized channels that are characterized by a laminar
flow regime.
Microtechnology The fabrication and application of materials, structures and systems
with micron or submicron-scale features.
Microwell array Array of miniaturized wells with diameters and a depths of a few tens
to hunders micrometers.
Minor groove see major groove
mRNA (messenger RNA)The RNA transcript of a protein-encoding gene. The informa-
tion encoded in the mRNA molecule is translated into a polypeptide of specific amino acid
sequence by the ribosomes. In eukaryotes, mRNAs transfer genetic information from the
DNA to ribosomes, where it is translated into protein.
ORF The open reading frame is a DNA sequence without a stop codon, which often used to
predict the presence a gene or protein-coding regions.
PBM A protein-binding microarray is a high-throughput method to detect protein interactions
and determine their function. Based on the DNA microarray technology for genomics studies,
DNA oligonucleotides are immobilized to a solid support (generally a glass slide) and interro-
gated with proteins for a proteomics approach.
PCR Polymerase chain reactions are a widespread molecular biology procedure that al-
lows the production of multiple copies (amplification) of a specific DNA sequence, provided
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that the base pair sequence of each end of the target is known. It involves multiple cycles
of DNA denaturation, primer annealing, and strand extension, and requires a thermostable
DNA polymerase, deoxyribonucleotides, and specific oligonucleotides (primers).
PDMS Poly(dimethylsiloxane). An elastomeric silicone polymer that is commercially available
and has properties that make it well suited to applications in microbiology.
Photolithography A process used to transfer a pattern from a mask onto a thin film of
photosensitive polymer (photoresist) and then onto the surface of a substrate. Photolithogra-
phy is commonly used in semiconductor fabrication to fabricate integrated circuits.
Photoresist A photoreactive polymer that undergoes chemical changes that lead to changes
in physical properties (such as solubility) after exposure to ultraviolet light.
Plasmid Non-chromosomal, double-stranded DNA molecule that can replicate itself au-
tonomously in a host cell and which are naturally found in many bacteria. Plasmids vary
in sizes between 1 and 1000 kbp and often carry an antibiotic resistance genes are fre-
quently located on plasmids. Because of their simple modes of modification and transfer
between bacterial cells, plasmids are particularly important as vectors for genetic engineering.
Primer A short DNA fragment that anneals to a template of single-stranded DNA or RNA and
thereby provides a starting point from which DNA polymerase extends a new DNA strand to
produce a duplex molecule.
Promoter A specific region of DNA located near a gene, recognized by RNA polymerase for
the initiation of gene transcription.
Proteome The entire set of proteins expressed by a genome particular cell type, tissue
or organism, including all modifications. The term "proteome" is a mix of the words "protein"
and "genome" and reflects the interplay between material containing genetic information and
proteins on a systems level.
Proteomics The entire set of proteins expressed by a genome particular cell type, tis-
sue or organism. Coined in 1997 in analogy to "genomics" it generally refers to large-scale
protein analysis.
PWM In biology a position weight matrix or position-specific scoring matrix is a representation
of DNA binding or consensus sequence that a protein binds to and is usually visualized as a
sequence logo.
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RNA Ribonucleic acid. An organic acid composed of repeating nucleotide units of ade-
nine, guanine, cytosine and uracil, whose ribose components are linked by phospho-diester
bonds. RNA is the only information-carrying material in some viruses.
RNA polymerase is an enzyme that initiates the transcription the genetic information from
double-stranded DNA onto a single strand of RNA through binding to a specific region of
DNA, known as promoter.
Saccharomyces cerevisiae is a species of yeast often used as a simple eukaryotic model
organism in molecular and cell biology, which is naturally found on ripe fruits.
SDS-PAGE Abbreviation for sodium dodecyl sulfate polyacrylamide gel electrophoresis,
a technique used to separate proteins according to their electrophoretic mobility, a function
of the length and charge of the polypeptide chain, which migrate through an inert matrix
(polyacrylamide gel) as a result of an imposed electric field and reside at a position that can
be correlated to their size.
SELEX stands for Systematic Evolution of Ligands by EXponential enrichment and is also re-
ferred to a in vitro selection or in vitro evolution. A combinatorial technique used in molecular
biology to select for oligonucleotide sequences that bind specifically and with high affinity to
target ligands.
Sequence logo Graphical representation of nucleotide sequences (in one strand of DNA or
RNA) to which proteins bind with a high probability (often referred to as binding motif). Also
used to display amino acids in protein sequences.
Soft lithography A set of techniques that makes microstructures by printing, moulding
and embossing using a patterned, elastomeric stamp or mould, and/or a polymeric substrate.
Spin coating A process for depositing uniform layers of polymer on a substrate. Rotat-
ing the substrate at a high speed spreads the material uniformly over the surface. The
viscosity of the material and the rotational velocity of the substrate control the thickness of
the layer of material; surface tension flattens the surface of the spun film.
TMCS Trimethylchlorosilane, used as anti-adhesive in microfabrication.
Terminator Specific DNA sequence downstream of a genes coding region that is recognized
by RNA polymerase as a signal to stop transcription.
Transcription Process of RNA synthesis from a DNA template via the enzyme RNA poly-
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merase, in which the genetic information is copied from a double-stranded (DNA) to a
single-stranded oligonucleotide (RNA), enabling the transport to the place of translation.
Transcription factor A protein that binds to specific DNA sequences and regulates the
transcription of genes by either activation or repression.
Translation Final process of protein synthesis, in which genetic information in the form
of nucleotides on mRNA is translated or decoded into specific amino acids, which are carried
by the mediator molecule tRNA and chained together into a specific amino acid sequence
when the mRNA passes through the ribosome. The growing chain of amino acids forms a
polypeptide and finally folds into an active protein.
tRNA each transfer RNA carries a specific amino acids to the ribosome during protein
translation, where it recognizes a specific codon in the mRNA.
UTR In molecular genetics, the untranslated region refers to either the 5’UTR or the 3’UTR,
which are sections flanking the 5’ or 3’ side, respectively, of a coding sequence (CDS) on a
mRNA strand.
Vector A plasmid or phage that is used to deliver selected foreign DNA for cloning and
in gene transfer.
Wafer Thin disk usually made of pure silicon that is used as substrate for microfabrica-
tion.
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